id	sid	tid	token	lemma	pos
iajs-3765	1	1	265	265	NUM
iajs-3765	1	2	©	©	PROPN
iajs-3765	1	3	2025	2025	NUM
iajs-3765	1	4	the	the	DET
iajs-3765	1	5	author(s	author(s	NOUN
iajs-3765	1	6	)	)	PUNCT
iajs-3765	1	7	.	.	PUNCT
iajs-3765	2	1	published	publish	VERB
iajs-3765	2	2	by	by	ADP
iajs-3765	2	3	college	college	NOUN
iajs-3765	2	4	of	of	ADP
iajs-3765	2	5	education	education	NOUN
iajs-3765	2	6	for	for	ADP
iajs-3765	2	7	pure	pure	ADJ
iajs-3765	2	8	science	science	NOUN
iajs-3765	2	9	(	(	PUNCT
iajs-3765	2	10	ibn	ibn	PROPN
iajs-3765	2	11	al	al	PROPN
iajs-3765	2	12	-	-	PUNCT
iajs-3765	2	13	haitham	haitham	PROPN
iajs-3765	2	14	)	)	PUNCT
iajs-3765	2	15	,	,	PUNCT
iajs-3765	2	16	university	university	NOUN
iajs-3765	2	17	of	of	ADP
iajs-3765	2	18	baghdad	baghdad	PROPN
iajs-3765	2	19	.	.	PUNCT
iajs-3765	3	1	this	this	PRON
iajs-3765	3	2	is	be	AUX
iajs-3765	3	3	an	an	DET
iajs-3765	3	4	open	open	ADJ
iajs-3765	3	5	-	-	PUNCT
iajs-3765	3	6	access	access	NOUN
iajs-3765	3	7	article	article	NOUN
iajs-3765	3	8	distributed	distribute	VERB
iajs-3765	3	9	under	under	ADP
iajs-3765	3	10	the	the	DET
iajs-3765	3	11	terms	term	NOUN
iajs-3765	3	12	of	of	ADP
iajs-3765	3	13	the	the	DET
iajs-3765	3	14	creative	creative	ADJ
iajs-3765	3	15	commons	common	NOUN
iajs-3765	3	16	attribution	attribution	NOUN
iajs-3765	3	17	4.0	4.0	NUM
iajs-3765	3	18	international	international	ADJ
iajs-3765	3	19	license	license	NOUN
iajs-3765	3	20	evaluation	evaluation	NOUN
iajs-3765	3	21	of	of	ADP
iajs-3765	3	22	some	some	DET
iajs-3765	3	23	biochemical	biochemical	ADJ
iajs-3765	3	24	factors	factor	NOUN
iajs-3765	3	25	associated	associate	VERB
iajs-3765	3	26	with	with	ADP
iajs-3765	3	27	rheumatoid	rheumatoid	NOUN
iajs-3765	3	28	arthritis	arthritis	NOUN
iajs-3765	3	29	tabarak	tabarak	PROPN
iajs-3765	3	30	siraj	siraj	PROPN
iajs-3765	3	31	ibrahim	ibrahim	PROPN
iajs-3765	3	32	1	1	NUM
iajs-3765	3	33	and	and	CCONJ
iajs-3765	3	34	bushra	bushra	PROPN
iajs-3765	3	35	faris	faris	PROPN
iajs-3765	3	36	hasan	hasan	PROPN
iajs-3765	3	37	2	2	NUM
iajs-3765	3	38	*	*	SYM
iajs-3765	3	39	1,2	1,2	NUM
iajs-3765	3	40	department	department	NOUN
iajs-3765	3	41	of	of	ADP
iajs-3765	3	42	chemistry	chemistry	NOUN
iajs-3765	3	43	,	,	PUNCT
iajs-3765	3	44	college	college	NOUN
iajs-3765	3	45	of	of	ADP
iajs-3765	3	46	science	science	NOUN
iajs-3765	3	47	for	for	ADP
iajs-3765	3	48	women	woman	NOUN
iajs-3765	3	49	,	,	PUNCT
iajs-3765	3	50	university	university	NOUN
iajs-3765	3	51	of	of	ADP
iajs-3765	3	52	baghdad	baghdad	PROPN
iajs-3765	3	53	,	,	PUNCT
iajs-3765	3	54	baghdad	baghdad	PROPN
iajs-3765	3	55	,	,	PUNCT
iajs-3765	3	56	iraq	iraq	PROPN
iajs-3765	3	57	.	.	PUNCT
iajs-3765	4	1	*	*	PUNCT
iajs-3765	4	2	corresponding	correspond	VERB
iajs-3765	4	3	author	author	NOUN
iajs-3765	4	4	.	.	PUNCT
iajs-3765	5	1	received	receive	VERB
iajs-3765	5	2	:	:	PUNCT
iajs-3765	5	3	29	29	NUM
iajs-3765	5	4	september	september	PROPN
iajs-3765	5	5	2023	2023	NUM
iajs-3765	5	6	accepted	accept	VERB
iajs-3765	5	7	:	:	PUNCT
iajs-3765	5	8	2	2	NUM
iajs-3765	5	9	january	january	NOUN
iajs-3765	5	10	2024	2024	NUM
iajs-3765	5	11	published	publish	VERB
iajs-3765	5	12	:	:	PUNCT
iajs-3765	5	13	20	20	NUM
iajs-3765	5	14	july	july	PROPN
iajs-3765	5	15	2025	2025	NUM
iajs-3765	5	16	doi.org/10.30526/38.3.3765	doi.org/10.30526/38.3.3765	PROPN
iajs-3765	5	17	abstract	abstract	ADJ
iajs-3765	5	18	rheumatoid	rheumatoid	VERB
iajs-3765	5	19	arthritis	arthritis	NOUN
iajs-3765	5	20	(	(	PUNCT
iajs-3765	5	21	ra	ra	NOUN
iajs-3765	5	22	)	)	PUNCT
iajs-3765	5	23	is	be	AUX
iajs-3765	5	24	a	a	DET
iajs-3765	5	25	systemic	systemic	ADJ
iajs-3765	5	26	disease	disease	NOUN
iajs-3765	5	27	that	that	PRON
iajs-3765	5	28	causes	cause	VERB
iajs-3765	5	29	chronic	chronic	ADJ
iajs-3765	5	30	inflammation	inflammation	NOUN
iajs-3765	5	31	,	,	PUNCT
iajs-3765	5	32	primarily	primarily	ADV
iajs-3765	5	33	affecting	affect	VERB
iajs-3765	5	34	the	the	DET
iajs-3765	5	35	synovial	synovial	ADJ
iajs-3765	5	36	joints	joint	NOUN
iajs-3765	5	37	in	in	ADP
iajs-3765	5	38	the	the	DET
iajs-3765	5	39	hands	hand	NOUN
iajs-3765	5	40	and	and	CCONJ
iajs-3765	5	41	feet	foot	NOUN
iajs-3765	5	42	.	.	PUNCT
iajs-3765	6	1	laboratory	laboratory	NOUN
iajs-3765	6	2	investigations	investigation	NOUN
iajs-3765	6	3	,	,	PUNCT
iajs-3765	6	4	such	such	ADJ
iajs-3765	6	5	as	as	ADP
iajs-3765	6	6	c	c	NOUN
iajs-3765	6	7	-	-	PUNCT
iajs-3765	6	8	reactive	reactive	ADJ
iajs-3765	6	9	protein	protein	NOUN
iajs-3765	6	10	(	(	PUNCT
iajs-3765	6	11	crp	crp	PROPN
iajs-3765	6	12	)	)	PUNCT
iajs-3765	6	13	,	,	PUNCT
iajs-3765	6	14	erythrocyte	erythrocyte	NOUN
iajs-3765	6	15	sedimentation	sedimentation	NOUN
iajs-3765	6	16	rate	rate	NOUN
iajs-3765	6	17	(	(	PUNCT
iajs-3765	6	18	esr	esr	PROPN
iajs-3765	6	19	)	)	PUNCT
iajs-3765	6	20	,	,	PUNCT
iajs-3765	6	21	lipid	lipid	NOUN
iajs-3765	6	22	profile	profile	NOUN
iajs-3765	6	23	,	,	PUNCT
iajs-3765	6	24	and	and	CCONJ
iajs-3765	6	25	matrix	matrix	NOUN
iajs-3765	6	26	metalloproteinase-1	metalloproteinase-1	PROPN
iajs-3765	6	27	(	(	PUNCT
iajs-3765	6	28	mmp-1	mmp-1	NOUN
iajs-3765	6	29	)	)	PUNCT
iajs-3765	6	30	,	,	PUNCT
iajs-3765	6	31	evaluate	evaluate	VERB
iajs-3765	6	32	the	the	DET
iajs-3765	6	33	body	body	NOUN
iajs-3765	6	34	's	's	PART
iajs-3765	6	35	inflammation	inflammation	ADJ
iajs-3765	6	36	level	level	NOUN
iajs-3765	6	37	.	.	PUNCT
iajs-3765	7	1	rheumatoid	rheumatoid	NOUN
iajs-3765	7	2	arthritis	arthritis	NOUN
iajs-3765	7	3	is	be	AUX
iajs-3765	7	4	generally	generally	ADV
iajs-3765	7	5	progressive	progressive	ADJ
iajs-3765	7	6	,	,	PUNCT
iajs-3765	7	7	causing	cause	VERB
iajs-3765	7	8	fatigue	fatigue	NOUN
iajs-3765	7	9	and	and	CCONJ
iajs-3765	7	10	weakening	weakening	NOUN
iajs-3765	7	11	of	of	ADP
iajs-3765	7	12	the	the	DET
iajs-3765	7	13	muscle	muscle	NOUN
iajs-3765	7	14	joints	joint	NOUN
iajs-3765	7	15	.	.	PUNCT
iajs-3765	8	1	despite	despite	SCONJ
iajs-3765	8	2	recent	recent	ADJ
iajs-3765	8	3	treatment	treatment	NOUN
iajs-3765	8	4	improvements	improvement	NOUN
iajs-3765	8	5	,	,	PUNCT
iajs-3765	8	6	there	there	PRON
iajs-3765	8	7	is	be	VERB
iajs-3765	8	8	no	no	DET
iajs-3765	8	9	known	know	VERB
iajs-3765	8	10	cure	cure	NOUN
iajs-3765	8	11	for	for	ADP
iajs-3765	8	12	ra	ra	PROPN
iajs-3765	8	13	.	.	PUNCT
iajs-3765	9	1	the	the	DET
iajs-3765	9	2	study	study	NOUN
iajs-3765	9	3	aims	aim	VERB
iajs-3765	9	4	to	to	PART
iajs-3765	9	5	find	find	VERB
iajs-3765	9	6	the	the	DET
iajs-3765	9	7	role	role	NOUN
iajs-3765	9	8	of	of	ADP
iajs-3765	9	9	chemokine	chemokine	ADJ
iajs-3765	9	10	mmp-1	mmp-1	PUNCT
iajs-3765	9	11	as	as	ADP
iajs-3765	9	12	a	a	DET
iajs-3765	9	13	biomarker	biomarker	NOUN
iajs-3765	9	14	in	in	ADP
iajs-3765	9	15	serum	serum	NOUN
iajs-3765	9	16	samples	sample	NOUN
iajs-3765	9	17	of	of	ADP
iajs-3765	9	18	80	80	NUM
iajs-3765	9	19	patients	patient	NOUN
iajs-3765	9	20	with	with	ADP
iajs-3765	9	21	ra	ra	PROPN
iajs-3765	9	22	and	and	CCONJ
iajs-3765	9	23	40	40	NUM
iajs-3765	9	24	healthy	healthy	ADJ
iajs-3765	9	25	subjects	subject	NOUN
iajs-3765	9	26	.	.	PUNCT
iajs-3765	10	1	the	the	DET
iajs-3765	10	2	mean	mean	NOUN
iajs-3765	10	3	of	of	ADP
iajs-3765	10	4	mmp-1	mmp-1	PUNCT
iajs-3765	10	5	was	be	AUX
iajs-3765	10	6	significantly	significantly	ADV
iajs-3765	10	7	higher	high	ADJ
iajs-3765	10	8	in	in	ADP
iajs-3765	10	9	patients	patient	NOUN
iajs-3765	10	10	with	with	ADP
iajs-3765	10	11	ra	ra	PROPN
iajs-3765	10	12	compared	compare	VERB
iajs-3765	10	13	to	to	ADP
iajs-3765	10	14	the	the	DET
iajs-3765	10	15	control	control	NOUN
iajs-3765	10	16	group	group	NOUN
iajs-3765	10	17	(	(	PUNCT
iajs-3765	10	18	mmp-1	mmp-1	NOUN
iajs-3765	10	19	:	:	PUNCT
iajs-3765	10	20	3.27	3.27	NUM
iajs-3765	10	21	±	±	NUM
iajs-3765	10	22	0.10	0.10	NUM
iajs-3765	10	23	ng	ng	NOUN
iajs-3765	10	24	/	/	SYM
iajs-3765	10	25	ml	ml	X
iajs-3765	10	26	vs.	vs.	ADP
iajs-3765	10	27	1.40	1.40	NUM
iajs-3765	10	28	±	±	NUM
iajs-3765	10	29	0.11	0.11	NUM
iajs-3765	10	30	ng	ng	PROPN
iajs-3765	10	31	/	/	SYM
iajs-3765	10	32	ml	ml	PROPN
iajs-3765	10	33	,	,	PUNCT
iajs-3765	10	34	respectively	respectively	ADV
iajs-3765	10	35	)	)	PUNCT
iajs-3765	10	36	.	.	PUNCT
iajs-3765	11	1	the	the	DET
iajs-3765	11	2	results	result	NOUN
iajs-3765	11	3	demonstrated	demonstrate	VERB
iajs-3765	11	4	a	a	DET
iajs-3765	11	5	statistically	statistically	ADV
iajs-3765	11	6	significant	significant	ADJ
iajs-3765	11	7	distinction	distinction	NOUN
iajs-3765	11	8	between	between	ADP
iajs-3765	11	9	the	the	DET
iajs-3765	11	10	two	two	NUM
iajs-3765	11	11	groups	group	NOUN
iajs-3765	11	12	.	.	PUNCT
iajs-3765	12	1	the	the	DET
iajs-3765	12	2	binary	binary	PROPN
iajs-3765	12	3	logistic	logistic	PROPN
iajs-3765	12	4	regression	regression	NOUN
iajs-3765	12	5	analysis	analysis	NOUN
iajs-3765	12	6	revealed	reveal	VERB
iajs-3765	12	7	that	that	SCONJ
iajs-3765	12	8	mmp-1	mmp-1	PUNCT
iajs-3765	12	9	had	have	VERB
iajs-3765	12	10	a	a	DET
iajs-3765	12	11	statistically	statistically	ADV
iajs-3765	12	12	significant	significant	ADJ
iajs-3765	12	13	association	association	NOUN
iajs-3765	12	14	with	with	ADP
iajs-3765	12	15	the	the	DET
iajs-3765	12	16	occurrence	occurrence	NOUN
iajs-3765	12	17	of	of	ADP
iajs-3765	12	18	ra	ra	PROPN
iajs-3765	12	19	.	.	PUNCT
iajs-3765	13	1	additionally	additionally	ADV
iajs-3765	13	2	,	,	PUNCT
iajs-3765	13	3	it	it	PRON
iajs-3765	13	4	was	be	AUX
iajs-3765	13	5	shown	show	VERB
iajs-3765	13	6	that	that	SCONJ
iajs-3765	13	7	mmp-1	mmp-1	PUNCT
iajs-3765	13	8	had	have	VERB
iajs-3765	13	9	an	an	DET
iajs-3765	13	10	area	area	NOUN
iajs-3765	13	11	under	under	ADP
iajs-3765	13	12	the	the	DET
iajs-3765	13	13	curve	curve	NOUN
iajs-3765	13	14	of	of	ADP
iajs-3765	13	15	0.939	0.939	NUM
iajs-3765	13	16	in	in	ADP
iajs-3765	13	17	people	people	NOUN
iajs-3765	13	18	diagnosed	diagnose	VERB
iajs-3765	13	19	with	with	ADP
iajs-3765	13	20	ra	ra	PROPN
iajs-3765	13	21	.	.	PUNCT
iajs-3765	14	1	both	both	PRON
iajs-3765	14	2	of	of	ADP
iajs-3765	14	3	these	these	DET
iajs-3765	14	4	experiments	experiment	NOUN
iajs-3765	14	5	provided	provide	VERB
iajs-3765	14	6	evidence	evidence	NOUN
iajs-3765	14	7	of	of	ADP
iajs-3765	14	8	this	this	DET
iajs-3765	14	9	result	result	NOUN
iajs-3765	14	10	.	.	PUNCT
iajs-3765	15	1	according	accord	VERB
iajs-3765	15	2	to	to	ADP
iajs-3765	15	3	the	the	DET
iajs-3765	15	4	findings	finding	NOUN
iajs-3765	15	5	of	of	ADP
iajs-3765	15	6	the	the	DET
iajs-3765	15	7	study	study	NOUN
iajs-3765	15	8	,	,	PUNCT
iajs-3765	15	9	there	there	PRON
iajs-3765	15	10	is	be	VERB
iajs-3765	15	11	a	a	DET
iajs-3765	15	12	possibility	possibility	NOUN
iajs-3765	15	13	that	that	SCONJ
iajs-3765	15	14	mmp-1	mmp-1	PUNCT
iajs-3765	15	15	has	have	AUX
iajs-3765	15	16	a	a	DET
iajs-3765	15	17	role	role	NOUN
iajs-3765	15	18	in	in	ADP
iajs-3765	15	19	the	the	DET
iajs-3765	15	20	pathogenesis	pathogenesis	NOUN
iajs-3765	15	21	of	of	ADP
iajs-3765	15	22	ra	ra	PROPN
iajs-3765	15	23	since	since	SCONJ
iajs-3765	15	24	it	it	PRON
iajs-3765	15	25	was	be	AUX
iajs-3765	15	26	shown	show	VERB
iajs-3765	15	27	that	that	SCONJ
iajs-3765	15	28	patients	patient	NOUN
iajs-3765	15	29	with	with	ADP
iajs-3765	15	30	ra	ra	PROPN
iajs-3765	15	31	had	have	VERB
iajs-3765	15	32	higher	high	ADJ
iajs-3765	15	33	levels	level	NOUN
iajs-3765	15	34	of	of	ADP
iajs-3765	15	35	serum	serum	NOUN
iajs-3765	15	36	mmp-1	mmp-1	NOUN
iajs-3765	15	37	,	,	PUNCT
iajs-3765	15	38	crp	crp	PROPN
iajs-3765	15	39	,	,	PUNCT
iajs-3765	15	40	esr	esr	PROPN
iajs-3765	15	41	,	,	PUNCT
iajs-3765	15	42	and	and	CCONJ
iajs-3765	15	43	lipid	lipid	NOUN
iajs-3765	15	44	profile	profile	NOUN
iajs-3765	15	45	when	when	SCONJ
iajs-3765	15	46	compared	compare	VERB
iajs-3765	15	47	to	to	ADP
iajs-3765	15	48	the	the	DET
iajs-3765	15	49	control	control	NOUN
iajs-3765	15	50	group	group	NOUN
iajs-3765	15	51	.	.	PUNCT
iajs-3765	16	1	in	in	ADP
iajs-3765	16	2	conclusion	conclusion	NOUN
iajs-3765	16	3	,	,	PUNCT
iajs-3765	16	4	serum	serum	NOUN
iajs-3765	16	5	mmp-1	mmp-1	PUNCT
iajs-3765	16	6	serves	serve	VERB
iajs-3765	16	7	as	as	ADP
iajs-3765	16	8	a	a	DET
iajs-3765	16	9	reliable	reliable	ADJ
iajs-3765	16	10	diagnostic	diagnostic	ADJ
iajs-3765	16	11	marker	marker	NOUN
iajs-3765	16	12	,	,	PUNCT
iajs-3765	16	13	accurately	accurately	ADV
iajs-3765	16	14	distinguishing	distinguish	VERB
iajs-3765	16	15	individuals	individual	NOUN
iajs-3765	16	16	with	with	ADP
iajs-3765	16	17	active	active	ADJ
iajs-3765	16	18	ra	ra	PROPN
iajs-3765	16	19	from	from	ADP
iajs-3765	16	20	control	control	NOUN
iajs-3765	16	21	subjects	subject	NOUN
iajs-3765	16	22	.	.	PUNCT
iajs-3765	17	1	keywords	keyword	NOUN
iajs-3765	17	2	:	:	PUNCT
iajs-3765	17	3	c	c	X
iajs-3765	17	4	-	-	PUNCT
iajs-3765	17	5	reactive	reactive	ADJ
iajs-3765	17	6	protein	protein	NOUN
iajs-3765	17	7	,	,	PUNCT
iajs-3765	17	8	lipid	lipid	NOUN
iajs-3765	17	9	profile	profile	NOUN
iajs-3765	17	10	,	,	PUNCT
iajs-3765	17	11	matrix	matrix	NOUN
iajs-3765	17	12	metalloproteinase-1	metalloproteinase-1	PROPN
iajs-3765	17	13	,	,	PUNCT
iajs-3765	17	14	rheumatoid	rheumatoid	NOUN
iajs-3765	17	15	arthritis	arthritis	NOUN
iajs-3765	17	16	,	,	PUNCT
iajs-3765	17	17	rheumatoid	rheumatoid	NOUN
iajs-3765	17	18	factor	factor	NOUN
iajs-3765	17	19	.	.	PUNCT
iajs-3765	18	1	1	1	X
iajs-3765	18	2	.	.	X
iajs-3765	18	3	introduction	introduction	NOUN
iajs-3765	18	4	rheumatoid	rheumatoid	NOUN
iajs-3765	18	5	arthritis	arthritis	NOUN
iajs-3765	18	6	(	(	PUNCT
iajs-3765	18	7	ra	ra	NOUN
iajs-3765	18	8	)	)	PUNCT
iajs-3765	18	9	is	be	AUX
iajs-3765	18	10	an	an	DET
iajs-3765	18	11	inflammatory	inflammatory	ADJ
iajs-3765	18	12	disease	disease	NOUN
iajs-3765	18	13	that	that	PRON
iajs-3765	18	14	affects	affect	VERB
iajs-3765	18	15	the	the	DET
iajs-3765	18	16	entire	entire	ADJ
iajs-3765	18	17	body	body	NOUN
iajs-3765	18	18	,	,	PUNCT
iajs-3765	18	19	causing	cause	VERB
iajs-3765	18	20	long	long	ADJ
iajs-3765	18	21	-	-	PUNCT
iajs-3765	18	22	term	term	NOUN
iajs-3765	18	23	inflammation	inflammation	NOUN
iajs-3765	18	24	of	of	ADP
iajs-3765	18	25	the	the	DET
iajs-3765	18	26	synovial	synovial	ADJ
iajs-3765	18	27	membrane	membrane	NOUN
iajs-3765	18	28	and	and	CCONJ
iajs-3765	18	29	gradual	gradual	ADJ
iajs-3765	18	30	degradation	degradation	NOUN
iajs-3765	18	31	of	of	ADP
iajs-3765	18	32	the	the	DET
iajs-3765	18	33	joints	joint	NOUN
iajs-3765	18	34	.	.	PUNCT
iajs-3765	19	1	this	this	DET
iajs-3765	19	2	condition	condition	NOUN
iajs-3765	19	3	ultimately	ultimately	ADV
iajs-3765	19	4	leads	lead	VERB
iajs-3765	19	5	to	to	ADP
iajs-3765	19	6	a	a	DET
iajs-3765	19	7	decline	decline	NOUN
iajs-3765	19	8	in	in	ADP
iajs-3765	19	9	physical	physical	ADJ
iajs-3765	19	10	ability	ability	NOUN
iajs-3765	19	11	,	,	PUNCT
iajs-3765	19	12	work	work	NOUN
iajs-3765	19	13	-	-	PUNCT
iajs-3765	19	14	related	relate	VERB
iajs-3765	19	15	limitations	limitation	NOUN
iajs-3765	19	16	,	,	PUNCT
iajs-3765	19	17	and	and	CCONJ
iajs-3765	19	18	a	a	DET
iajs-3765	19	19	reduced	reduce	VERB
iajs-3765	19	20	overall	overall	ADJ
iajs-3765	19	21	quality	quality	NOUN
iajs-3765	19	22	of	of	ADP
iajs-3765	19	23	life	life	NOUN
iajs-3765	19	24	)	)	PUNCT
iajs-3765	19	25	1	1	NUM
iajs-3765	19	26	)	)	PUNCT
iajs-3765	19	27	.	.	PUNCT
iajs-3765	20	1	the	the	DET
iajs-3765	20	2	global	global	ADJ
iajs-3765	20	3	incidence	incidence	NOUN
iajs-3765	20	4	of	of	ADP
iajs-3765	20	5	ra	ra	PROPN
iajs-3765	20	6	remains	remain	VERB
iajs-3765	20	7	inadequately	inadequately	ADV
iajs-3765	20	8	characterized	characterize	VERB
iajs-3765	20	9	due	due	ADP
iajs-3765	20	10	to	to	ADP
iajs-3765	20	11	the	the	DET
iajs-3765	20	12	lack	lack	NOUN
iajs-3765	20	13	of	of	ADP
iajs-3765	20	14	comprehensive	comprehensive	ADJ
iajs-3765	20	15	epidemiological	epidemiological	ADJ
iajs-3765	20	16	studies	study	NOUN
iajs-3765	20	17	conducted	conduct	VERB
iajs-3765	20	18	across	across	ADP
iajs-3765	20	19	different	different	ADJ
iajs-3765	20	20	geographical	geographical	ADJ
iajs-3765	20	21	regions	region	NOUN
iajs-3765	20	22	.	.	PUNCT
iajs-3765	21	1	nevertheless	nevertheless	ADV
iajs-3765	21	2	,	,	PUNCT
iajs-3765	21	3	it	it	PRON
iajs-3765	21	4	has	have	AUX
iajs-3765	21	5	been	be	AUX
iajs-3765	21	6	suggested	suggest	VERB
iajs-3765	21	7	that	that	SCONJ
iajs-3765	21	8	the	the	DET
iajs-3765	21	9	occurrence	occurrence	NOUN
iajs-3765	21	10	of	of	ADP
iajs-3765	21	11	ra	ra	PROPN
iajs-3765	21	12	is	be	AUX
iajs-3765	21	13	approximately	approximately	ADV
iajs-3765	21	14	3	3	NUM
iajs-3765	21	15	times	time	NOUN
iajs-3765	21	16	more	more	ADV
iajs-3765	21	17	common	common	ADJ
iajs-3765	21	18	in	in	ADP
iajs-3765	21	19	women	woman	NOUN
iajs-3765	21	20	compared	compare	VERB
iajs-3765	21	21	to	to	ADP
iajs-3765	21	22	men	man	NOUN
iajs-3765	21	23	)	)	PUNCT
iajs-3765	21	24	2–4	2–4	NUM
iajs-3765	21	25	)	)	PUNCT
iajs-3765	21	26	.	.	PUNCT
iajs-3765	22	1	https://orcid.org/0009-0009-4983-347x	https://orcid.org/0009-0009-4983-347x	ADJ
iajs-3765	22	2	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	ADJ
iajs-3765	22	3	https://orcid.org/0000-0002-4766-6120	https://orcid.org/0000-0002-4766-6120	ADJ
iajs-3765	22	4	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3765	22	5	https://orcid.org/0009-0009-4983-347x	https://orcid.org/0009-0009-4983-347x	ADP
iajs-3765	22	6	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	ADP
iajs-3765	22	7	https://orcid.org/0000-0002-4766-6120	https://orcid.org/0000-0002-4766-6120	ADJ
iajs-3765	22	8	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3765	22	9	https://orcid.org/0009-0009-4983-347x	https://orcid.org/0009-0009-4983-347x	SCONJ
iajs-3765	22	10	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	ADP
iajs-3765	22	11	https://orcid.org/0000-0002-4766-6120	https://orcid.org/0000-0002-4766-6120	ADJ
iajs-3765	22	12	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3765	22	13	https://orcid.org/0009-0009-4983-347x	https://orcid.org/0009-0009-4983-347x	SCONJ
iajs-3765	22	14	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	ADP
iajs-3765	22	15	https://orcid.org/0000-0002-4766-6120	https://orcid.org/0000-0002-4766-6120	ADJ
iajs-3765	22	16	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3765	22	17	https://orcid.org/0009-0009-4983-347x	https://orcid.org/0009-0009-4983-347x	SCONJ
iajs-3765	22	18	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	ADP
iajs-3765	22	19	https://orcid.org/0000-0002-4766-6120	https://orcid.org/0000-0002-4766-6120	ADJ
iajs-3765	22	20	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3765	22	21	https://orcid.org/0009-0009-4983-347x	https://orcid.org/0009-0009-4983-347x	ADJ
iajs-3765	22	22	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	mailto:tabarak.seraj2305m@csw.uobaghdad.edu.iq	ADP
iajs-3765	22	23	https://orcid.org/0000-0002-4766-6120	https://orcid.org/0000-0002-4766-6120	ADJ
iajs-3765	22	24	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3765	22	25	ihjpas	ihjpa	NOUN
iajs-3765	22	26	.	.	PUNCT
iajs-3765	23	1	2025	2025	NUM
iajs-3765	23	2	,	,	PUNCT
iajs-3765	23	3	38(3	38(3	NUM
iajs-3765	23	4	)	)	PUNCT
iajs-3765	23	5	266	266	NUM
iajs-3765	23	6	inflammatory	inflammatory	ADJ
iajs-3765	23	7	arthritis	arthritis	NOUN
iajs-3765	23	8	,	,	PUNCT
iajs-3765	23	9	which	which	PRON
iajs-3765	23	10	often	often	ADV
iajs-3765	23	11	affects	affect	VERB
iajs-3765	23	12	the	the	DET
iajs-3765	23	13	tiny	tiny	ADJ
iajs-3765	23	14	joints	joint	NOUN
iajs-3765	23	15	in	in	ADP
iajs-3765	23	16	the	the	DET
iajs-3765	23	17	hands	hand	NOUN
iajs-3765	23	18	and	and	CCONJ
iajs-3765	23	19	feet	foot	NOUN
iajs-3765	23	20	,	,	PUNCT
iajs-3765	23	21	is	be	AUX
iajs-3765	23	22	its	its	PRON
iajs-3765	23	23	primary	primary	ADJ
iajs-3765	23	24	symptom	symptom	NOUN
iajs-3765	23	25	.	.	PUNCT
iajs-3765	24	1	it	it	PRON
iajs-3765	24	2	is	be	AUX
iajs-3765	24	3	characterized	characterize	VERB
iajs-3765	24	4	by	by	ADP
iajs-3765	24	5	symmetric	symmetric	ADJ
iajs-3765	24	6	,	,	PUNCT
iajs-3765	24	7	polyarticular	polyarticular	ADJ
iajs-3765	24	8	pain	pain	NOUN
iajs-3765	24	9	and	and	CCONJ
iajs-3765	24	10	swelling	swelling	NOUN
iajs-3765	24	11	.	.	PUNCT
iajs-3765	25	1	on	on	ADP
iajs-3765	25	2	the	the	DET
iajs-3765	25	3	other	other	ADJ
iajs-3765	25	4	hand	hand	NOUN
iajs-3765	25	5	,	,	PUNCT
iajs-3765	25	6	it	it	PRON
iajs-3765	25	7	is	be	AUX
iajs-3765	25	8	a	a	DET
iajs-3765	25	9	systemic	systemic	ADJ
iajs-3765	25	10	disease	disease	NOUN
iajs-3765	25	11	linked	link	VERB
iajs-3765	25	12	to	to	ADP
iajs-3765	25	13	numerous	numerous	ADJ
iajs-3765	25	14	concomitant	concomitant	ADJ
iajs-3765	25	15	diseases	disease	NOUN
iajs-3765	25	16	and	and	CCONJ
iajs-3765	25	17	extra	extra	ADJ
iajs-3765	25	18	-	-	ADJ
iajs-3765	25	19	articular	articular	ADJ
iajs-3765	25	20	symptoms	symptom	NOUN
iajs-3765	25	21	.	.	PUNCT
iajs-3765	26	1	inflammatory	inflammatory	ADJ
iajs-3765	26	2	synovitis	synovitis	PROPN
iajs-3765	26	3	develops	develop	VERB
iajs-3765	26	4	as	as	ADP
iajs-3765	26	5	a	a	DET
iajs-3765	26	6	result	result	NOUN
iajs-3765	26	7	of	of	ADP
iajs-3765	26	8	the	the	DET
iajs-3765	26	9	interaction	interaction	NOUN
iajs-3765	26	10	between	between	ADP
iajs-3765	26	11	specific	specific	ADJ
iajs-3765	26	12	environmental	environmental	ADJ
iajs-3765	26	13	exposures	exposure	NOUN
iajs-3765	26	14	and	and	CCONJ
iajs-3765	26	15	genetic	genetic	ADJ
iajs-3765	26	16	factors	factor	NOUN
iajs-3765	26	17	)	)	PUNCT
iajs-3765	26	18	5,6	5,6	NUM
iajs-3765	26	19	)	)	PUNCT
iajs-3765	26	20	.	.	PUNCT
iajs-3765	27	1	before	before	SCONJ
iajs-3765	27	2	a	a	DET
iajs-3765	27	3	condition	condition	NOUN
iajs-3765	27	4	can	can	AUX
iajs-3765	27	5	be	be	AUX
iajs-3765	27	6	labeled	label	VERB
iajs-3765	27	7	as	as	ADP
iajs-3765	27	8	ra	ra	PROPN
iajs-3765	27	9	,	,	PUNCT
iajs-3765	27	10	the	the	DET
iajs-3765	27	11	illness	illness	NOUN
iajs-3765	27	12	process	process	NOUN
iajs-3765	27	13	typically	typically	ADV
iajs-3765	27	14	starts	start	VERB
iajs-3765	27	15	years	year	NOUN
iajs-3765	27	16	before	before	ADP
iajs-3765	27	17	clinically	clinically	ADV
iajs-3765	27	18	apparent	apparent	ADJ
iajs-3765	27	19	arthritis	arthritis	NOUN
iajs-3765	27	20	.	.	PUNCT
iajs-3765	28	1	it	it	PRON
iajs-3765	28	2	presents	present	VERB
iajs-3765	28	3	as	as	ADP
iajs-3765	28	4	a	a	DET
iajs-3765	28	5	continuum	continuum	NOUN
iajs-3765	28	6	that	that	PRON
iajs-3765	28	7	begins	begin	VERB
iajs-3765	28	8	with	with	ADP
iajs-3765	28	9	asymptomatic	asymptomatic	ADJ
iajs-3765	28	10	immune	immune	ADJ
iajs-3765	28	11	dysfunction	dysfunction	NOUN
iajs-3765	28	12	and	and	CCONJ
iajs-3765	28	13	proceeds	proceed	VERB
iajs-3765	28	14	through	through	ADP
iajs-3765	28	15	several	several	ADJ
iajs-3765	28	16	stages	stage	NOUN
iajs-3765	28	17	)	)	PUNCT
iajs-3765	28	18	7	7	NUM
iajs-3765	28	19	)	)	PUNCT
iajs-3765	28	20	.	.	PUNCT
iajs-3765	29	1	the	the	DET
iajs-3765	29	2	trajectory	trajectory	NOUN
iajs-3765	29	3	of	of	ADP
iajs-3765	29	4	joint	joint	ADJ
iajs-3765	29	5	erosion	erosion	NOUN
iajs-3765	29	6	is	be	AUX
iajs-3765	29	7	characterized	characterize	VERB
iajs-3765	29	8	by	by	ADP
iajs-3765	29	9	unpredictability	unpredictability	NOUN
iajs-3765	29	10	and	and	CCONJ
iajs-3765	29	11	may	may	AUX
iajs-3765	29	12	persist	persist	VERB
iajs-3765	29	13	despite	despite	SCONJ
iajs-3765	29	14	the	the	DET
iajs-3765	29	15	implementation	implementation	NOUN
iajs-3765	29	16	of	of	ADP
iajs-3765	29	17	measures	measure	NOUN
iajs-3765	29	18	to	to	PART
iajs-3765	29	19	control	control	VERB
iajs-3765	29	20	inflammation	inflammation	NOUN
iajs-3765	29	21	actively	actively	ADV
iajs-3765	29	22	)	)	PUNCT
iajs-3765	30	1	8)	8)	X
iajs-3765	30	2	.	.	PUNCT
iajs-3765	31	1	nevertheless	nevertheless	ADV
iajs-3765	31	2	,	,	PUNCT
iajs-3765	31	3	ra	ra	PROPN
iajs-3765	31	4	is	be	AUX
iajs-3765	31	5	regarded	regard	VERB
iajs-3765	31	6	as	as	ADP
iajs-3765	31	7	a	a	DET
iajs-3765	31	8	disease	disease	NOUN
iajs-3765	31	9	with	with	ADP
iajs-3765	31	10	the	the	DET
iajs-3765	31	11	possibility	possibility	NOUN
iajs-3765	31	12	of	of	ADP
iajs-3765	31	13	a	a	DET
iajs-3765	31	14	cure	cure	NOUN
iajs-3765	31	15	,	,	PUNCT
iajs-3765	31	16	particularly	particularly	ADV
iajs-3765	31	17	when	when	SCONJ
iajs-3765	31	18	diagnosed	diagnose	VERB
iajs-3765	31	19	in	in	ADP
iajs-3765	31	20	its	its	PRON
iajs-3765	31	21	initial	initial	ADJ
iajs-3765	31	22	phases	phase	NOUN
iajs-3765	31	23	and	and	CCONJ
iajs-3765	31	24	managed	manage	VERB
iajs-3765	31	25	with	with	ADP
iajs-3765	31	26	suitable	suitable	ADJ
iajs-3765	31	27	treatment	treatment	NOUN
iajs-3765	31	28	)	)	PUNCT
iajs-3765	31	29	9	9	NUM
iajs-3765	31	30	)	)	PUNCT
iajs-3765	31	31	.	.	PUNCT
iajs-3765	32	1	the	the	DET
iajs-3765	32	2	disease	disease	NOUN
iajs-3765	32	3	activity	activity	NOUN
iajs-3765	32	4	indicators	indicator	NOUN
iajs-3765	32	5	commonly	commonly	ADV
iajs-3765	32	6	used	use	VERB
iajs-3765	32	7	lack	lack	NOUN
iajs-3765	32	8	specificity	specificity	NOUN
iajs-3765	32	9	in	in	ADP
iajs-3765	32	10	the	the	DET
iajs-3765	32	11	context	context	NOUN
iajs-3765	32	12	of	of	ADP
iajs-3765	32	13	arthritis	arthritis	NOUN
iajs-3765	32	14	.	.	PUNCT
iajs-3765	33	1	novel	novel	ADJ
iajs-3765	33	2	biomarkers	biomarker	NOUN
iajs-3765	33	3	have	have	AUX
iajs-3765	33	4	been	be	AUX
iajs-3765	33	5	established	establish	VERB
iajs-3765	33	6	to	to	PART
iajs-3765	33	7	forecast	forecast	VERB
iajs-3765	33	8	the	the	DET
iajs-3765	33	9	occurrence	occurrence	NOUN
iajs-3765	33	10	of	of	ADP
iajs-3765	33	11	structural	structural	ADJ
iajs-3765	33	12	damage	damage	NOUN
iajs-3765	33	13	and	and	CCONJ
iajs-3765	33	14	disease	disease	NOUN
iajs-3765	33	15	progression	progression	NOUN
iajs-3765	33	16	in	in	ADP
iajs-3765	33	17	ra	ra	PROPN
iajs-3765	33	18	)	)	PUNCT
iajs-3765	33	19	10	10	NUM
iajs-3765	33	20	)	)	PUNCT
iajs-3765	33	21	.	.	PUNCT
iajs-3765	34	1	there	there	PRON
iajs-3765	34	2	is	be	VERB
iajs-3765	34	3	a	a	DET
iajs-3765	34	4	proposal	proposal	NOUN
iajs-3765	34	5	suggesting	suggest	VERB
iajs-3765	34	6	that	that	SCONJ
iajs-3765	34	7	the	the	DET
iajs-3765	34	8	pathophysiologic	pathophysiologic	ADJ
iajs-3765	34	9	mechanisms	mechanism	NOUN
iajs-3765	34	10	behind	behind	ADP
iajs-3765	34	11	synovial	synovial	ADJ
iajs-3765	34	12	inflammation	inflammation	NOUN
iajs-3765	34	13	and	and	CCONJ
iajs-3765	34	14	articular	articular	ADJ
iajs-3765	34	15	erosion	erosion	NOUN
iajs-3765	34	16	may	may	AUX
iajs-3765	34	17	exhibit	exhibit	VERB
iajs-3765	34	18	distinct	distinct	ADJ
iajs-3765	34	19	differences	difference	NOUN
iajs-3765	34	20	)	)	PUNCT
iajs-3765	34	21	11	11	NUM
iajs-3765	34	22	)	)	PUNCT
iajs-3765	34	23	.	.	PUNCT
iajs-3765	35	1	matrix	matrix	NOUN
iajs-3765	35	2	metalloproteinases	metalloproteinase	NOUN
iajs-3765	35	3	(	(	PUNCT
iajs-3765	35	4	mmps	mmp	NOUN
iajs-3765	35	5	)	)	PUNCT
iajs-3765	35	6	are	be	AUX
iajs-3765	35	7	a	a	DET
iajs-3765	35	8	collective	collective	NOUN
iajs-3765	35	9	of	of	ADP
iajs-3765	35	10	extracellular	extracellular	ADJ
iajs-3765	35	11	enzymes	enzyme	NOUN
iajs-3765	35	12	.	.	PUNCT
iajs-3765	36	1	during	during	ADP
iajs-3765	36	2	the	the	DET
iajs-3765	36	3	state	state	NOUN
iajs-3765	36	4	of	of	ADP
iajs-3765	36	5	normal	normal	ADJ
iajs-3765	36	6	equilibrium	equilibrium	NOUN
iajs-3765	36	7	,	,	PUNCT
iajs-3765	36	8	they	they	PRON
iajs-3765	36	9	play	play	VERB
iajs-3765	36	10	a	a	DET
iajs-3765	36	11	significant	significant	ADJ
iajs-3765	36	12	part	part	NOUN
iajs-3765	36	13	in	in	ADP
iajs-3765	36	14	the	the	DET
iajs-3765	36	15	process	process	NOUN
iajs-3765	36	16	of	of	ADP
iajs-3765	36	17	tissue	tissue	NOUN
iajs-3765	36	18	remodeling	remodeling	NOUN
iajs-3765	36	19	.	.	PUNCT
iajs-3765	37	1	however	however	ADV
iajs-3765	37	2	,	,	PUNCT
iajs-3765	37	3	in	in	ADP
iajs-3765	37	4	pathological	pathological	ADJ
iajs-3765	37	5	conditions	condition	NOUN
iajs-3765	37	6	,	,	PUNCT
iajs-3765	37	7	they	they	PRON
iajs-3765	37	8	contribute	contribute	VERB
iajs-3765	37	9	to	to	ADP
iajs-3765	37	10	the	the	DET
iajs-3765	37	11	detrimental	detrimental	ADJ
iajs-3765	37	12	process	process	NOUN
iajs-3765	37	13	of	of	ADP
iajs-3765	37	14	tissue	tissue	NOUN
iajs-3765	37	15	destruction	destruction	NOUN
iajs-3765	37	16	)	)	PUNCT
iajs-3765	37	17	12	12	NUM
iajs-3765	37	18	)	)	PUNCT
iajs-3765	37	19	.	.	PUNCT
iajs-3765	38	1	the	the	PRON
iajs-3765	38	2	mmp-1	mmp-1	PUNCT
iajs-3765	38	3	plays	play	VERB
iajs-3765	38	4	significant	significant	ADJ
iajs-3765	38	5	functions	function	NOUN
iajs-3765	38	6	in	in	ADP
iajs-3765	38	7	the	the	DET
iajs-3765	38	8	process	process	NOUN
iajs-3765	38	9	of	of	ADP
iajs-3765	38	10	bone	bone	NOUN
iajs-3765	38	11	and	and	CCONJ
iajs-3765	38	12	cartilage	cartilage	NOUN
iajs-3765	38	13	breakdown	breakdown	NOUN
iajs-3765	38	14	and	and	CCONJ
iajs-3765	38	15	disintegration	disintegration	NOUN
iajs-3765	38	16	)	)	PUNCT
iajs-3765	38	17	13	13	NUM
iajs-3765	38	18	)	)	PUNCT
iajs-3765	38	19	.	.	PUNCT
iajs-3765	39	1	the	the	DET
iajs-3765	39	2	production	production	NOUN
iajs-3765	39	3	of	of	ADP
iajs-3765	39	4	these	these	DET
iajs-3765	39	5	substances	substance	NOUN
iajs-3765	39	6	occurs	occur	VERB
iajs-3765	39	7	within	within	ADP
iajs-3765	39	8	the	the	DET
iajs-3765	39	9	inflamed	inflame	VERB
iajs-3765	39	10	joint	joint	NOUN
iajs-3765	39	11	by	by	ADP
iajs-3765	39	12	synovial	synovial	ADJ
iajs-3765	39	13	fibroblasts	fibroblast	NOUN
iajs-3765	39	14	and	and	CCONJ
iajs-3765	39	15	chondrocytes	chondrocyte	NOUN
iajs-3765	39	16	,	,	PUNCT
iajs-3765	39	17	and	and	CCONJ
iajs-3765	39	18	their	their	PRON
iajs-3765	39	19	activation	activation	NOUN
iajs-3765	39	20	is	be	AUX
iajs-3765	39	21	a	a	DET
iajs-3765	39	22	consequence	consequence	NOUN
iajs-3765	39	23	of	of	ADP
iajs-3765	39	24	cytokine	cytokine	NOUN
iajs-3765	39	25	-	-	PUNCT
iajs-3765	39	26	mediated	mediate	VERB
iajs-3765	39	27	stimulation	stimulation	NOUN
iajs-3765	39	28	)	)	PUNCT
iajs-3765	39	29	14	14	NUM
iajs-3765	39	30	)	)	PUNCT
iajs-3765	39	31	.	.	PUNCT
iajs-3765	40	1	subsequently	subsequently	ADV
iajs-3765	40	2	,	,	PUNCT
iajs-3765	40	3	they	they	PRON
iajs-3765	40	4	are	be	AUX
iajs-3765	40	5	released	release	VERB
iajs-3765	40	6	into	into	ADP
iajs-3765	40	7	the	the	DET
iajs-3765	40	8	bloodstream	bloodstream	NOUN
iajs-3765	40	9	.	.	PUNCT
iajs-3765	41	1	consequently	consequently	ADV
iajs-3765	41	2	,	,	PUNCT
iajs-3765	41	3	these	these	DET
iajs-3765	41	4	substances	substance	NOUN
iajs-3765	41	5	have	have	VERB
iajs-3765	41	6	the	the	DET
iajs-3765	41	7	potential	potential	NOUN
iajs-3765	41	8	to	to	PART
iajs-3765	41	9	serve	serve	VERB
iajs-3765	41	10	as	as	ADP
iajs-3765	41	11	a	a	DET
iajs-3765	41	12	direct	direct	ADJ
iajs-3765	41	13	indicator	indicator	NOUN
iajs-3765	41	14	of	of	ADP
iajs-3765	41	15	joint	joint	ADJ
iajs-3765	41	16	inflammation	inflammation	NOUN
iajs-3765	41	17	and	and	CCONJ
iajs-3765	41	18	damage	damage	NOUN
iajs-3765	41	19	in	in	ADP
iajs-3765	41	20	rheumatic	rheumatic	ADJ
iajs-3765	41	21	diseases	disease	NOUN
iajs-3765	41	22	,	,	PUNCT
iajs-3765	41	23	particularly	particularly	ADV
iajs-3765	41	24	ra	ra	NOUN
iajs-3765	41	25	)	)	PUNCT
iajs-3765	41	26	15	15	NUM
iajs-3765	41	27	)	)	PUNCT
iajs-3765	41	28	.	.	PUNCT
iajs-3765	42	1	matrix	matrix	NOUN
iajs-3765	42	2	metalloproteinase-1	metalloproteinase-1	NOUN
iajs-3765	42	3	is	be	AUX
iajs-3765	42	4	a	a	DET
iajs-3765	42	5	variety	variety	NOUN
iajs-3765	42	6	of	of	ADP
iajs-3765	42	7	proteins	protein	NOUN
iajs-3765	42	8	that	that	PRON
iajs-3765	42	9	break	break	VERB
iajs-3765	42	10	down	down	ADP
iajs-3765	42	11	the	the	DET
iajs-3765	42	12	majority	majority	NOUN
iajs-3765	42	13	of	of	ADP
iajs-3765	42	14	extracellular	extracellular	ADJ
iajs-3765	42	15	matrix	matrix	NOUN
iajs-3765	42	16	enzymes	enzyme	NOUN
iajs-3765	42	17	during	during	ADP
iajs-3765	42	18	organ	organ	NOUN
iajs-3765	42	19	formation	formation	NOUN
iajs-3765	42	20	,	,	PUNCT
iajs-3765	42	21	growth	growth	NOUN
iajs-3765	42	22	,	,	PUNCT
iajs-3765	42	23	and	and	CCONJ
iajs-3765	42	24	tissue	tissue	NOUN
iajs-3765	42	25	turnover	turnover	NOUN
iajs-3765	42	26	.	.	PUNCT
iajs-3765	43	1	the	the	DET
iajs-3765	43	2	mmp1	mmp1	NOUN
iajs-3765	43	3	expression	expression	NOUN
iajs-3765	43	4	and	and	CCONJ
iajs-3765	43	5	activity	activity	NOUN
iajs-3765	43	6	in	in	ADP
iajs-3765	43	7	adult	adult	NOUN
iajs-3765	43	8	tissues	tissue	NOUN
iajs-3765	43	9	are	be	AUX
iajs-3765	43	10	usually	usually	ADV
iajs-3765	43	11	very	very	ADV
iajs-3765	43	12	low	low	ADJ
iajs-3765	43	13	but	but	CCONJ
iajs-3765	43	14	are	be	AUX
iajs-3765	43	15	significantly	significantly	ADV
iajs-3765	43	16	increased	increase	VERB
iajs-3765	43	17	in	in	ADP
iajs-3765	43	18	various	various	ADJ
iajs-3765	43	19	immune	immune	NOUN
iajs-3765	43	20	-	-	PUNCT
iajs-3765	43	21	mediated	mediate	VERB
iajs-3765	43	22	conditions	condition	NOUN
iajs-3765	43	23	,	,	PUNCT
iajs-3765	43	24	such	such	ADJ
iajs-3765	43	25	as	as	ADP
iajs-3765	43	26	inflammatory	inflammatory	ADJ
iajs-3765	43	27	disorders	disorder	NOUN
iajs-3765	43	28	,	,	PUNCT
iajs-3765	43	29	that	that	PRON
iajs-3765	43	30	may	may	AUX
iajs-3765	43	31	lead	lead	VERB
iajs-3765	43	32	to	to	ADP
iajs-3765	43	33	tissue	tissue	NOUN
iajs-3765	43	34	destruction	destruction	NOUN
iajs-3765	43	35	.	.	PUNCT
iajs-3765	44	1	it	it	PRON
iajs-3765	44	2	has	have	AUX
iajs-3765	44	3	been	be	AUX
iajs-3765	44	4	abundantly	abundantly	ADV
iajs-3765	44	5	clear	clear	ADJ
iajs-3765	44	6	in	in	ADP
iajs-3765	44	7	recent	recent	ADJ
iajs-3765	44	8	years	year	NOUN
iajs-3765	44	9	that	that	SCONJ
iajs-3765	44	10	genetic	genetic	ADJ
iajs-3765	44	11	and	and	CCONJ
iajs-3765	44	12	epigenetic	epigenetic	ADJ
iajs-3765	44	13	variables	variable	NOUN
iajs-3765	44	14	contribute	contribute	VERB
iajs-3765	44	15	to	to	ADP
iajs-3765	44	16	the	the	DET
iajs-3765	44	17	development	development	NOUN
iajs-3765	44	18	of	of	ADP
iajs-3765	44	19	ra	ra	PROPN
iajs-3765	44	20	)	)	PUNCT
iajs-3765	44	21	16	16	NUM
iajs-3765	44	22	(	(	PUNCT
iajs-3765	44	23	,	,	PUNCT
iajs-3765	44	24	which	which	PRON
iajs-3765	44	25	is	be	AUX
iajs-3765	44	26	generally	generally	ADV
iajs-3765	44	27	progressive	progressive	ADJ
iajs-3765	44	28	and	and	CCONJ
iajs-3765	44	29	reduces	reduce	VERB
iajs-3765	44	30	physical	physical	ADJ
iajs-3765	44	31	functionality	functionality	NOUN
iajs-3765	44	32	,	,	PUNCT
iajs-3765	44	33	leading	lead	VERB
iajs-3765	44	34	to	to	ADP
iajs-3765	44	35	fatigue	fatigue	NOUN
iajs-3765	44	36	and	and	CCONJ
iajs-3765	44	37	weakened	weaken	VERB
iajs-3765	44	38	joints	joint	NOUN
iajs-3765	44	39	)	)	PUNCT
iajs-3765	44	40	2,17	2,17	NUM
iajs-3765	44	41	(	(	PUNCT
iajs-3765	44	42	.	.	PUNCT
iajs-3765	45	1	however	however	ADV
iajs-3765	45	2	,	,	PUNCT
iajs-3765	45	3	the	the	DET
iajs-3765	45	4	exact	exact	ADJ
iajs-3765	45	5	causes	cause	NOUN
iajs-3765	45	6	of	of	ADP
iajs-3765	45	7	ra	ra	PROPN
iajs-3765	45	8	are	be	AUX
iajs-3765	45	9	still	still	ADV
iajs-3765	45	10	not	not	PART
iajs-3765	45	11	understood	understand	VERB
iajs-3765	45	12	)	)	PUNCT
iajs-3765	45	13	18	18	NUM
iajs-3765	45	14	(	(	PUNCT
iajs-3765	45	15	.	.	PUNCT
iajs-3765	46	1	there	there	PRON
iajs-3765	46	2	are	be	VERB
iajs-3765	46	3	more	more	ADJ
iajs-3765	46	4	than	than	ADP
iajs-3765	46	5	one	one	NUM
iajs-3765	46	6	hundred	hundred	NUM
iajs-3765	46	7	different	different	ADJ
iajs-3765	46	8	varieties	variety	NOUN
iajs-3765	46	9	of	of	ADP
iajs-3765	46	10	arthritis	arthritis	NOUN
iajs-3765	46	11	,	,	PUNCT
iajs-3765	46	12	and	and	CCONJ
iajs-3765	46	13	many	many	ADJ
iajs-3765	46	14	of	of	ADP
iajs-3765	46	15	the	the	DET
iajs-3765	46	16	issues	issue	NOUN
iajs-3765	46	17	that	that	PRON
iajs-3765	46	18	affect	affect	VERB
iajs-3765	46	19	the	the	DET
iajs-3765	46	20	joints	joint	NOUN
iajs-3765	46	21	are	be	AUX
iajs-3765	46	22	similar	similar	ADJ
iajs-3765	46	23	;	;	PUNCT
iajs-3765	46	24	thus	thus	ADV
iajs-3765	46	25	,	,	PUNCT
iajs-3765	46	26	there	there	PRON
iajs-3765	46	27	are	be	VERB
iajs-3765	46	28	many	many	ADJ
iajs-3765	46	29	varied	varied	ADJ
iajs-3765	46	30	symptoms	symptom	NOUN
iajs-3765	46	31	.	.	PUNCT
iajs-3765	47	1	this	this	PRON
iajs-3765	47	2	makes	make	VERB
iajs-3765	47	3	it	it	PRON
iajs-3765	47	4	challenging	challenge	VERB
iajs-3765	47	5	to	to	PART
iajs-3765	47	6	differentiate	differentiate	VERB
iajs-3765	47	7	between	between	ADP
iajs-3765	47	8	the	the	DET
iajs-3765	47	9	diseases	disease	NOUN
iajs-3765	47	10	.	.	PUNCT
iajs-3765	48	1	laboratory	laboratory	NOUN
iajs-3765	48	2	investigations	investigation	NOUN
iajs-3765	48	3	for	for	ADP
iajs-3765	48	4	ra	ra	PROPN
iajs-3765	48	5	include	include	VERB
iajs-3765	48	6	blood	blood	NOUN
iajs-3765	48	7	tests	test	NOUN
iajs-3765	48	8	that	that	PRON
iajs-3765	48	9	evaluate	evaluate	VERB
iajs-3765	48	10	the	the	DET
iajs-3765	48	11	body	body	NOUN
iajs-3765	48	12	's	's	PART
iajs-3765	48	13	level	level	NOUN
iajs-3765	48	14	of	of	ADP
iajs-3765	48	15	inflammation	inflammation	NOUN
iajs-3765	48	16	,	,	PUNCT
iajs-3765	48	17	such	such	ADJ
iajs-3765	48	18	as	as	ADP
iajs-3765	48	19	the	the	DET
iajs-3765	48	20	erythrocyte	erythrocyte	PROPN
iajs-3765	48	21	sedimentation	sedimentation	NOUN
iajs-3765	48	22	rate	rate	NOUN
iajs-3765	48	23	(	(	PUNCT
iajs-3765	48	24	esr	esr	PROPN
iajs-3765	48	25	)	)	PUNCT
iajs-3765	48	26	,	,	PUNCT
iajs-3765	48	27	c	c	NOUN
iajs-3765	48	28	-	-	PUNCT
iajs-3765	48	29	reactive	reactive	ADJ
iajs-3765	48	30	protein	protein	NOUN
iajs-3765	48	31	(	(	PUNCT
iajs-3765	48	32	crp	crp	PROPN
iajs-3765	48	33	)	)	PUNCT
iajs-3765	48	34	,	,	PUNCT
iajs-3765	48	35	lipid	lipid	NOUN
iajs-3765	48	36	profile	profile	NOUN
iajs-3765	48	37	,	,	PUNCT
iajs-3765	48	38	and	and	CCONJ
iajs-3765	48	39	mmps	mmp	NOUN
iajs-3765	48	40	)	)	PUNCT
iajs-3765	48	41	3,19	3,19	NUM
iajs-3765	48	42	(	(	PUNCT
iajs-3765	48	43	.	.	PUNCT
iajs-3765	49	1	the	the	DET
iajs-3765	49	2	mmps	mmp	NOUN
iajs-3765	49	3	have	have	AUX
iajs-3765	49	4	been	be	AUX
iajs-3765	49	5	identified	identify	VERB
iajs-3765	49	6	as	as	ADP
iajs-3765	49	7	key	key	ADJ
iajs-3765	49	8	contributors	contributor	NOUN
iajs-3765	49	9	to	to	ADP
iajs-3765	49	10	the	the	DET
iajs-3765	49	11	development	development	NOUN
iajs-3765	49	12	of	of	ADP
iajs-3765	49	13	ra	ra	PROPN
iajs-3765	49	14	)	)	PUNCT
iajs-3765	49	15	20	20	NUM
iajs-3765	49	16	)	)	PUNCT
iajs-3765	49	17	.	.	PUNCT
iajs-3765	50	1	the	the	DET
iajs-3765	50	2	upregulation	upregulation	NOUN
iajs-3765	50	3	of	of	ADP
iajs-3765	50	4	mmp-1	mmp-1	NOUN
iajs-3765	50	5	,	,	PUNCT
iajs-3765	50	6	mmp-3	mmp-3	NOUN
iajs-3765	50	7	,	,	PUNCT
iajs-3765	50	8	mmp-9	mmp-9	NOUN
iajs-3765	50	9	,	,	PUNCT
iajs-3765	50	10	and	and	CCONJ
iajs-3765	50	11	mmp-13	mmp-13	VERB
iajs-3765	50	12	expression	expression	NOUN
iajs-3765	50	13	in	in	ADP
iajs-3765	50	14	ra	ra	PROPN
iajs-3765	50	15	synovial	synovial	ADJ
iajs-3765	50	16	fibroblasts	fibroblast	NOUN
iajs-3765	50	17	(	(	PUNCT
iajs-3765	50	18	rasfs	rasfs	PROPN
iajs-3765	50	19	)	)	PUNCT
iajs-3765	50	20	suggests	suggest	VERB
iajs-3765	50	21	that	that	SCONJ
iajs-3765	50	22	mmps	mmp	NOUN
iajs-3765	50	23	have	have	VERB
iajs-3765	50	24	a	a	DET
iajs-3765	50	25	significant	significant	ADJ
iajs-3765	50	26	impact	impact	NOUN
iajs-3765	50	27	on	on	ADP
iajs-3765	50	28	the	the	DET
iajs-3765	50	29	degradation	degradation	NOUN
iajs-3765	50	30	of	of	ADP
iajs-3765	50	31	cartilage	cartilage	NOUN
iajs-3765	50	32	in	in	ADP
iajs-3765	50	33	the	the	DET
iajs-3765	50	34	joints	joint	NOUN
iajs-3765	50	35	affected	affect	VERB
iajs-3765	50	36	by	by	ADP
iajs-3765	50	37	ra	ra	PROPN
iajs-3765	50	38	)	)	PUNCT
iajs-3765	50	39	21	21	NUM
iajs-3765	50	40	)	)	PUNCT
iajs-3765	50	41	.	.	PUNCT
iajs-3765	51	1	the	the	DET
iajs-3765	51	2	mmp-1	mmp-1	NOUN
iajs-3765	51	3	,	,	PUNCT
iajs-3765	51	4	also	also	ADV
iajs-3765	51	5	known	know	VERB
iajs-3765	51	6	as	as	ADP
iajs-3765	51	7	collagenase	collagenase	NOUN
iajs-3765	51	8	1	1	NUM
iajs-3765	51	9	,	,	PUNCT
iajs-3765	51	10	and	and	CCONJ
iajs-3765	51	11	mmp-13	mmp-13	NOUN
iajs-3765	51	12	,	,	PUNCT
iajs-3765	51	13	also	also	ADV
iajs-3765	51	14	known	know	VERB
iajs-3765	51	15	as	as	ADP
iajs-3765	51	16	collagenase	collagenase	NOUN
iajs-3765	51	17	3	3	NUM
iajs-3765	51	18	,	,	PUNCT
iajs-3765	51	19	are	be	AUX
iajs-3765	51	20	enzymes	enzyme	NOUN
iajs-3765	51	21	that	that	PRON
iajs-3765	51	22	specifically	specifically	ADV
iajs-3765	51	23	cleave	cleave	VERB
iajs-3765	51	24	collagen	collagen	NOUN
iajs-3765	51	25	.	.	PUNCT
iajs-3765	52	1	on	on	ADP
iajs-3765	52	2	the	the	DET
iajs-3765	52	3	other	other	ADJ
iajs-3765	52	4	hand	hand	NOUN
iajs-3765	52	5	,	,	PUNCT
iajs-3765	52	6	mmp-3	mmp-3	ADV
iajs-3765	52	7	,	,	PUNCT
iajs-3765	52	8	also	also	ADV
iajs-3765	52	9	referred	refer	VERB
iajs-3765	52	10	to	to	ADP
iajs-3765	52	11	as	as	ADP
iajs-3765	52	12	stromelysin	stromelysin	NOUN
iajs-3765	52	13	1	1	NUM
iajs-3765	52	14	,	,	PUNCT
iajs-3765	52	15	and	and	CCONJ
iajs-3765	52	16	mmp-9	mmp-9	NUM
iajs-3765	52	17	,	,	PUNCT
iajs-3765	52	18	also	also	ADV
iajs-3765	52	19	known	know	VERB
iajs-3765	52	20	as	as	ADP
iajs-3765	52	21	gelatinase	gelatinase	NOUN
iajs-3765	52	22	b	b	NOUN
iajs-3765	52	23	,	,	PUNCT
iajs-3765	52	24	are	be	AUX
iajs-3765	52	25	enzymes	enzyme	NOUN
iajs-3765	52	26	that	that	PRON
iajs-3765	52	27	primarily	primarily	ADV
iajs-3765	52	28	target	target	VERB
iajs-3765	52	29	proteoglycans	proteoglycan	NOUN
iajs-3765	52	30	composed	compose	VERB
iajs-3765	52	31	of	of	ADP
iajs-3765	52	32	aggrecan	aggrecan	PROPN
iajs-3765	52	33	.	.	PUNCT
iajs-3765	53	1	the	the	DET
iajs-3765	53	2	deterioration	deterioration	NOUN
iajs-3765	53	3	of	of	ADP
iajs-3765	53	4	proteoglycans	proteoglycan	NOUN
iajs-3765	53	5	located	locate	VERB
iajs-3765	53	6	on	on	ADP
iajs-3765	53	7	the	the	DET
iajs-3765	53	8	surface	surface	NOUN
iajs-3765	53	9	,	,	PUNCT
iajs-3765	53	10	coupled	couple	VERB
iajs-3765	53	11	with	with	ADP
iajs-3765	53	12	the	the	DET
iajs-3765	53	13	breakdown	breakdown	NOUN
iajs-3765	53	14	of	of	ADP
iajs-3765	53	15	collagen	collagen	NOUN
iajs-3765	53	16	fibrils	fibril	NOUN
iajs-3765	53	17	in	in	ADP
iajs-3765	53	18	the	the	DET
iajs-3765	53	19	deep	deep	ADJ
iajs-3765	53	20	zone	zone	NOUN
iajs-3765	53	21	,	,	PUNCT
iajs-3765	53	22	collectively	collectively	ADV
iajs-3765	53	23	contributes	contribute	VERB
iajs-3765	53	24	to	to	ADP
iajs-3765	53	25	the	the	DET
iajs-3765	53	26	degradation	degradation	NOUN
iajs-3765	53	27	of	of	ADP
iajs-3765	53	28	articular	articular	ADJ
iajs-3765	53	29	cartilage	cartilage	NOUN
iajs-3765	53	30	)	)	PUNCT
iajs-3765	53	31	22	22	NUM
iajs-3765	53	32	)	)	PUNCT
iajs-3765	53	33	.	.	PUNCT
iajs-3765	54	1	the	the	DET
iajs-3765	54	2	mmps	mmp	NOUN
iajs-3765	54	3	may	may	AUX
iajs-3765	54	4	therefore	therefore	ADV
iajs-3765	54	5	have	have	VERB
iajs-3765	54	6	a	a	DET
iajs-3765	54	7	unique	unique	ADJ
iajs-3765	54	8	function	function	NOUN
iajs-3765	54	9	in	in	ADP
iajs-3765	54	10	the	the	DET
iajs-3765	54	11	joint	joint	ADJ
iajs-3765	54	12	degradation	degradation	NOUN
iajs-3765	54	13	process	process	NOUN
iajs-3765	54	14	in	in	ADP
iajs-3765	54	15	ra	ra	PROPN
iajs-3765	54	16	)	)	PUNCT
iajs-3765	54	17	23	23	NUM
iajs-3765	54	18	)	)	PUNCT
iajs-3765	54	19	.	.	PUNCT
iajs-3765	55	1	the	the	DET
iajs-3765	55	2	ihjpas	ihjpas	PROPN
iajs-3765	55	3	.	.	PUNCT
iajs-3765	56	1	2025	2025	NUM
iajs-3765	56	2	,	,	PUNCT
iajs-3765	56	3	38(3	38(3	NUM
iajs-3765	56	4	)	)	PUNCT
iajs-3765	56	5	267	267	NUM
iajs-3765	56	6	effective	effective	ADJ
iajs-3765	56	7	management	management	NOUN
iajs-3765	56	8	of	of	ADP
iajs-3765	56	9	ra	ra	PROPN
iajs-3765	56	10	requires	require	VERB
iajs-3765	56	11	a	a	DET
iajs-3765	56	12	comprehensive	comprehensive	ADJ
iajs-3765	56	13	understanding	understanding	NOUN
iajs-3765	56	14	of	of	ADP
iajs-3765	56	15	the	the	DET
iajs-3765	56	16	regulatory	regulatory	ADJ
iajs-3765	56	17	mechanisms	mechanism	NOUN
iajs-3765	56	18	that	that	PRON
iajs-3765	56	19	activate	activate	VERB
iajs-3765	56	20	mmp	mmp	PROPN
iajs-3765	56	21	genes	gene	NOUN
iajs-3765	56	22	in	in	ADP
iajs-3765	56	23	rasfs	rasfs	PROPN
iajs-3765	56	24	,	,	PUNCT
iajs-3765	56	25	which	which	PRON
iajs-3765	56	26	may	may	AUX
iajs-3765	56	27	significantly	significantly	ADV
iajs-3765	56	28	contribute	contribute	VERB
iajs-3765	56	29	to	to	ADP
iajs-3765	56	30	knowledge	knowledge	NOUN
iajs-3765	56	31	of	of	ADP
iajs-3765	56	32	the	the	DET
iajs-3765	56	33	pathological	pathological	ADJ
iajs-3765	56	34	processes	process	NOUN
iajs-3765	56	35	and	and	CCONJ
iajs-3765	56	36	facilitate	facilitate	VERB
iajs-3765	56	37	the	the	DET
iajs-3765	56	38	development	development	NOUN
iajs-3765	56	39	of	of	ADP
iajs-3765	56	40	novel	novel	ADJ
iajs-3765	56	41	therapeutic	therapeutic	ADJ
iajs-3765	56	42	approaches	approach	NOUN
iajs-3765	56	43	for	for	ADP
iajs-3765	56	44	this	this	DET
iajs-3765	56	45	illness	illness	NOUN
iajs-3765	56	46	)	)	PUNCT
iajs-3765	56	47	24	24	NUM
iajs-3765	56	48	)	)	PUNCT
iajs-3765	56	49	.	.	PUNCT
iajs-3765	57	1	this	this	DET
iajs-3765	57	2	study	study	NOUN
iajs-3765	57	3	aims	aim	VERB
iajs-3765	57	4	to	to	PART
iajs-3765	57	5	evaluate	evaluate	VERB
iajs-3765	57	6	serum	serum	NOUN
iajs-3765	57	7	mmp-1	mmp-1	PUNCT
iajs-3765	57	8	and	and	CCONJ
iajs-3765	57	9	certain	certain	ADJ
iajs-3765	57	10	biochemical	biochemical	ADJ
iajs-3765	57	11	factors	factor	NOUN
iajs-3765	57	12	in	in	ADP
iajs-3765	57	13	patients	patient	NOUN
iajs-3765	57	14	with	with	ADP
iajs-3765	57	15	ra	ra	PROPN
iajs-3765	57	16	and	and	CCONJ
iajs-3765	57	17	to	to	PART
iajs-3765	57	18	investigate	investigate	VERB
iajs-3765	57	19	their	their	PRON
iajs-3765	57	20	correlation	correlation	NOUN
iajs-3765	57	21	with	with	ADP
iajs-3765	57	22	disease	disease	NOUN
iajs-3765	57	23	activity	activity	NOUN
iajs-3765	57	24	among	among	ADP
iajs-3765	57	25	iraqi	iraqi	ADJ
iajs-3765	57	26	patients	patient	NOUN
iajs-3765	57	27	.	.	PUNCT
iajs-3765	58	1	2	2	X
iajs-3765	58	2	.	.	X
iajs-3765	58	3	materials	material	NOUN
iajs-3765	58	4	and	and	CCONJ
iajs-3765	58	5	methods	method	NOUN
iajs-3765	58	6	the	the	DET
iajs-3765	58	7	current	current	ADJ
iajs-3765	58	8	study	study	NOUN
iajs-3765	58	9	included	include	VERB
iajs-3765	58	10	120	120	NUM
iajs-3765	58	11	subjects	subject	NOUN
iajs-3765	58	12	divided	divide	VERB
iajs-3765	58	13	into	into	ADP
iajs-3765	58	14	two	two	NUM
iajs-3765	58	15	groups	group	NOUN
iajs-3765	58	16	:	:	PUNCT
iajs-3765	58	17	80	80	NUM
iajs-3765	58	18	patients	patient	NOUN
iajs-3765	58	19	with	with	ADP
iajs-3765	58	20	ra	ra	PROPN
iajs-3765	58	21	were	be	AUX
iajs-3765	58	22	enrolled	enrol	VERB
iajs-3765	58	23	in	in	ADP
iajs-3765	58	24	the	the	DET
iajs-3765	58	25	study	study	NOUN
iajs-3765	58	26	(	(	PUNCT
iajs-3765	58	27	74	74	NUM
iajs-3765	58	28	females	female	NOUN
iajs-3765	58	29	and	and	CCONJ
iajs-3765	58	30	6	6	NUM
iajs-3765	58	31	males	male	NOUN
iajs-3765	58	32	)	)	PUNCT
iajs-3765	58	33	.	.	PUNCT
iajs-3765	59	1	the	the	DET
iajs-3765	59	2	patients	patient	NOUN
iajs-3765	59	3	'	'	PART
iajs-3765	59	4	ages	age	NOUN
iajs-3765	59	5	ranged	range	VERB
iajs-3765	59	6	from	from	ADP
iajs-3765	59	7	24	24	NUM
iajs-3765	59	8	to	to	PART
iajs-3765	59	9	74	74	NUM
iajs-3765	59	10	years	year	NOUN
iajs-3765	59	11	.	.	PUNCT
iajs-3765	60	1	additionally	additionally	ADV
iajs-3765	60	2	,	,	PUNCT
iajs-3765	60	3	forty	forty	NUM
iajs-3765	60	4	control	control	NOUN
iajs-3765	60	5	subjects	subject	NOUN
iajs-3765	60	6	were	be	AUX
iajs-3765	60	7	individuals	individual	NOUN
iajs-3765	60	8	whose	whose	DET
iajs-3765	60	9	ages	age	NOUN
iajs-3765	60	10	ranged	range	VERB
iajs-3765	60	11	from	from	ADP
iajs-3765	60	12	20	20	NUM
iajs-3765	60	13	to	to	PART
iajs-3765	60	14	60	60	NUM
iajs-3765	60	15	years	year	NOUN
iajs-3765	60	16	,	,	PUNCT
iajs-3765	60	17	and	and	CCONJ
iajs-3765	60	18	their	their	PRON
iajs-3765	60	19	gender	gender	NOUN
iajs-3765	60	20	(	(	PUNCT
iajs-3765	60	21	33	33	NUM
iajs-3765	60	22	females	female	NOUN
iajs-3765	60	23	and	and	CCONJ
iajs-3765	60	24	7	7	NUM
iajs-3765	60	25	males	male	NOUN
iajs-3765	60	26	)	)	PUNCT
iajs-3765	60	27	,	,	PUNCT
iajs-3765	60	28	during	during	ADP
iajs-3765	60	29	the	the	DET
iajs-3765	60	30	period	period	NOUN
iajs-3765	60	31	from	from	ADP
iajs-3765	60	32	march	march	PROPN
iajs-3765	60	33	2023	2023	NUM
iajs-3765	60	34	to	to	ADP
iajs-3765	60	35	june	june	PROPN
iajs-3765	60	36	2023	2023	NUM
iajs-3765	60	37	.	.	PUNCT
iajs-3765	61	1	this	this	DET
iajs-3765	61	2	study	study	NOUN
iajs-3765	61	3	was	be	AUX
iajs-3765	61	4	conducted	conduct	VERB
iajs-3765	61	5	at	at	ADP
iajs-3765	61	6	the	the	DET
iajs-3765	61	7	medical	medical	ADJ
iajs-3765	61	8	city	city	NOUN
iajs-3765	61	9	hospital	hospital	NOUN
iajs-3765	61	10	.	.	PUNCT
iajs-3765	62	1	before	before	ADP
iajs-3765	62	2	participating	participate	VERB
iajs-3765	62	3	in	in	ADP
iajs-3765	62	4	the	the	DET
iajs-3765	62	5	study	study	NOUN
iajs-3765	62	6	,	,	PUNCT
iajs-3765	62	7	each	each	DET
iajs-3765	62	8	individual	individual	NOUN
iajs-3765	62	9	gave	give	VERB
iajs-3765	62	10	their	their	PRON
iajs-3765	62	11	informed	informed	ADJ
iajs-3765	62	12	consent	consent	NOUN
iajs-3765	62	13	.	.	PUNCT
iajs-3765	63	1	the	the	DET
iajs-3765	63	2	national	national	ADJ
iajs-3765	63	3	center	center	NOUN
iajs-3765	63	4	for	for	ADP
iajs-3765	63	5	the	the	DET
iajs-3765	63	6	development	development	NOUN
iajs-3765	63	7	of	of	ADP
iajs-3765	63	8	humans	human	NOUN
iajs-3765	63	9	and	and	CCONJ
iajs-3765	63	10	the	the	DET
iajs-3765	63	11	medical	medical	ADJ
iajs-3765	63	12	city	city	NOUN
iajs-3765	63	13	's	's	PART
iajs-3765	63	14	approval	approval	NOUN
iajs-3765	63	15	of	of	ADP
iajs-3765	63	16	the	the	DET
iajs-3765	63	17	study	study	NOUN
iajs-3765	63	18	.	.	PUNCT
iajs-3765	64	1	each	each	DET
iajs-3765	64	2	subject	subject	ADJ
iajs-3765	64	3	underwent	undergo	VERB
iajs-3765	64	4	subsequent	subsequent	ADJ
iajs-3765	64	5	laboratory	laboratory	NOUN
iajs-3765	64	6	tests	test	NOUN
iajs-3765	64	7	,	,	PUNCT
iajs-3765	64	8	including	include	VERB
iajs-3765	64	9	mmp-1	mmp-1	NOUN
iajs-3765	64	10	,	,	PUNCT
iajs-3765	64	11	crp	crp	PROPN
iajs-3765	64	12	,	,	PUNCT
iajs-3765	64	13	esr	esr	PROPN
iajs-3765	64	14	,	,	PUNCT
iajs-3765	64	15	rheumatoid	rheumatoid	NOUN
iajs-3765	64	16	factor	factor	NOUN
iajs-3765	64	17	(	(	PUNCT
iajs-3765	64	18	rf	rf	NOUN
iajs-3765	64	19	)	)	PUNCT
iajs-3765	64	20	,	,	PUNCT
iajs-3765	64	21	and	and	CCONJ
iajs-3765	64	22	lipid	lipid	NOUN
iajs-3765	64	23	profile	profile	NOUN
iajs-3765	65	1	[	[	X
iajs-3765	65	2	(	(	PUNCT
iajs-3765	65	3	cholesterol	cholesterol	NOUN
iajs-3765	65	4	triglycerides	triglyceride	NOUN
iajs-3765	65	5	,	,	PUNCT
iajs-3765	65	6	high	high	ADJ
iajs-3765	65	7	-	-	PUNCT
iajs-3765	65	8	density	density	NOUN
iajs-3765	65	9	lipoprotein	lipoprotein	ADJ
iajs-3765	65	10	cholesterol	cholesterol	NOUN
iajs-3765	65	11	(	(	PUNCT
iajs-3765	65	12	hdl	hdl	NOUN
iajs-3765	65	13	-	-	PUNCT
iajs-3765	65	14	c	c	NOUN
iajs-3765	65	15	)	)	PUNCT
iajs-3765	65	16	,	,	PUNCT
iajs-3765	65	17	low	low	ADJ
iajs-3765	65	18	-	-	PUNCT
iajs-3765	65	19	density	density	NOUN
iajs-3765	65	20	lipoprotein	lipoprotein	ADJ
iajs-3765	65	21	cholesterol	cholesterol	NOUN
iajs-3765	65	22	(	(	PUNCT
iajs-3765	65	23	ldl	ldl	NOUN
iajs-3765	65	24	-	-	PUNCT
iajs-3765	65	25	c	c	NOUN
iajs-3765	65	26	)	)	PUNCT
iajs-3765	65	27	,	,	PUNCT
iajs-3765	65	28	and	and	CCONJ
iajs-3765	65	29	very	very	ADV
iajs-3765	65	30	low	low	ADJ
iajs-3765	65	31	-	-	PUNCT
iajs-3765	65	32	density	density	NOUN
iajs-3765	65	33	lipoprotein	lipoprotein	ADJ
iajs-3765	65	34	(	(	PUNCT
iajs-3765	65	35	vldl	vldl	NOUN
iajs-3765	65	36	)	)	PUNCT
iajs-3765	65	37	]	]	PUNCT
iajs-3765	65	38	.	.	PUNCT
iajs-3765	66	1	2.1	2.1	NUM
iajs-3765	66	2	.	.	PUNCT
iajs-3765	66	3	inclusion	inclusion	NOUN
iajs-3765	66	4	and	and	CCONJ
iajs-3765	66	5	exclusion	exclusion	NOUN
iajs-3765	66	6	criteria	criterion	NOUN
iajs-3765	66	7	this	this	DET
iajs-3765	66	8	study	study	NOUN
iajs-3765	66	9	included	include	VERB
iajs-3765	66	10	patients	patient	NOUN
iajs-3765	66	11	with	with	ADP
iajs-3765	66	12	ra	ra	PROPN
iajs-3765	66	13	aged	aged	ADJ
iajs-3765	66	14	24	24	NUM
iajs-3765	66	15	to	to	PART
iajs-3765	66	16	74	74	NUM
iajs-3765	66	17	years	year	NOUN
iajs-3765	66	18	.	.	PUNCT
iajs-3765	67	1	the	the	DET
iajs-3765	67	2	ra	ra	PROPN
iajs-3765	67	3	patients	patient	NOUN
iajs-3765	67	4	were	be	AUX
iajs-3765	67	5	found	find	VERB
iajs-3765	67	6	to	to	PART
iajs-3765	67	7	have	have	VERB
iajs-3765	67	8	another	another	DET
iajs-3765	67	9	autoimmune	autoimmune	ADJ
iajs-3765	67	10	disease	disease	NOUN
iajs-3765	67	11	,	,	PUNCT
iajs-3765	67	12	gout	gout	NOUN
iajs-3765	67	13	,	,	PUNCT
iajs-3765	67	14	osteoarthritis	osteoarthritis	NOUN
iajs-3765	67	15	,	,	PUNCT
iajs-3765	67	16	polycystic	polycystic	ADJ
iajs-3765	67	17	ovary	ovary	ADJ
iajs-3765	67	18	syndrome	syndrome	NOUN
iajs-3765	67	19	,	,	PUNCT
iajs-3765	67	20	disabilities	disability	NOUN
iajs-3765	67	21	,	,	PUNCT
iajs-3765	67	22	and	and	CCONJ
iajs-3765	67	23	cancer	cancer	NOUN
iajs-3765	67	24	,	,	PUNCT
iajs-3765	67	25	and	and	CCONJ
iajs-3765	67	26	pregnant	pregnant	ADJ
iajs-3765	67	27	women	woman	NOUN
iajs-3765	67	28	were	be	AUX
iajs-3765	67	29	excluded	exclude	VERB
iajs-3765	67	30	from	from	ADP
iajs-3765	67	31	the	the	DET
iajs-3765	67	32	current	current	ADJ
iajs-3765	67	33	work	work	NOUN
iajs-3765	67	34	.	.	PUNCT
iajs-3765	68	1	six	six	NUM
iajs-3765	68	2	milliliters	milliliter	NOUN
iajs-3765	68	3	of	of	ADP
iajs-3765	68	4	blood	blood	NOUN
iajs-3765	68	5	were	be	AUX
iajs-3765	68	6	collected	collect	VERB
iajs-3765	68	7	from	from	ADP
iajs-3765	68	8	each	each	DET
iajs-3765	68	9	individual	individual	NOUN
iajs-3765	68	10	.	.	PUNCT
iajs-3765	69	1	after	after	SCONJ
iajs-3765	69	2	the	the	DET
iajs-3765	69	3	blood	blood	NOUN
iajs-3765	69	4	was	be	AUX
iajs-3765	69	5	put	put	VERB
iajs-3765	69	6	into	into	ADP
iajs-3765	69	7	gel	gel	NOUN
iajs-3765	69	8	tubes	tube	NOUN
iajs-3765	69	9	and	and	CCONJ
iajs-3765	69	10	left	leave	VERB
iajs-3765	69	11	to	to	PART
iajs-3765	69	12	coagulate	coagulate	VERB
iajs-3765	69	13	for	for	ADP
iajs-3765	69	14	30	30	NUM
iajs-3765	69	15	minutes	minute	NOUN
iajs-3765	69	16	at	at	ADP
iajs-3765	69	17	room	room	NOUN
iajs-3765	69	18	temperature	temperature	NOUN
iajs-3765	69	19	,	,	PUNCT
iajs-3765	69	20	each	each	DET
iajs-3765	69	21	sample	sample	NOUN
iajs-3765	69	22	was	be	AUX
iajs-3765	69	23	centrifuged	centrifuge	VERB
iajs-3765	69	24	for	for	ADP
iajs-3765	69	25	5	5	NUM
iajs-3765	69	26	minutes	minute	NOUN
iajs-3765	69	27	at	at	ADP
iajs-3765	69	28	3000	3000	NUM
iajs-3765	69	29	×	×	NOUN
iajs-3765	69	30	g.	g.	NOUN
iajs-3765	69	31	after	after	ADP
iajs-3765	69	32	that	that	PRON
iajs-3765	69	33	,	,	PUNCT
iajs-3765	69	34	the	the	DET
iajs-3765	69	35	serum	serum	NOUN
iajs-3765	69	36	was	be	AUX
iajs-3765	69	37	separated	separate	VERB
iajs-3765	69	38	into	into	ADP
iajs-3765	69	39	eppendorf	eppendorf	PROPN
iajs-3765	69	40	tubes	tube	NOUN
iajs-3765	69	41	and	and	CCONJ
iajs-3765	69	42	stored	store	VERB
iajs-3765	69	43	at	at	ADP
iajs-3765	69	44	-20	-20	NUM
iajs-3765	69	45	°	°	NOUN
iajs-3765	69	46	c	c	NOUN
iajs-3765	69	47	for	for	ADP
iajs-3765	69	48	mmp-1	mmp-1	NOUN
iajs-3765	69	49	,	,	PUNCT
iajs-3765	69	50	crp	crp	PROPN
iajs-3765	69	51	,	,	PUNCT
iajs-3765	69	52	rf	rf	NOUN
iajs-3765	69	53	,	,	PUNCT
iajs-3765	69	54	and	and	CCONJ
iajs-3765	69	55	the	the	DET
iajs-3765	69	56	lipid	lipid	NOUN
iajs-3765	69	57	profile	profile	NOUN
iajs-3765	69	58	,	,	PUNCT
iajs-3765	69	59	among	among	ADP
iajs-3765	69	60	others	other	NOUN
iajs-3765	69	61	.	.	PUNCT
iajs-3765	70	1	the	the	DET
iajs-3765	70	2	quantitative	quantitative	ADJ
iajs-3765	70	3	sandwich	sandwich	NOUN
iajs-3765	70	4	enzyme	enzyme	NOUN
iajs-3765	70	5	-	-	PUNCT
iajs-3765	70	6	linked	link	VERB
iajs-3765	70	7	immunosorbent	immunosorbent	NOUN
iajs-3765	70	8	assay	assay	PROPN
iajs-3765	70	9	(	(	PUNCT
iajs-3765	70	10	elisa	elisa	NOUN
iajs-3765	70	11	)	)	PUNCT
iajs-3765	70	12	technique	technique	NOUN
iajs-3765	70	13	was	be	AUX
iajs-3765	70	14	used	use	VERB
iajs-3765	70	15	to	to	PART
iajs-3765	70	16	measure	measure	VERB
iajs-3765	70	17	the	the	DET
iajs-3765	70	18	levels	level	NOUN
iajs-3765	70	19	of	of	ADP
iajs-3765	70	20	mmp-1	mmp-1	X
iajs-3765	70	21	,	,	PUNCT
iajs-3765	70	22	crp	crp	PROPN
iajs-3765	70	23	,	,	PUNCT
iajs-3765	70	24	rf	rf	NOUN
iajs-3765	70	25	,	,	PUNCT
iajs-3765	70	26	and	and	CCONJ
iajs-3765	70	27	lipid	lipid	NOUN
iajs-3765	70	28	profile	profile	NOUN
iajs-3765	70	29	in	in	ADP
iajs-3765	70	30	serum	serum	NOUN
iajs-3765	70	31	using	use	VERB
iajs-3765	70	32	pepro	pepro	ADJ
iajs-3765	70	33	tec	tec	ADJ
iajs-3765	70	34	kits	kit	NOUN
iajs-3765	70	35	from	from	ADP
iajs-3765	70	36	the	the	DET
iajs-3765	70	37	usa	usa	PROPN
iajs-3765	70	38	,	,	PUNCT
iajs-3765	70	39	according	accord	VERB
iajs-3765	70	40	to	to	ADP
iajs-3765	70	41	the	the	DET
iajs-3765	70	42	manufacturer	manufacturer	NOUN
iajs-3765	70	43	's	's	PART
iajs-3765	70	44	instructions	instruction	NOUN
iajs-3765	70	45	.	.	PUNCT
iajs-3765	71	1	anti	anti	ADJ
iajs-3765	71	2	-	-	ADJ
iajs-3765	71	3	mmp-1	mmp-1	NOUN
iajs-3765	71	4	,	,	PUNCT
iajs-3765	71	5	crp	crp	PROPN
iajs-3765	71	6	,	,	PUNCT
iajs-3765	71	7	rf	rf	NOUN
iajs-3765	71	8	,	,	PUNCT
iajs-3765	71	9	and	and	CCONJ
iajs-3765	71	10	lipid	lipid	NOUN
iajs-3765	71	11	profile	profile	NOUN
iajs-3765	71	12	antibody	antibody	NOUN
iajs-3765	71	13	(	(	PUNCT
iajs-3765	71	14	the	the	DET
iajs-3765	71	15	arresting	arrest	VERB
iajs-3765	71	16	antibody	antibody	NOUN
iajs-3765	71	17	)	)	PUNCT
iajs-3765	71	18	were	be	AUX
iajs-3765	71	19	coated	coat	VERB
iajs-3765	71	20	in	in	ADP
iajs-3765	71	21	the	the	DET
iajs-3765	71	22	wells	well	NOUN
iajs-3765	71	23	of	of	ADP
iajs-3765	71	24	a	a	DET
iajs-3765	71	25	12x8	12x8	NUM
iajs-3765	71	26	-	-	PUNCT
iajs-3765	71	27	well	well	NOUN
iajs-3765	71	28	plate	plate	NOUN
iajs-3765	71	29	.	.	PUNCT
iajs-3765	72	1	a	a	DET
iajs-3765	72	2	serum	serum	NOUN
iajs-3765	72	3	or	or	CCONJ
iajs-3765	72	4	standard	standard	NOUN
iajs-3765	72	5	was	be	AUX
iajs-3765	72	6	then	then	ADV
iajs-3765	72	7	added	add	VERB
iajs-3765	72	8	to	to	ADP
iajs-3765	72	9	the	the	DET
iajs-3765	72	10	relevant	relevant	ADJ
iajs-3765	72	11	wells	well	NOUN
iajs-3765	72	12	.	.	PUNCT
iajs-3765	73	1	an	an	DET
iajs-3765	73	2	antibody	antibody	NOUN
iajs-3765	73	3	for	for	ADP
iajs-3765	73	4	detecting	detect	VERB
iajs-3765	73	5	bioavailable	bioavailable	ADJ
iajs-3765	73	6	anti	anti	ADJ
iajs-3765	73	7	-	-	ADJ
iajs-3765	73	8	human	human	ADJ
iajs-3765	73	9	chemokines	chemokine	NOUN
iajs-3765	73	10	was	be	AUX
iajs-3765	73	11	added	add	VERB
iajs-3765	73	12	.	.	PUNCT
iajs-3765	74	1	after	after	SCONJ
iajs-3765	74	2	the	the	DET
iajs-3765	74	3	wells	well	NOUN
iajs-3765	74	4	had	have	AUX
iajs-3765	74	5	been	be	AUX
iajs-3765	74	6	cleaned	clean	VERB
iajs-3765	74	7	,	,	PUNCT
iajs-3765	74	8	avidin	avidin	NOUN
iajs-3765	74	9	and	and	CCONJ
iajs-3765	74	10	horseradish	horseradish	ADJ
iajs-3765	74	11	peroxidase	peroxidase	NOUN
iajs-3765	74	12	(	(	PUNCT
iajs-3765	74	13	hrp	hrp	PROPN
iajs-3765	74	14	)	)	PUNCT
iajs-3765	74	15	were	be	AUX
iajs-3765	74	16	added	add	VERB
iajs-3765	74	17	.	.	PUNCT
iajs-3765	75	1	once	once	SCONJ
iajs-3765	75	2	the	the	DET
iajs-3765	75	3	wells	well	NOUN
iajs-3765	75	4	have	have	AUX
iajs-3765	75	5	been	be	AUX
iajs-3765	75	6	cleaned	clean	VERB
iajs-3765	75	7	to	to	PART
iajs-3765	75	8	remove	remove	VERB
iajs-3765	75	9	.	.	PUNCT
iajs-3765	76	1	the	the	DET
iajs-3765	76	2	substrate	substrate	NOUN
iajs-3765	76	3	solution	solution	NOUN
iajs-3765	76	4	and	and	CCONJ
iajs-3765	76	5	the	the	DET
iajs-3765	76	6	unstructured	unstructured	ADJ
iajs-3765	76	7	avidin	avidin	NOUN
iajs-3765	76	8	-	-	PUNCT
iajs-3765	76	9	enzyme	enzyme	NOUN
iajs-3765	76	10	reagent	reagent	ADJ
iajs-3765	76	11	interact	interact	NOUN
iajs-3765	76	12	,	,	PUNCT
iajs-3765	76	13	changing	change	VERB
iajs-3765	76	14	color	color	NOUN
iajs-3765	76	15	before	before	ADP
iajs-3765	76	16	ceasing	cease	VERB
iajs-3765	76	17	.	.	PUNCT
iajs-3765	77	1	the	the	DET
iajs-3765	77	2	color	color	NOUN
iajs-3765	77	3	change	change	NOUN
iajs-3765	77	4	was	be	AUX
iajs-3765	77	5	measured	measure	VERB
iajs-3765	77	6	spectrophotometrically	spectrophotometrically	ADV
iajs-3765	77	7	at	at	ADP
iajs-3765	77	8	a	a	DET
iajs-3765	77	9	wavelength	wavelength	NOUN
iajs-3765	77	10	of	of	ADP
iajs-3765	77	11	450	450	NUM
iajs-3765	77	12	nm	nm	PRON
iajs-3765	77	13	±	±	NUM
iajs-3765	77	14	10	10	NUM
iajs-3765	77	15	nm	nm	NOUN
iajs-3765	77	16	.	.	PUNCT
iajs-3765	78	1	2.2	2.2	NUM
iajs-3765	78	2	.	.	PUNCT
iajs-3765	79	1	statistical	statistical	ADJ
iajs-3765	79	2	analysis	analysis	NOUN
iajs-3765	79	3	the	the	DET
iajs-3765	79	4	statistical	statistical	ADJ
iajs-3765	79	5	package	package	NOUN
iajs-3765	79	6	for	for	ADP
iajs-3765	79	7	the	the	DET
iajs-3765	79	8	social	social	ADJ
iajs-3765	79	9	sciences	sciences	PROPN
iajs-3765	79	10	(	(	PUNCT
iajs-3765	79	11	spss	spss	PROPN
iajs-3765	79	12	)	)	PUNCT
iajs-3765	79	13	,	,	PUNCT
iajs-3765	79	14	version	version	NOUN
iajs-3765	79	15	26	26	NUM
iajs-3765	79	16	,	,	PUNCT
iajs-3765	79	17	was	be	AUX
iajs-3765	79	18	employed	employ	VERB
iajs-3765	79	19	to	to	PART
iajs-3765	79	20	assess	assess	VERB
iajs-3765	79	21	the	the	DET
iajs-3765	79	22	influence	influence	NOUN
iajs-3765	79	23	of	of	ADP
iajs-3765	79	24	different	different	ADJ
iajs-3765	79	25	factors	factor	NOUN
iajs-3765	79	26	on	on	ADP
iajs-3765	79	27	the	the	DET
iajs-3765	79	28	study	study	NOUN
iajs-3765	79	29	's	's	PART
iajs-3765	79	30	parameters	parameter	NOUN
iajs-3765	79	31	.	.	PUNCT
iajs-3765	80	1	data	datum	NOUN
iajs-3765	80	2	were	be	AUX
iajs-3765	80	3	expressed	express	VERB
iajs-3765	80	4	as	as	ADP
iajs-3765	80	5	mean	mean	NOUN
iajs-3765	80	6	±	±	NUM
iajs-3765	80	7	standard	standard	ADJ
iajs-3765	80	8	error	error	NOUN
iajs-3765	80	9	(	(	PUNCT
iajs-3765	80	10	se	se	ADJ
iajs-3765	80	11	)	)	PUNCT
iajs-3765	80	12	,	,	PUNCT
iajs-3765	80	13	and	and	CCONJ
iajs-3765	80	14	a	a	DET
iajs-3765	80	15	t	t	NOUN
iajs-3765	80	16	-	-	PUNCT
iajs-3765	80	17	test	test	NOUN
iajs-3765	80	18	was	be	AUX
iajs-3765	80	19	employed	employ	VERB
iajs-3765	80	20	in	in	ADP
iajs-3765	80	21	this	this	DET
iajs-3765	80	22	specific	specific	ADJ
iajs-3765	80	23	inquiry	inquiry	NOUN
iajs-3765	80	24	to	to	PART
iajs-3765	80	25	make	make	VERB
iajs-3765	80	26	statistically	statistically	ADV
iajs-3765	80	27	significant	significant	ADJ
iajs-3765	80	28	comparisons	comparison	NOUN
iajs-3765	80	29	between	between	ADP
iajs-3765	80	30	various	various	ADJ
iajs-3765	80	31	means	mean	NOUN
iajs-3765	80	32	.	.	PUNCT
iajs-3765	81	1	the	the	DET
iajs-3765	81	2	pearson	pearson	PROPN
iajs-3765	81	3	's	's	PART
iajs-3765	81	4	method	method	NOUN
iajs-3765	81	5	was	be	AUX
iajs-3765	81	6	used	use	VERB
iajs-3765	81	7	to	to	PART
iajs-3765	81	8	determine	determine	VERB
iajs-3765	81	9	the	the	DET
iajs-3765	81	10	correlation	correlation	NOUN
iajs-3765	81	11	(	(	PUNCT
iajs-3765	81	12	r	r	NOUN
iajs-3765	81	13	-	-	NOUN
iajs-3765	81	14	coefficient	coefficient	NOUN
iajs-3765	81	15	)	)	PUNCT
iajs-3765	81	16	between	between	ADP
iajs-3765	81	17	mmp-1	mmp-1	PUNCT
iajs-3765	81	18	and	and	CCONJ
iajs-3765	81	19	other	other	ADJ
iajs-3765	81	20	parameters	parameter	NOUN
iajs-3765	81	21	.	.	PUNCT
iajs-3765	82	1	a	a	DET
iajs-3765	82	2	p	p	NOUN
iajs-3765	82	3	-	-	PUNCT
iajs-3765	82	4	value	value	NOUN
iajs-3765	82	5	less	less	ADJ
iajs-3765	82	6	than	than	ADP
iajs-3765	82	7	0.05	0.05	NUM
iajs-3765	82	8	was	be	AUX
iajs-3765	82	9	considered	consider	VERB
iajs-3765	82	10	statistically	statistically	ADV
iajs-3765	82	11	significant	significant	ADJ
iajs-3765	82	12	.	.	PUNCT
iajs-3765	83	1	additionally	additionally	ADV
iajs-3765	83	2	,	,	PUNCT
iajs-3765	83	3	receiver	receiver	ADV
iajs-3765	83	4	operating	operate	VERB
iajs-3765	83	5	characteristic	characteristic	NOUN
iajs-3765	83	6	(	(	PUNCT
iajs-3765	83	7	roc	roc	PROPN
iajs-3765	83	8	)	)	PUNCT
iajs-3765	83	9	analysis	analysis	NOUN
iajs-3765	83	10	was	be	AUX
iajs-3765	83	11	used	use	VERB
iajs-3765	83	12	to	to	PART
iajs-3765	83	13	determine	determine	VERB
iajs-3765	83	14	the	the	DET
iajs-3765	83	15	sensitivity	sensitivity	NOUN
iajs-3765	83	16	and	and	CCONJ
iajs-3765	83	17	specificity	specificity	NOUN
iajs-3765	83	18	of	of	ADP
iajs-3765	83	19	the	the	DET
iajs-3765	83	20	markers	marker	NOUN
iajs-3765	83	21	,	,	PUNCT
iajs-3765	83	22	while	while	SCONJ
iajs-3765	83	23	multivariate	multivariate	NOUN
iajs-3765	83	24	cluster	cluster	NOUN
iajs-3765	83	25	analysis	analysis	NOUN
iajs-3765	83	26	was	be	AUX
iajs-3765	83	27	also	also	ADV
iajs-3765	83	28	used	use	VERB
iajs-3765	83	29	.	.	PUNCT
iajs-3765	84	1	the	the	DET
iajs-3765	84	2	chi	chi	ADJ
iajs-3765	84	3	-	-	PUNCT
iajs-3765	84	4	square	square	ADJ
iajs-3765	84	5	test	test	NOUN
iajs-3765	84	6	was	be	AUX
iajs-3765	84	7	used	use	VERB
iajs-3765	84	8	to	to	PART
iajs-3765	84	9	investigate	investigate	VERB
iajs-3765	84	10	the	the	DET
iajs-3765	84	11	possible	possible	ADJ
iajs-3765	84	12	association	association	NOUN
iajs-3765	84	13	between	between	ADP
iajs-3765	84	14	baseline	baseline	PROPN
iajs-3765	84	15	characteristics	characteristic	NOUN
iajs-3765	84	16	(	(	PUNCT
iajs-3765	84	17	bmi	bmi	NOUN
iajs-3765	84	18	and	and	CCONJ
iajs-3765	84	19	sex	sex	NOUN
iajs-3765	84	20	)	)	PUNCT
iajs-3765	84	21	and	and	CCONJ
iajs-3765	84	22	the	the	DET
iajs-3765	84	23	distribution	distribution	NOUN
iajs-3765	84	24	of	of	ADP
iajs-3765	84	25	the	the	DET
iajs-3765	84	26	analyzed	analyze	VERB
iajs-3765	84	27	groups	group	NOUN
iajs-3765	84	28	.	.	PUNCT
iajs-3765	85	1	ihjpas	ihjpas	PROPN
iajs-3765	85	2	.	.	PUNCT
iajs-3765	86	1	2025	2025	NUM
iajs-3765	86	2	,	,	PUNCT
iajs-3765	86	3	38(3	38(3	NUM
iajs-3765	86	4	)	)	PUNCT
iajs-3765	86	5	268	268	NUM
iajs-3765	86	6	3	3	NUM
iajs-3765	86	7	.	.	PUNCT
iajs-3765	86	8	results	result	VERB
iajs-3765	86	9	the	the	DET
iajs-3765	86	10	results	result	NOUN
iajs-3765	86	11	indicated	indicate	VERB
iajs-3765	86	12	that	that	SCONJ
iajs-3765	86	13	there	there	PRON
iajs-3765	86	14	was	be	VERB
iajs-3765	86	15	no	no	DET
iajs-3765	86	16	statistically	statistically	ADV
iajs-3765	86	17	significant	significant	ADJ
iajs-3765	86	18	correlation	correlation	NOUN
iajs-3765	86	19	at	at	ADP
iajs-3765	86	20	the	the	DET
iajs-3765	86	21	predetermined	predetermine	VERB
iajs-3765	86	22	significance	significance	NOUN
iajs-3765	86	23	level	level	NOUN
iajs-3765	86	24	of	of	ADP
iajs-3765	86	25	0.05	0.05	NUM
iajs-3765	86	26	.	.	PUNCT
iajs-3765	87	1	in	in	ADP
iajs-3765	87	2	contrast	contrast	NOUN
iajs-3765	87	3	,	,	PUNCT
iajs-3765	87	4	the	the	DET
iajs-3765	87	5	results	result	NOUN
iajs-3765	87	6	for	for	ADP
iajs-3765	87	7	age	age	NOUN
iajs-3765	87	8	,	,	PUNCT
iajs-3765	87	9	smoking	smoking	NOUN
iajs-3765	87	10	,	,	PUNCT
iajs-3765	87	11	and	and	CCONJ
iajs-3765	87	12	menopause	menopause	NOUN
iajs-3765	87	13	suggest	suggest	VERB
iajs-3765	87	14	a	a	DET
iajs-3765	87	15	highly	highly	ADV
iajs-3765	87	16	significant	significant	ADJ
iajs-3765	87	17	increase	increase	NOUN
iajs-3765	87	18	in	in	ADP
iajs-3765	87	19	the	the	DET
iajs-3765	87	20	patient	patient	NOUN
iajs-3765	87	21	group	group	NOUN
iajs-3765	87	22	compared	compare	VERB
iajs-3765	87	23	to	to	ADP
iajs-3765	87	24	the	the	DET
iajs-3765	87	25	control	control	NOUN
iajs-3765	87	26	group	group	NOUN
iajs-3765	87	27	(	(	PUNCT
iajs-3765	87	28	p	p	X
iajs-3765	87	29	<	<	X
iajs-3765	87	30	0.05	0.05	NUM
iajs-3765	87	31	)	)	PUNCT
iajs-3765	87	32	,	,	PUNCT
iajs-3765	87	33	as	as	SCONJ
iajs-3765	87	34	shown	show	VERB
iajs-3765	87	35	in	in	ADP
iajs-3765	87	36	table	table	NOUN
iajs-3765	87	37	(	(	PUNCT
iajs-3765	87	38	1	1	NUM
iajs-3765	87	39	)	)	PUNCT
iajs-3765	87	40	.	.	PUNCT
iajs-3765	88	1	table	table	NOUN
iajs-3765	88	2	1	1	NUM
iajs-3765	88	3	.	.	PUNCT
iajs-3765	89	1	groups	group	NOUN
iajs-3765	89	2	distribution	distribution	NOUN
iajs-3765	89	3	according	accord	VERB
iajs-3765	89	4	to	to	ADP
iajs-3765	89	5	the	the	DET
iajs-3765	89	6	baseline	baseline	PROPN
iajs-3765	89	7	characteristics	characteristic	NOUN
iajs-3765	89	8	*	*	PUNCT
iajs-3765	89	9	significant	significant	ADJ
iajs-3765	89	10	difference	difference	NOUN
iajs-3765	89	11	at	at	ADP
iajs-3765	89	12	p	p	X
iajs-3765	89	13	<	<	X
iajs-3765	89	14	0.05	0.05	NUM
iajs-3765	89	15	level	level	NOUN
iajs-3765	89	16	.	.	PUNCT
iajs-3765	90	1	serum	serum	PROPN
iajs-3765	90	2	mmp-1	mmp-1	NOUN
iajs-3765	90	3	,	,	PUNCT
iajs-3765	90	4	crp	crp	PROPN
iajs-3765	90	5	,	,	PUNCT
iajs-3765	90	6	and	and	CCONJ
iajs-3765	90	7	rf	rf	NOUN
iajs-3765	90	8	levels	level	NOUN
iajs-3765	90	9	revealed	reveal	VERB
iajs-3765	90	10	significant	significant	ADJ
iajs-3765	90	11	increases	increase	NOUN
iajs-3765	90	12	in	in	ADP
iajs-3765	90	13	ra	ra	PROPN
iajs-3765	90	14	patients	patient	NOUN
iajs-3765	90	15	compared	compare	VERB
iajs-3765	90	16	to	to	ADP
iajs-3765	90	17	the	the	DET
iajs-3765	90	18	controls	control	NOUN
iajs-3765	90	19	.	.	PUNCT
iajs-3765	91	1	the	the	DET
iajs-3765	91	2	median	median	PROPN
iajs-3765	91	3	esr	esr	PROPN
iajs-3765	91	4	level	level	NOUN
iajs-3765	91	5	in	in	ADP
iajs-3765	91	6	ra	ra	PROPN
iajs-3765	91	7	was	be	AUX
iajs-3765	91	8	substantially	substantially	ADV
iajs-3765	91	9	higher	high	ADJ
iajs-3765	91	10	than	than	ADP
iajs-3765	91	11	that	that	PRON
iajs-3765	91	12	in	in	ADP
iajs-3765	91	13	the	the	DET
iajs-3765	91	14	control	control	NOUN
iajs-3765	91	15	group	group	NOUN
iajs-3765	91	16	,	,	PUNCT
iajs-3765	91	17	as	as	SCONJ
iajs-3765	91	18	shown	show	VERB
iajs-3765	91	19	in	in	ADP
iajs-3765	91	20	table	table	NOUN
iajs-3765	91	21	(	(	PUNCT
iajs-3765	91	22	2	2	NUM
iajs-3765	91	23	)	)	PUNCT
iajs-3765	91	24	.	.	PUNCT
iajs-3765	92	1	the	the	DET
iajs-3765	92	2	results	result	NOUN
iajs-3765	92	3	show	show	VERB
iajs-3765	92	4	that	that	SCONJ
iajs-3765	92	5	there	there	PRON
iajs-3765	92	6	was	be	VERB
iajs-3765	92	7	a	a	DET
iajs-3765	92	8	significant	significant	ADJ
iajs-3765	92	9	increase	increase	NOUN
iajs-3765	92	10	in	in	ADP
iajs-3765	92	11	the	the	DET
iajs-3765	92	12	serum	serum	NOUN
iajs-3765	92	13	lipid	lipid	NOUN
iajs-3765	92	14	profile	profile	NOUN
iajs-3765	92	15	in	in	ADP
iajs-3765	92	16	ra	ra	PROPN
iajs-3765	92	17	patients	patient	NOUN
iajs-3765	92	18	compared	compare	VERB
iajs-3765	92	19	to	to	ADP
iajs-3765	92	20	the	the	DET
iajs-3765	92	21	control	control	NOUN
iajs-3765	92	22	,	,	PUNCT
iajs-3765	92	23	except	except	SCONJ
iajs-3765	92	24	for	for	ADP
iajs-3765	92	25	serum	serum	NOUN
iajs-3765	92	26	hdl	hdl	PROPN
iajs-3765	92	27	-	-	PUNCT
iajs-3765	92	28	c	c	PROPN
iajs-3765	92	29	,	,	PUNCT
iajs-3765	92	30	which	which	PRON
iajs-3765	92	31	showed	show	VERB
iajs-3765	92	32	a	a	DET
iajs-3765	92	33	significant	significant	ADJ
iajs-3765	92	34	decrease	decrease	NOUN
iajs-3765	92	35	in	in	ADP
iajs-3765	92	36	ra	ra	PROPN
iajs-3765	92	37	patients	patient	NOUN
iajs-3765	92	38	compared	compare	VERB
iajs-3765	92	39	to	to	ADP
iajs-3765	92	40	the	the	DET
iajs-3765	92	41	control	control	NOUN
iajs-3765	92	42	(	(	PUNCT
iajs-3765	92	43	table	table	NOUN
iajs-3765	92	44	3	3	NUM
iajs-3765	92	45	)	)	PUNCT
iajs-3765	92	46	.	.	PUNCT
iajs-3765	93	1	the	the	DET
iajs-3765	93	2	correlation	correlation	NOUN
iajs-3765	93	3	between	between	ADP
iajs-3765	93	4	mmp-1	mmp-1	PUNCT
iajs-3765	93	5	and	and	CCONJ
iajs-3765	93	6	other	other	ADJ
iajs-3765	93	7	parameters	parameter	NOUN
iajs-3765	93	8	in	in	ADP
iajs-3765	93	9	ra	ra	PROPN
iajs-3765	93	10	patients	patient	NOUN
iajs-3765	93	11	is	be	AUX
iajs-3765	93	12	demonstrated	demonstrate	VERB
iajs-3765	93	13	in	in	ADP
iajs-3765	93	14	table	table	NOUN
iajs-3765	93	15	(	(	PUNCT
iajs-3765	93	16	4	4	NUM
iajs-3765	93	17	)	)	PUNCT
iajs-3765	93	18	.	.	PUNCT
iajs-3765	94	1	table	table	NOUN
iajs-3765	94	2	2	2	NUM
iajs-3765	94	3	.	.	PUNCT
iajs-3765	94	4	serum	serum	NOUN
iajs-3765	94	5	level	level	NOUN
iajs-3765	94	6	of	of	ADP
iajs-3765	94	7	mmp-1	mmp-1	X
iajs-3765	94	8	,	,	PUNCT
iajs-3765	94	9	crp	crp	PROPN
iajs-3765	94	10	,	,	PUNCT
iajs-3765	94	11	rf	rf	NOUN
iajs-3765	94	12	,	,	PUNCT
iajs-3765	94	13	and	and	CCONJ
iajs-3765	94	14	esr	esr	PROPN
iajs-3765	94	15	between	between	ADP
iajs-3765	94	16	ra	ra	PROPN
iajs-3765	94	17	patients	patient	NOUN
iajs-3765	94	18	and	and	CCONJ
iajs-3765	94	19	control	control	NOUN
iajs-3765	94	20	.	.	PUNCT
iajs-3765	95	1	*	*	PUNCT
iajs-3765	95	2	significant	significant	ADJ
iajs-3765	95	3	difference	difference	NOUN
iajs-3765	95	4	between	between	ADP
iajs-3765	95	5	two	two	NUM
iajs-3765	95	6	independent	independent	ADJ
iajs-3765	95	7	means	mean	NOUN
iajs-3765	95	8	using	use	VERB
iajs-3765	95	9	students	student	NOUN
iajs-3765	95	10	-	-	PUNCT
iajs-3765	95	11	t	t	NOUN
iajs-3765	95	12	-	-	PUNCT
iajs-3765	95	13	test	test	NOUN
iajs-3765	95	14	at	at	ADP
iajs-3765	95	15	0.05	0.05	NUM
iajs-3765	95	16	level	level	NOUN
iajs-3765	95	17	.	.	PUNCT
iajs-3765	96	1	mmp-1=	mmp-1=	NOUN
iajs-3765	96	2	matrix	matrix	NOUN
iajs-3765	96	3	metalloproteinase-1	metalloproteinase-1	NUM
iajs-3765	96	4	;	;	PUNCT
iajs-3765	96	5	crp	crp	PROPN
iajs-3765	96	6	=	=	SYM
iajs-3765	96	7	c	c	NOUN
iajs-3765	96	8	-	-	PUNCT
iajs-3765	96	9	reactive	reactive	ADJ
iajs-3765	96	10	protein	protein	NOUN
iajs-3765	96	11	;	;	PUNCT
iajs-3765	96	12	rf=	rf=	VERB
iajs-3765	96	13	rheumatoid	rheumatoid	NOUN
iajs-3765	96	14	factor	factor	NOUN
iajs-3765	96	15	;	;	PUNCT
iajs-3765	96	16	esr=	esr=	PROPN
iajs-3765	96	17	erythrocyte	erythrocyte	NOUN
iajs-3765	96	18	sedimentation	sedimentation	NOUN
iajs-3765	96	19	rate	rate	NOUN
iajs-3765	96	20	;	;	PUNCT
iajs-3765	96	21	ra=	ra=	VERB
iajs-3765	96	22	rheumatoid	rheumatoid	NOUN
iajs-3765	96	23	arthritis	arthritis	NOUN
iajs-3765	96	24	.	.	PUNCT
iajs-3765	97	1	table	table	NOUN
iajs-3765	97	2	3	3	NUM
iajs-3765	97	3	.	.	X
iajs-3765	97	4	serum	serum	NOUN
iajs-3765	97	5	lipid	lipid	PROPN
iajs-3765	97	6	profile	profile	NOUN
iajs-3765	97	7	in	in	ADP
iajs-3765	97	8	ra	ra	PROPN
iajs-3765	97	9	patients	patient	NOUN
iajs-3765	97	10	and	and	CCONJ
iajs-3765	97	11	control	control	NOUN
iajs-3765	97	12	parameters	parameter	NOUN
iajs-3765	97	13	mean	mean	VERB
iajs-3765	97	14	±	±	NUM
iajs-3765	97	15	se	se	X
iajs-3765	97	16	p	p	NOUN
iajs-3765	97	17	-	-	PUNCT
iajs-3765	97	18	value	value	NOUN
iajs-3765	97	19	ra	ra	NOUN
iajs-3765	97	20	patients	patient	NOUN
iajs-3765	97	21	(	(	PUNCT
iajs-3765	97	22	n	n	NOUN
iajs-3765	97	23	=	=	NUM
iajs-3765	97	24	80	80	NUM
iajs-3765	97	25	)	)	PUNCT
iajs-3765	97	26	control	control	NOUN
iajs-3765	97	27	(	(	PUNCT
iajs-3765	97	28	n	n	NOUN
iajs-3765	97	29	=	=	NUM
iajs-3765	97	30	40	40	NUM
iajs-3765	97	31	)	)	PUNCT
iajs-3765	97	32	cholesterol	cholesterol	NOUN
iajs-3765	97	33	(	(	PUNCT
iajs-3765	97	34	mg	mg	PROPN
iajs-3765	97	35	/	/	SYM
iajs-3765	97	36	dl	dl	NOUN
iajs-3765	97	37	)	)	PUNCT
iajs-3765	97	38	196.63±4.29	196.63±4.29	NUM
iajs-3765	97	39	105.83±3.32	105.83±3.32	NUM
iajs-3765	97	40	0.0001	0.0001	NUM
iajs-3765	97	41	*	*	PUNCT
iajs-3765	97	42	tg	tg	INTJ
iajs-3765	97	43	(	(	PUNCT
iajs-3765	97	44	mg	mg	PROPN
iajs-3765	97	45	/	/	SYM
iajs-3765	97	46	dl	dl	PROPN
iajs-3765	97	47	)	)	PUNCT
iajs-3765	97	48	210.11±1.59	210.11±1.59	NUM
iajs-3765	97	49	168.35±3.56	168.35±3.56	NUM
iajs-3765	97	50	0.0001	0.0001	NUM
iajs-3765	97	51	*	*	PUNCT
iajs-3765	97	52	hdl	hdl	PROPN
iajs-3765	97	53	-	-	PUNCT
iajs-3765	97	54	c	c	PROPN
iajs-3765	97	55	(	(	PUNCT
iajs-3765	97	56	mg	mg	PROPN
iajs-3765	97	57	/	/	SYM
iajs-3765	97	58	dl	dl	PROPN
iajs-3765	97	59	)	)	PUNCT
iajs-3765	97	60	33.15±0.59	33.15±0.59	NOUN
iajs-3765	97	61	42.75±0.54	42.75±0.54	NUM
iajs-3765	98	1	0.0001	0.0001	NUM
iajs-3765	98	2	*	*	PUNCT
iajs-3765	98	3	ldl	ldl	NOUN
iajs-3765	98	4	-	-	PUNCT
iajs-3765	98	5	c	c	NOUN
iajs-3765	98	6	(	(	PUNCT
iajs-3765	98	7	mg	mg	PROPN
iajs-3765	98	8	/	/	SYM
iajs-3765	98	9	dl	dl	NOUN
iajs-3765	98	10	)	)	PUNCT
iajs-3765	98	11	121.45±4.14	121.45±4.14	NUM
iajs-3765	98	12	29.43±2.95	29.43±2.95	NUM
iajs-3765	98	13	0.0001	0.0001	NUM
iajs-3765	98	14	*	*	PUNCT
iajs-3765	98	15	vldl	vldl	PROPN
iajs-3765	98	16	-	-	PUNCT
iajs-3765	98	17	c	c	NOUN
iajs-3765	98	18	(	(	PUNCT
iajs-3765	98	19	mg	mg	PROPN
iajs-3765	98	20	/	/	SYM
iajs-3765	98	21	dl	dl	PROPN
iajs-3765	98	22	)	)	PUNCT
iajs-3765	98	23	42.02±0.31	42.02±0.31	NUM
iajs-3765	98	24	33.67±0.71	33.67±0.71	NUM
iajs-3765	98	25	0.0001	0.0001	NUM
iajs-3765	98	26	*	*	NOUN
iajs-3765	98	27	data	datum	NOUN
iajs-3765	98	28	were	be	AUX
iajs-3765	98	29	presented	present	VERB
iajs-3765	98	30	as	as	ADP
iajs-3765	98	31	mean	mean	NOUN
iajs-3765	98	32	±	±	NUM
iajs-3765	98	33	se.*significant	se.*significant	NOUN
iajs-3765	98	34	difference	difference	NOUN
iajs-3765	98	35	between	between	ADP
iajs-3765	98	36	two	two	NUM
iajs-3765	98	37	independent	independent	ADJ
iajs-3765	98	38	means	mean	NOUN
iajs-3765	98	39	using	use	VERB
iajs-3765	98	40	students	student	NOUN
iajs-3765	98	41	-	-	PUNCT
iajs-3765	98	42	ttest	ttest	NOUN
iajs-3765	98	43	at	at	ADP
iajs-3765	98	44	0.05	0.05	NUM
iajs-3765	98	45	level	level	NOUN
iajs-3765	98	46	.	.	PUNCT
iajs-3765	99	1	parameters	parameter	NOUN
iajs-3765	99	2	ra	ra	PROPN
iajs-3765	99	3	patients	patient	NOUN
iajs-3765	99	4	(	(	PUNCT
iajs-3765	99	5	n	n	NOUN
iajs-3765	99	6	=	=	NUM
iajs-3765	99	7	80	80	NUM
iajs-3765	99	8	)	)	PUNCT
iajs-3765	99	9	control	control	NOUN
iajs-3765	99	10	(	(	PUNCT
iajs-3765	99	11	n	n	NOUN
iajs-3765	99	12	=	=	SYM
iajs-3765	99	13	40	40	NUM
iajs-3765	99	14	)	)	PUNCT
iajs-3765	99	15	p	p	X
iajs-3765	99	16	-	-	PUNCT
iajs-3765	99	17	value	value	NOUN
iajs-3765	99	18	no	no	NOUN
iajs-3765	99	19	.	.	PUNCT
iajs-3765	100	1	(	(	PUNCT
iajs-3765	100	2	%	%	INTJ
iajs-3765	100	3	)	)	PUNCT
iajs-3765	100	4	no	no	INTJ
iajs-3765	100	5	.	.	PUNCT
iajs-3765	101	1	(	(	PUNCT
iajs-3765	101	2	%	%	NOUN
iajs-3765	101	3	)	)	PUNCT
iajs-3765	101	4	age	age	NOUN
iajs-3765	101	5	(	(	PUNCT
iajs-3765	101	6	years	year	NOUN
iajs-3765	101	7	)	)	PUNCT
iajs-3765	101	8	≤	≤	NUM
iajs-3765	101	9	50	50	NUM
iajs-3765	101	10	39	39	NUM
iajs-3765	101	11	(	(	PUNCT
iajs-3765	101	12	48.8	48.8	NUM
iajs-3765	101	13	%	%	NOUN
iajs-3765	101	14	)	)	PUNCT
iajs-3765	101	15	31	31	NUM
iajs-3765	101	16	(	(	PUNCT
iajs-3765	101	17	77.5	77.5	NUM
iajs-3765	101	18	%	%	NOUN
iajs-3765	101	19	)	)	PUNCT
iajs-3765	101	20	0.0001	0.0001	NUM
iajs-3765	101	21	*	*	PUNCT
iajs-3765	101	22	˃	˃	NOUN
iajs-3765	101	23	50	50	NUM
iajs-3765	101	24	41	41	NUM
iajs-3765	101	25	(	(	PUNCT
iajs-3765	101	26	51.2	51.2	NUM
iajs-3765	101	27	%	%	NOUN
iajs-3765	101	28	)	)	PUNCT
iajs-3765	101	29	9	9	NUM
iajs-3765	101	30	(	(	PUNCT
iajs-3765	101	31	22.5	22.5	NUM
iajs-3765	101	32	%	%	NOUN
iajs-3765	101	33	)	)	PUNCT
iajs-3765	101	34	bmi	bmi	NOUN
iajs-3765	101	35	(	(	PUNCT
iajs-3765	101	36	kg	kg	NOUN
iajs-3765	101	37	/	/	SYM
iajs-3765	101	38	m	m	VERB
iajs-3765	101	39	2	2	NUM
iajs-3765	101	40	)	)	PUNCT
iajs-3765	101	41	healthy	healthy	ADJ
iajs-3765	101	42	weight	weight	NOUN
iajs-3765	101	43	(	(	PUNCT
iajs-3765	101	44	18.5	18.5	NUM
iajs-3765	101	45	-	-	SYM
iajs-3765	101	46	24.9	24.9	NUM
iajs-3765	101	47	)	)	PUNCT
iajs-3765	101	48	14	14	NUM
iajs-3765	101	49	(	(	PUNCT
iajs-3765	101	50	17.5	17.5	NUM
iajs-3765	101	51	%	%	NOUN
iajs-3765	101	52	)	)	PUNCT
iajs-3765	101	53	13	13	NUM
iajs-3765	101	54	(	(	PUNCT
iajs-3765	101	55	32.5	32.5	NUM
iajs-3765	101	56	%	%	NOUN
iajs-3765	101	57	)	)	PUNCT
iajs-3765	102	1	0.078	0.078	NUM
iajs-3765	102	2	overweight	overweight	NOUN
iajs-3765	102	3	(	(	PUNCT
iajs-3765	102	4	25	25	NUM
iajs-3765	102	5	-	-	SYM
iajs-3765	102	6	29.9	29.9	NUM
iajs-3765	102	7	)	)	PUNCT
iajs-3765	102	8	27	27	NUM
iajs-3765	102	9	(	(	PUNCT
iajs-3765	102	10	33.8	33.8	NUM
iajs-3765	102	11	%	%	NOUN
iajs-3765	102	12	)	)	PUNCT
iajs-3765	102	13	17	17	NUM
iajs-3765	102	14	(	(	PUNCT
iajs-3765	102	15	42.5	42.5	NUM
iajs-3765	102	16	%	%	NOUN
iajs-3765	102	17	)	)	PUNCT
iajs-3765	102	18	obese	obese	NOUN
iajs-3765	102	19	(	(	PUNCT
iajs-3765	102	20	30	30	NUM
iajs-3765	102	21	-	-	SYM
iajs-3765	102	22	34.9	34.9	NUM
iajs-3765	102	23	)	)	PUNCT
iajs-3765	102	24	24	24	NUM
iajs-3765	102	25	(	(	PUNCT
iajs-3765	102	26	30	30	NUM
iajs-3765	102	27	%	%	NOUN
iajs-3765	102	28	)	)	PUNCT
iajs-3765	102	29	7	7	NUM
iajs-3765	102	30	(	(	PUNCT
iajs-3765	102	31	17.5	17.5	NUM
iajs-3765	102	32	%	%	NOUN
iajs-3765	102	33	)	)	PUNCT
iajs-3765	102	34	extremely	extremely	ADV
iajs-3765	102	35	obese	obese	ADJ
iajs-3765	102	36	(	(	PUNCT
iajs-3765	102	37	>	>	NOUN
iajs-3765	102	38	35	35	NUM
iajs-3765	102	39	)	)	PUNCT
iajs-3765	102	40	13	13	NUM
iajs-3765	102	41	(	(	PUNCT
iajs-3765	102	42	16.3	16.3	NUM
iajs-3765	102	43	%	%	NOUN
iajs-3765	102	44	)	)	PUNCT
iajs-3765	102	45	3	3	NUM
iajs-3765	102	46	(	(	PUNCT
iajs-3765	102	47	7.5	7.5	NUM
iajs-3765	102	48	%	%	NOUN
iajs-3765	102	49	)	)	PUNCT
iajs-3765	102	50	gender	gender	NOUN
iajs-3765	102	51	female	female	NOUN
iajs-3765	102	52	74	74	NUM
iajs-3765	102	53	(	(	PUNCT
iajs-3765	102	54	92.5	92.5	NUM
iajs-3765	102	55	%	%	NOUN
iajs-3765	102	56	)	)	PUNCT
iajs-3765	102	57	33	33	NUM
iajs-3765	102	58	(	(	PUNCT
iajs-3765	102	59	82.5	82.5	NUM
iajs-3765	102	60	%	%	NOUN
iajs-3765	102	61	)	)	PUNCT
iajs-3765	102	62	0.098	0.098	NUM
iajs-3765	102	63	male	male	NOUN
iajs-3765	102	64	6	6	NUM
iajs-3765	102	65	(	(	PUNCT
iajs-3765	102	66	7.5	7.5	NUM
iajs-3765	102	67	%	%	NOUN
iajs-3765	102	68	)	)	PUNCT
iajs-3765	102	69	7	7	NUM
iajs-3765	102	70	(	(	PUNCT
iajs-3765	102	71	17.5	17.5	NUM
iajs-3765	102	72	%	%	NOUN
iajs-3765	102	73	)	)	PUNCT
iajs-3765	102	74	smoking	smoke	VERB
iajs-3765	102	75	yes	yes	INTJ
iajs-3765	102	76	2	2	NUM
iajs-3765	102	77	(	(	PUNCT
iajs-3765	102	78	5	5	NUM
iajs-3765	102	79	%	%	NOUN
iajs-3765	102	80	)	)	PUNCT
iajs-3765	102	81	0.044	0.044	NUM
iajs-3765	102	82	*	*	PUNCT
iajs-3765	102	83	no	no	DET
iajs-3765	102	84	80	80	NUM
iajs-3765	102	85	(	(	PUNCT
iajs-3765	102	86	100	100	NUM
iajs-3765	102	87	%	%	NOUN
iajs-3765	102	88	)	)	PUNCT
iajs-3765	102	89	38	38	NUM
iajs-3765	102	90	(	(	PUNCT
iajs-3765	102	91	95	95	NUM
iajs-3765	102	92	%	%	NOUN
iajs-3765	102	93	)	)	PUNCT
iajs-3765	102	94	menopause	menopause	NOUN
iajs-3765	102	95	post	post	NOUN
iajs-3765	102	96	32	32	NUM
iajs-3765	102	97	(	(	PUNCT
iajs-3765	102	98	40	40	NUM
iajs-3765	102	99	%	%	NOUN
iajs-3765	102	100	)	)	PUNCT
iajs-3765	102	101	8	8	NUM
iajs-3765	102	102	(	(	PUNCT
iajs-3765	102	103	20	20	NUM
iajs-3765	102	104	%	%	NOUN
iajs-3765	102	105	)	)	PUNCT
iajs-3765	102	106	0.0001	0.0001	NUM
iajs-3765	102	107	*	*	PUNCT
iajs-3765	102	108	pre	pre	X
iajs-3765	102	109	43	43	NUM
iajs-3765	102	110	(	(	PUNCT
iajs-3765	102	111	53.8	53.8	NUM
iajs-3765	102	112	%	%	NOUN
iajs-3765	102	113	)	)	PUNCT
iajs-3765	102	114	25	25	NUM
iajs-3765	102	115	(	(	PUNCT
iajs-3765	102	116	65.5	65.5	NUM
iajs-3765	102	117	%	%	NOUN
iajs-3765	102	118	)	)	PUNCT
iajs-3765	102	119	parameters	parameter	NOUN
iajs-3765	102	120	mean	mean	VERB
iajs-3765	102	121	±	±	NUM
iajs-3765	102	122	se	se	X
iajs-3765	102	123	p	p	NOUN
iajs-3765	102	124	-	-	PUNCT
iajs-3765	102	125	value	value	NOUN
iajs-3765	102	126	ra	ra	NOUN
iajs-3765	102	127	patients	patient	NOUN
iajs-3765	102	128	(	(	PUNCT
iajs-3765	102	129	n	n	NOUN
iajs-3765	102	130	=	=	NUM
iajs-3765	102	131	80	80	NUM
iajs-3765	102	132	)	)	PUNCT
iajs-3765	102	133	control	control	NOUN
iajs-3765	102	134	(	(	PUNCT
iajs-3765	102	135	n	n	NOUN
iajs-3765	102	136	=	=	NUM
iajs-3765	102	137	40	40	NUM
iajs-3765	102	138	)	)	PUNCT
iajs-3765	102	139	mmp-1	mmp-1	ADP
iajs-3765	102	140	(	(	PUNCT
iajs-3765	102	141	ng	ng	PROPN
iajs-3765	102	142	/	/	SYM
iajs-3765	102	143	ml	ml	NOUN
iajs-3765	102	144	)	)	PUNCT
iajs-3765	102	145	3.27±0.10	3.27±0.10	NOUN
iajs-3765	102	146	1.40±0.11	1.40±0.11	NUM
iajs-3765	102	147	<	<	X
iajs-3765	102	148	0.0001	0.0001	NUM
iajs-3765	102	149	crp	crp	X
iajs-3765	102	150	(	(	PUNCT
iajs-3765	102	151	ng	ng	PROPN
iajs-3765	102	152	/	/	SYM
iajs-3765	102	153	ml	ml	PROPN
iajs-3765	102	154	)	)	PUNCT
iajs-3765	102	155	2443.09±17.33	2443.09±17.33	NUM
iajs-3765	102	156	1272.41±35.24	1272.41±35.24	NUM
iajs-3765	102	157	<	<	X
iajs-3765	102	158	0.0001	0.0001	NUM
iajs-3765	102	159	rf(ng	rf(ng	ADJ
iajs-3765	102	160	/	/	SYM
iajs-3765	102	161	ml	ml	NOUN
iajs-3765	102	162	)	)	PUNCT
iajs-3765	102	163	0.93±0.13	0.93±0.13	NOUN
iajs-3765	102	164	0.35±0.034	0.35±0.034	PUNCT
iajs-3765	102	165	<	<	X
iajs-3765	102	166	0.0001	0.0001	NUM
iajs-3765	102	167	esr	esr	NOUN
iajs-3765	102	168	(	(	PUNCT
iajs-3765	102	169	mm	mm	PROPN
iajs-3765	102	170	/	/	SYM
iajs-3765	102	171	hr	hr	NOUN
iajs-3765	102	172	)	)	PUNCT
iajs-3765	102	173	33.82±2.53	33.82±2.53	NUM
iajs-3765	102	174	15.54±1.14	15.54±1.14	NUM
iajs-3765	102	175	<	<	X
iajs-3765	102	176	0.0001	0.0001	NUM
iajs-3765	102	177	ihjpas	ihjpa	NOUN
iajs-3765	102	178	.	.	PUNCT
iajs-3765	103	1	2025	2025	NUM
iajs-3765	103	2	,	,	PUNCT
iajs-3765	103	3	38(3	38(3	NUM
iajs-3765	103	4	)	)	PUNCT
iajs-3765	103	5	269	269	NUM
iajs-3765	103	6	the	the	DET
iajs-3765	103	7	correlation	correlation	NOUN
iajs-3765	103	8	between	between	ADP
iajs-3765	103	9	mmp-1	mmp-1	PUNCT
iajs-3765	103	10	and	and	CCONJ
iajs-3765	103	11	other	other	ADJ
iajs-3765	103	12	parameters	parameter	NOUN
iajs-3765	103	13	in	in	ADP
iajs-3765	103	14	ra	ra	PROPN
iajs-3765	103	15	patients	patient	NOUN
iajs-3765	103	16	is	be	AUX
iajs-3765	103	17	demonstrated	demonstrate	VERB
iajs-3765	103	18	in	in	ADP
iajs-3765	103	19	table	table	NOUN
iajs-3765	103	20	(	(	PUNCT
iajs-3765	103	21	4	4	NUM
iajs-3765	103	22	)	)	PUNCT
iajs-3765	103	23	.	.	PUNCT
iajs-3765	104	1	table	table	NOUN
iajs-3765	104	2	4	4	NUM
iajs-3765	104	3	.	.	PUNCT
iajs-3765	104	4	correlation	correlation	NOUN
iajs-3765	104	5	between	between	ADP
iajs-3765	104	6	mmp-1	mmp-1	PUNCT
iajs-3765	104	7	and	and	CCONJ
iajs-3765	104	8	other	other	ADJ
iajs-3765	104	9	parameters	parameter	NOUN
iajs-3765	104	10	in	in	ADP
iajs-3765	104	11	ra	ra	PROPN
iajs-3765	104	12	patients	patient	NOUN
iajs-3765	104	13	*	*	PUNCT
iajs-3765	104	14	correlation	correlation	NOUN
iajs-3765	104	15	is	be	AUX
iajs-3765	104	16	significant	significant	ADJ
iajs-3765	104	17	at	at	ADP
iajs-3765	104	18	the	the	DET
iajs-3765	104	19	0.05	0.05	NUM
iajs-3765	104	20	level	level	NOUN
iajs-3765	104	21	.	.	PUNCT
iajs-3765	105	1	the	the	DET
iajs-3765	105	2	roc	roc	PROPN
iajs-3765	105	3	analysis	analysis	NOUN
iajs-3765	105	4	revealed	reveal	VERB
iajs-3765	105	5	that	that	SCONJ
iajs-3765	105	6	the	the	DET
iajs-3765	105	7	level	level	NOUN
iajs-3765	105	8	of	of	ADP
iajs-3765	105	9	mmp-1	mmp-1	NOUN
iajs-3765	105	10	in	in	ADP
iajs-3765	105	11	serum	serum	NOUN
iajs-3765	105	12	could	could	AUX
iajs-3765	105	13	discriminate	discriminate	VERB
iajs-3765	105	14	among	among	ADP
iajs-3765	105	15	ra	ra	PROPN
iajs-3765	105	16	patients	patient	NOUN
iajs-3765	105	17	with	with	ADP
iajs-3765	105	18	a	a	DET
iajs-3765	105	19	sensitivity	sensitivity	NOUN
iajs-3765	105	20	of	of	ADP
iajs-3765	105	21	0.963	0.963	NUM
iajs-3765	105	22	and	and	CCONJ
iajs-3765	105	23	a	a	DET
iajs-3765	105	24	specificity	specificity	NOUN
iajs-3765	105	25	of	of	ADP
iajs-3765	105	26	0.150	0.150	NUM
iajs-3765	105	27	(	(	PUNCT
iajs-3765	105	28	area	area	NOUN
iajs-3765	105	29	under	under	ADP
iajs-3765	105	30	curve	curve	NOUN
iajs-3765	105	31	=	=	PROPN
iajs-3765	105	32	0.939	0.939	NUM
iajs-3765	105	33	)	)	PUNCT
iajs-3765	105	34	,	,	PUNCT
iajs-3765	105	35	as	as	SCONJ
iajs-3765	105	36	shown	show	VERB
iajs-3765	105	37	in	in	ADP
iajs-3765	105	38	figure	figure	NOUN
iajs-3765	105	39	(	(	PUNCT
iajs-3765	105	40	1	1	NUM
iajs-3765	105	41	)	)	PUNCT
iajs-3765	105	42	.	.	PUNCT
iajs-3765	106	1	figure	figure	NOUN
iajs-3765	106	2	1	1	NUM
iajs-3765	106	3	.	.	PUNCT
iajs-3765	107	1	the	the	DET
iajs-3765	107	2	roc	roc	PROPN
iajs-3765	107	3	curve	curve	NOUN
iajs-3765	107	4	for	for	ADP
iajs-3765	107	5	mmp-1	mmp-1	PUNCT
iajs-3765	107	6	in	in	ADP
iajs-3765	107	7	ra	ra	PROPN
iajs-3765	107	8	patients	patient	NOUN
iajs-3765	107	9	4	4	NUM
iajs-3765	107	10	.	.	PUNCT
iajs-3765	107	11	discussion	discussion	NOUN
iajs-3765	107	12	the	the	DET
iajs-3765	107	13	current	current	ADJ
iajs-3765	107	14	data	datum	NOUN
iajs-3765	107	15	indicates	indicate	VERB
iajs-3765	107	16	the	the	DET
iajs-3765	107	17	predictive	predictive	ADJ
iajs-3765	107	18	value	value	NOUN
iajs-3765	107	19	of	of	ADP
iajs-3765	107	20	mmp-1	mmp-1	PUNCT
iajs-3765	107	21	as	as	ADP
iajs-3765	107	22	an	an	DET
iajs-3765	107	23	ra	ra	PROPN
iajs-3765	107	24	biomarker	biomarker	NOUN
iajs-3765	107	25	,	,	PUNCT
iajs-3765	107	26	which	which	PRON
iajs-3765	107	27	is	be	AUX
iajs-3765	107	28	more	more	ADV
iajs-3765	107	29	pronounced	pronounced	ADJ
iajs-3765	107	30	in	in	ADP
iajs-3765	107	31	malignant	malignant	ADJ
iajs-3765	107	32	lesions	lesion	NOUN
iajs-3765	107	33	.	.	PUNCT
iajs-3765	108	1	the	the	DET
iajs-3765	108	2	most	most	ADV
iajs-3765	108	3	notable	notable	ADJ
iajs-3765	108	4	finding	finding	NOUN
iajs-3765	108	5	in	in	ADP
iajs-3765	108	6	this	this	DET
iajs-3765	108	7	study	study	NOUN
iajs-3765	108	8	is	be	AUX
iajs-3765	108	9	the	the	DET
iajs-3765	108	10	higher	high	ADJ
iajs-3765	108	11	levels	level	NOUN
iajs-3765	108	12	of	of	ADP
iajs-3765	108	13	serum	serum	NOUN
iajs-3765	108	14	mmp-1	mmp-1	NOUN
iajs-3765	108	15	,	,	PUNCT
iajs-3765	108	16	crp	crp	PROPN
iajs-3765	108	17	,	,	PUNCT
iajs-3765	108	18	esr	esr	PROPN
iajs-3765	108	19	,	,	PUNCT
iajs-3765	108	20	and	and	CCONJ
iajs-3765	108	21	lipid	lipid	NOUN
iajs-3765	108	22	profiles	profile	NOUN
iajs-3765	108	23	in	in	ADP
iajs-3765	108	24	patients	patient	NOUN
iajs-3765	108	25	with	with	ADP
iajs-3765	108	26	ra	ra	PROPN
iajs-3765	108	27	compared	compare	VERB
iajs-3765	108	28	to	to	ADP
iajs-3765	108	29	the	the	DET
iajs-3765	108	30	control	control	NOUN
iajs-3765	108	31	group	group	NOUN
iajs-3765	108	32	.	.	PUNCT
iajs-3765	109	1	this	this	DET
iajs-3765	109	2	study	study	NOUN
iajs-3765	109	3	found	find	VERB
iajs-3765	109	4	that	that	SCONJ
iajs-3765	109	5	ra	ra	PROPN
iajs-3765	109	6	patients	patient	NOUN
iajs-3765	109	7	had	have	VERB
iajs-3765	109	8	higher	high	ADJ
iajs-3765	109	9	serum	serum	NOUN
iajs-3765	109	10	mmp-1	mmp-1	NOUN
iajs-3765	109	11	levels	level	NOUN
iajs-3765	109	12	than	than	ADP
iajs-3765	109	13	controls	control	NOUN
iajs-3765	109	14	,	,	PUNCT
iajs-3765	109	15	which	which	PRON
iajs-3765	109	16	may	may	AUX
iajs-3765	109	17	mmp-1	mmp-1	X
iajs-3765	109	18	(	(	PUNCT
iajs-3765	109	19	ng	ng	PROPN
iajs-3765	109	20	/	/	SYM
iajs-3765	109	21	ml	ml	NOUN
iajs-3765	109	22	)	)	PUNCT
iajs-3765	109	23	ra	ra	PROPN
iajs-3765	109	24	patients	patient	NOUN
iajs-3765	109	25	age	age	NOUN
iajs-3765	109	26	(	(	PUNCT
iajs-3765	109	27	years	year	NOUN
iajs-3765	109	28	)	)	PUNCT
iajs-3765	110	1	r	r	NOUN
iajs-3765	110	2	-0.082	-0.082	PROPN
iajs-3765	110	3	p	p	NOUN
iajs-3765	110	4	0.468	0.468	NUM
iajs-3765	110	5	bmi	bmi	NOUN
iajs-3765	110	6	(	(	PUNCT
iajs-3765	110	7	kg	kg	NOUN
iajs-3765	110	8	/	/	SYM
iajs-3765	110	9	m	m	VERB
iajs-3765	110	10	2	2	NUM
iajs-3765	110	11	)	)	PUNCT
iajs-3765	111	1	r	r	NOUN
iajs-3765	111	2	0.105	0.105	NUM
iajs-3765	111	3	p	p	NOUN
iajs-3765	111	4	0.354	0.354	NUM
iajs-3765	111	5	cholesterol	cholesterol	NOUN
iajs-3765	111	6	(	(	PUNCT
iajs-3765	111	7	mg	mg	PROPN
iajs-3765	111	8	/	/	SYM
iajs-3765	111	9	dl	dl	NOUN
iajs-3765	111	10	)	)	PUNCT
iajs-3765	111	11	r	r	NOUN
iajs-3765	111	12	0.223	0.223	NUM
iajs-3765	111	13	*	*	PUNCT
iajs-3765	111	14	p	p	PROPN
iajs-3765	111	15	0.047	0.047	NUM
iajs-3765	111	16	tg	tg	PROPN
iajs-3765	111	17	(	(	PUNCT
iajs-3765	111	18	mg	mg	PROPN
iajs-3765	111	19	/	/	SYM
iajs-3765	111	20	dl	dl	NOUN
iajs-3765	111	21	)	)	PUNCT
iajs-3765	111	22	r	r	NOUN
iajs-3765	111	23	-0.027	-0.027	NOUN
iajs-3765	112	1	p	p	NOUN
iajs-3765	112	2	0.810	0.810	NUM
iajs-3765	112	3	hdl	hdl	NOUN
iajs-3765	112	4	-	-	PUNCT
iajs-3765	112	5	c	c	PROPN
iajs-3765	112	6	(	(	PUNCT
iajs-3765	112	7	mg	mg	PROPN
iajs-3765	112	8	/	/	SYM
iajs-3765	112	9	dl	dl	NOUN
iajs-3765	112	10	)	)	PUNCT
iajs-3765	112	11	r	r	NOUN
iajs-3765	112	12	0.197	0.197	NUM
iajs-3765	112	13	p	p	NOUN
iajs-3765	112	14	0.080	0.080	NUM
iajs-3765	112	15	ldl	ldl	PROPN
iajs-3765	112	16	-	-	PUNCT
iajs-3765	112	17	c	c	NOUN
iajs-3765	112	18	(	(	PUNCT
iajs-3765	112	19	mg	mg	PROPN
iajs-3765	112	20	/	/	SYM
iajs-3765	112	21	dl	dl	NOUN
iajs-3765	112	22	)	)	PUNCT
iajs-3765	112	23	r	r	NOUN
iajs-3765	112	24	0.206	0.206	NUM
iajs-3765	112	25	p	p	NOUN
iajs-3765	112	26	0.067	0.067	NUM
iajs-3765	112	27	vldl	vldl	PROPN
iajs-3765	112	28	-	-	PUNCT
iajs-3765	112	29	c	c	NOUN
iajs-3765	112	30	(	(	PUNCT
iajs-3765	112	31	mg	mg	PROPN
iajs-3765	112	32	/	/	SYM
iajs-3765	112	33	dl	dl	NOUN
iajs-3765	112	34	)	)	PUNCT
iajs-3765	112	35	r	r	NOUN
iajs-3765	112	36	-0.027	-0.027	NOUN
iajs-3765	112	37	p	p	NOUN
iajs-3765	112	38	0.810	0.810	NUM
iajs-3765	112	39	crp	crp	NOUN
iajs-3765	112	40	(	(	PUNCT
iajs-3765	112	41	pg	pg	NOUN
iajs-3765	112	42	/	/	SYM
iajs-3765	112	43	ml	ml	NOUN
iajs-3765	112	44	)	)	PUNCT
iajs-3765	112	45	r	r	NOUN
iajs-3765	112	46	-0.007	-0.007	NOUN
iajs-3765	112	47	p	p	NOUN
iajs-3765	112	48	0.949	0.949	NUM
iajs-3765	112	49	esr	esr	PROPN
iajs-3765	112	50	(	(	PUNCT
iajs-3765	112	51	mm	mm	PROPN
iajs-3765	112	52	/	/	SYM
iajs-3765	112	53	h	h	NOUN
iajs-3765	112	54	)	)	PUNCT
iajs-3765	112	55	r	r	NOUN
iajs-3765	112	56	-0.036	-0.036	NOUN
iajs-3765	113	1	p	p	NOUN
iajs-3765	113	2	0.753	0.753	NUM
iajs-3765	113	3	rf	rf	PROPN
iajs-3765	113	4	(	(	PUNCT
iajs-3765	113	5	ng	ng	PROPN
iajs-3765	113	6	/	/	SYM
iajs-3765	113	7	ml	ml	NOUN
iajs-3765	113	8	)	)	PUNCT
iajs-3765	113	9	r	r	NOUN
iajs-3765	113	10	-0.160	-0.160	NOUN
iajs-3765	113	11	p	p	PROPN
iajs-3765	113	12	0.156	0.156	NUM
iajs-3765	113	13	ihjpas	ihjpas	PROPN
iajs-3765	113	14	.	.	PUNCT
iajs-3765	114	1	2025	2025	NUM
iajs-3765	114	2	,	,	PUNCT
iajs-3765	114	3	38(3	38(3	NUM
iajs-3765	114	4	)	)	PUNCT
iajs-3765	114	5	270	270	NUM
iajs-3765	114	6	indicate	indicate	VERB
iajs-3765	114	7	the	the	DET
iajs-3765	114	8	presence	presence	NOUN
iajs-3765	114	9	of	of	ADP
iajs-3765	114	10	the	the	DET
iajs-3765	114	11	disease	disease	NOUN
iajs-3765	114	12	and	and	CCONJ
iajs-3765	114	13	its	its	PRON
iajs-3765	114	14	progression	progression	NOUN
iajs-3765	114	15	.	.	PUNCT
iajs-3765	115	1	the	the	DET
iajs-3765	115	2	ra	ra	PROPN
iajs-3765	115	3	can	can	AUX
iajs-3765	115	4	develop	develop	VERB
iajs-3765	115	5	from	from	ADP
iajs-3765	115	6	a	a	DET
iajs-3765	115	7	moderate	moderate	ADJ
iajs-3765	115	8	,	,	PUNCT
iajs-3765	115	9	non	non	ADJ
iajs-3765	115	10	-	-	ADJ
iajs-3765	115	11	destructive	destructive	ADJ
iajs-3765	115	12	type	type	NOUN
iajs-3765	115	13	to	to	ADP
iajs-3765	115	14	a	a	DET
iajs-3765	115	15	serious	serious	ADJ
iajs-3765	115	16	,	,	PUNCT
iajs-3765	115	17	rapidly	rapidly	ADV
iajs-3765	115	18	degenerative	degenerative	VERB
iajs-3765	115	19	joint	joint	ADJ
iajs-3765	115	20	condition	condition	NOUN
iajs-3765	115	21	.	.	PUNCT
iajs-3765	116	1	it	it	PRON
iajs-3765	116	2	could	could	AUX
iajs-3765	116	3	be	be	AUX
iajs-3765	116	4	used	use	VERB
iajs-3765	116	5	to	to	PART
iajs-3765	116	6	estimate	estimate	VERB
iajs-3765	116	7	ra	ra	NOUN
iajs-3765	116	8	progression	progression	NOUN
iajs-3765	116	9	and	and	CCONJ
iajs-3765	116	10	identify	identify	VERB
iajs-3765	116	11	the	the	DET
iajs-3765	116	12	best	good	ADJ
iajs-3765	116	13	course	course	NOUN
iajs-3765	116	14	of	of	ADP
iajs-3765	116	15	therapy	therapy	NOUN
iajs-3765	116	16	.	.	PUNCT
iajs-3765	117	1	previous	previous	ADJ
iajs-3765	117	2	research	research	NOUN
iajs-3765	117	3	had	have	VERB
iajs-3765	117	4	relevant	relevant	ADJ
iajs-3765	117	5	results	result	NOUN
iajs-3765	117	6	,	,	PUNCT
iajs-3765	117	7	and	and	CCONJ
iajs-3765	117	8	such	such	ADJ
iajs-3765	117	9	chemokines	chemokine	NOUN
iajs-3765	117	10	have	have	AUX
iajs-3765	117	11	been	be	AUX
iajs-3765	117	12	linked	link	VERB
iajs-3765	117	13	to	to	ADP
iajs-3765	117	14	the	the	DET
iajs-3765	117	15	development	development	NOUN
iajs-3765	117	16	of	of	ADP
iajs-3765	117	17	ra	ra	PROPN
iajs-3765	117	18	.	.	PUNCT
iajs-3765	118	1	there	there	PRON
iajs-3765	118	2	has	have	AUX
iajs-3765	118	3	been	be	AUX
iajs-3765	118	4	little	little	ADJ
iajs-3765	118	5	research	research	NOUN
iajs-3765	118	6	on	on	ADP
iajs-3765	118	7	the	the	DET
iajs-3765	118	8	effects	effect	NOUN
iajs-3765	118	9	of	of	ADP
iajs-3765	118	10	serum	serum	NOUN
iajs-3765	118	11	mmp-1	mmp-1	PUNCT
iajs-3765	118	12	on	on	ADP
iajs-3765	118	13	ra	ra	PROPN
iajs-3765	118	14	,	,	PUNCT
iajs-3765	118	15	and	and	CCONJ
iajs-3765	118	16	most	most	ADJ
iajs-3765	118	17	studies	study	NOUN
iajs-3765	118	18	have	have	AUX
iajs-3765	118	19	been	be	AUX
iajs-3765	118	20	conducted	conduct	VERB
iajs-3765	118	21	in	in	ADP
iajs-3765	118	22	vitro	vitro	X
iajs-3765	118	23	and	and	CCONJ
iajs-3765	118	24	human	human	ADJ
iajs-3765	118	25	models	model	NOUN
iajs-3765	118	26	)	)	PUNCT
iajs-3765	118	27	25	25	NUM
iajs-3765	118	28	-	-	SYM
iajs-3765	118	29	27	27	NUM
iajs-3765	118	30	)	)	PUNCT
iajs-3765	118	31	.	.	PUNCT
iajs-3765	119	1	it	it	PRON
iajs-3765	119	2	has	have	AUX
iajs-3765	119	3	been	be	AUX
iajs-3765	119	4	suggested	suggest	VERB
iajs-3765	119	5	that	that	SCONJ
iajs-3765	119	6	their	their	PRON
iajs-3765	119	7	serum	serum	NOUN
iajs-3765	119	8	levels	level	NOUN
iajs-3765	119	9	correlate	correlate	VERB
iajs-3765	119	10	with	with	ADP
iajs-3765	119	11	levels	level	NOUN
iajs-3765	119	12	produced	produce	VERB
iajs-3765	119	13	by	by	ADP
iajs-3765	119	14	the	the	DET
iajs-3765	119	15	synovium	synovium	NOUN
iajs-3765	119	16	and	and	CCONJ
iajs-3765	119	17	thus	thus	ADV
iajs-3765	119	18	reflect	reflect	VERB
iajs-3765	119	19	the	the	DET
iajs-3765	119	20	level	level	NOUN
iajs-3765	119	21	of	of	ADP
iajs-3765	119	22	inflammation	inflammation	NOUN
iajs-3765	119	23	and	and	CCONJ
iajs-3765	119	24	activity	activity	NOUN
iajs-3765	119	25	of	of	ADP
iajs-3765	119	26	rheumatoid	rheumatoid	PROPN
iajs-3765	119	27	synovitis	synovitis	PROPN
iajs-3765	119	28	.	.	PUNCT
iajs-3765	120	1	the	the	DET
iajs-3765	120	2	pathophysiologic	pathophysiologic	ADJ
iajs-3765	120	3	mechanisms	mechanism	NOUN
iajs-3765	120	4	of	of	ADP
iajs-3765	120	5	joint	joint	ADJ
iajs-3765	120	6	inflammation	inflammation	NOUN
iajs-3765	120	7	and	and	CCONJ
iajs-3765	120	8	bony	bony	NOUN
iajs-3765	120	9	erosion	erosion	NOUN
iajs-3765	120	10	may	may	AUX
iajs-3765	120	11	be	be	AUX
iajs-3765	120	12	partially	partially	ADV
iajs-3765	120	13	independent	independent	ADJ
iajs-3765	120	14	;	;	PUNCT
iajs-3765	120	15	each	each	PRON
iajs-3765	120	16	might	might	AUX
iajs-3765	120	17	be	be	AUX
iajs-3765	120	18	determined	determine	VERB
iajs-3765	120	19	by	by	ADP
iajs-3765	120	20	a	a	DET
iajs-3765	120	21	principal	principal	ADJ
iajs-3765	120	22	cytokine	cytokine	NOUN
iajs-3765	120	23	or	or	CCONJ
iajs-3765	120	24	protease	protease	NOUN
iajs-3765	120	25	in	in	ADP
iajs-3765	120	26	different	different	ADJ
iajs-3765	120	27	disease	disease	NOUN
iajs-3765	120	28	conditions	condition	NOUN
iajs-3765	120	29	.	.	PUNCT
iajs-3765	121	1	this	this	PRON
iajs-3765	121	2	could	could	AUX
iajs-3765	121	3	be	be	AUX
iajs-3765	121	4	explained	explain	VERB
iajs-3765	121	5	by	by	ADP
iajs-3765	121	6	the	the	DET
iajs-3765	121	7	abundant	abundant	ADJ
iajs-3765	121	8	expression	expression	NOUN
iajs-3765	121	9	of	of	ADP
iajs-3765	121	10	mmp-1	mmp-1	PUNCT
iajs-3765	121	11	by	by	ADP
iajs-3765	121	12	articular	articular	ADJ
iajs-3765	121	13	synovial	synovial	ADJ
iajs-3765	121	14	cells	cell	NOUN
iajs-3765	121	15	,	,	PUNCT
iajs-3765	121	16	fibroblasts	fibroblast	NOUN
iajs-3765	121	17	,	,	PUNCT
iajs-3765	121	18	and	and	CCONJ
iajs-3765	121	19	chondrocytes	chondrocyte	NOUN
iajs-3765	121	20	in	in	ADP
iajs-3765	121	21	inflamed	inflame	VERB
iajs-3765	121	22	rheumatoid	rheumatoid	NOUN
iajs-3765	121	23	synovium	synovium	NOUN
iajs-3765	121	24	,	,	PUNCT
iajs-3765	121	25	which	which	PRON
iajs-3765	121	26	is	be	AUX
iajs-3765	121	27	then	then	ADV
iajs-3765	121	28	released	release	VERB
iajs-3765	121	29	into	into	ADP
iajs-3765	121	30	the	the	DET
iajs-3765	121	31	bloodstream	bloodstream	NOUN
iajs-3765	121	32	.	.	PUNCT
iajs-3765	122	1	therefore	therefore	ADV
iajs-3765	122	2	,	,	PUNCT
iajs-3765	122	3	their	their	PRON
iajs-3765	122	4	serum	serum	NOUN
iajs-3765	122	5	concentrations	concentration	NOUN
iajs-3765	122	6	can	can	AUX
iajs-3765	122	7	be	be	AUX
iajs-3765	122	8	considered	consider	VERB
iajs-3765	122	9	alternative	alternative	ADJ
iajs-3765	122	10	non	non	ADJ
iajs-3765	122	11	-	-	ADJ
iajs-3765	122	12	invasive	invasive	ADJ
iajs-3765	122	13	biomarkers	biomarker	NOUN
iajs-3765	122	14	of	of	ADP
iajs-3765	122	15	ra	ra	PROPN
iajs-3765	122	16	activity	activity	NOUN
iajs-3765	122	17	in	in	ADP
iajs-3765	122	18	clinical	clinical	ADJ
iajs-3765	122	19	practice	practice	NOUN
iajs-3765	122	20	)	)	PUNCT
iajs-3765	122	21	27	27	NUM
iajs-3765	122	22	)	)	PUNCT
iajs-3765	122	23	.	.	PUNCT
iajs-3765	123	1	rheumatoid	rheumatoid	VERB
iajs-3765	123	2	arthritis	arthritis	NOUN
iajs-3765	123	3	patients	patient	NOUN
iajs-3765	123	4	also	also	ADV
iajs-3765	123	5	had	have	VERB
iajs-3765	123	6	a	a	DET
iajs-3765	123	7	higher	high	ADJ
iajs-3765	123	8	bmi	bmi	NOUN
iajs-3765	123	9	in	in	ADP
iajs-3765	123	10	the	the	DET
iajs-3765	123	11	obese	obese	NOUN
iajs-3765	123	12	and	and	CCONJ
iajs-3765	123	13	extremely	extremely	ADV
iajs-3765	123	14	obese	obese	ADJ
iajs-3765	123	15	groups	group	NOUN
iajs-3765	123	16	,	,	PUNCT
iajs-3765	123	17	as	as	SCONJ
iajs-3765	123	18	presented	present	VERB
iajs-3765	123	19	in	in	ADP
iajs-3765	123	20	table	table	NOUN
iajs-3765	123	21	(	(	PUNCT
iajs-3765	123	22	1	1	NUM
iajs-3765	123	23	)	)	PUNCT
iajs-3765	123	24	.	.	PUNCT
iajs-3765	124	1	in	in	ADP
iajs-3765	124	2	contrast	contrast	NOUN
iajs-3765	124	3	to	to	ADP
iajs-3765	124	4	the	the	DET
iajs-3765	124	5	current	current	ADJ
iajs-3765	124	6	study	study	NOUN
iajs-3765	124	7	,	,	PUNCT
iajs-3765	124	8	abd	abd	PROPN
iajs-3765	124	9	-	-	PUNCT
iajs-3765	124	10	allah	allah	PROPN
iajs-3765	124	11	et	et	PROPN
iajs-3765	124	12	al	al	PROPN
iajs-3765	124	13	.	.	PROPN
iajs-3765	124	14	)	)	PUNCT
iajs-3765	124	15	28	28	NUM
iajs-3765	124	16	)	)	PUNCT
iajs-3765	124	17	found	find	VERB
iajs-3765	124	18	no	no	DET
iajs-3765	124	19	link	link	NOUN
iajs-3765	124	20	between	between	ADP
iajs-3765	124	21	the	the	DET
iajs-3765	124	22	mmp1	mmp1	NOUN
iajs-3765	124	23	polymorphism	polymorphism	NOUN
iajs-3765	124	24	and	and	CCONJ
iajs-3765	124	25	ra	ra	PROPN
iajs-3765	124	26	susceptibility	susceptibility	NOUN
iajs-3765	124	27	in	in	ADP
iajs-3765	124	28	patients	patient	NOUN
iajs-3765	124	29	from	from	ADP
iajs-3765	124	30	brazil	brazil	PROPN
iajs-3765	124	31	,	,	PUNCT
iajs-3765	124	32	spain	spain	PROPN
iajs-3765	124	33	,	,	PUNCT
iajs-3765	124	34	and	and	CCONJ
iajs-3765	124	35	korea	korea	PROPN
iajs-3765	124	36	.	.	PUNCT
iajs-3765	125	1	the	the	DET
iajs-3765	125	2	roc	roc	PROPN
iajs-3765	125	3	curve	curve	NOUN
iajs-3765	125	4	study	study	NOUN
iajs-3765	125	5	for	for	ADP
iajs-3765	125	6	mmp-1	mmp-1	PUNCT
iajs-3765	125	7	has	have	VERB
iajs-3765	125	8	the	the	DET
iajs-3765	125	9	best	good	ADJ
iajs-3765	125	10	auc	auc	NOUN
iajs-3765	125	11	as	as	ADP
iajs-3765	125	12	an	an	DET
iajs-3765	125	13	ra	ra	NOUN
iajs-3765	125	14	marker	marker	NOUN
iajs-3765	125	15	.	.	PUNCT
iajs-3765	126	1	however	however	ADV
iajs-3765	126	2	,	,	PUNCT
iajs-3765	126	3	one	one	NUM
iajs-3765	126	4	study	study	NOUN
iajs-3765	126	5	found	find	VERB
iajs-3765	126	6	no	no	DET
iajs-3765	126	7	statistically	statistically	ADV
iajs-3765	126	8	significant	significant	ADJ
iajs-3765	126	9	change	change	NOUN
iajs-3765	126	10	in	in	ADP
iajs-3765	126	11	mmp-1	mmp-1	PUNCT
iajs-3765	126	12	levels	level	NOUN
iajs-3765	126	13	between	between	ADP
iajs-3765	126	14	the	the	DET
iajs-3765	126	15	ra	ra	PROPN
iajs-3765	126	16	and	and	CCONJ
iajs-3765	126	17	control	control	NOUN
iajs-3765	126	18	groups	group	NOUN
iajs-3765	126	19	)	)	PUNCT
iajs-3765	126	20	28	28	NUM
iajs-3765	126	21	)	)	PUNCT
iajs-3765	126	22	.	.	PUNCT
iajs-3765	127	1	according	accord	VERB
iajs-3765	127	2	to	to	ADP
iajs-3765	127	3	this	this	DET
iajs-3765	127	4	study	study	NOUN
iajs-3765	127	5	,	,	PUNCT
iajs-3765	127	6	blood	blood	NOUN
iajs-3765	127	7	mmp-1	mmp-1	ADP
iajs-3765	127	8	levels	level	NOUN
iajs-3765	127	9	predict	predict	VERB
iajs-3765	127	10	clinical	clinical	ADJ
iajs-3765	127	11	remission	remission	NOUN
iajs-3765	127	12	of	of	ADP
iajs-3765	127	13	ra	ra	PROPN
iajs-3765	127	14	better	well	ADJ
iajs-3765	127	15	than	than	ADP
iajs-3765	127	16	crp	crp	NOUN
iajs-3765	127	17	levels	level	NOUN
iajs-3765	127	18	.	.	PUNCT
iajs-3765	128	1	patients	patient	NOUN
iajs-3765	128	2	with	with	ADP
iajs-3765	128	3	ra	ra	PROPN
iajs-3765	128	4	who	who	PRON
iajs-3765	128	5	have	have	AUX
iajs-3765	128	6	n't	not	PART
iajs-3765	128	7	been	be	AUX
iajs-3765	128	8	treated	treat	VERB
iajs-3765	128	9	and	and	CCONJ
iajs-3765	128	10	have	have	VERB
iajs-3765	128	11	persistent	persistent	ADJ
iajs-3765	128	12	systemic	systemic	ADJ
iajs-3765	128	13	inflammation	inflammation	NOUN
iajs-3765	128	14	have	have	VERB
iajs-3765	128	15	different	different	ADJ
iajs-3765	128	16	lipoprotein	lipoprotein	ADJ
iajs-3765	128	17	and	and	CCONJ
iajs-3765	128	18	apolipoprotein	apolipoprotein	ADJ
iajs-3765	128	19	profiles	profile	NOUN
iajs-3765	128	20	,	,	PUNCT
iajs-3765	128	21	which	which	PRON
iajs-3765	128	22	may	may	AUX
iajs-3765	128	23	make	make	VERB
iajs-3765	128	24	them	they	PRON
iajs-3765	128	25	more	more	ADV
iajs-3765	128	26	likely	likely	ADJ
iajs-3765	128	27	to	to	PART
iajs-3765	128	28	develop	develop	VERB
iajs-3765	128	29	atherosclerosis	atherosclerosis	NOUN
iajs-3765	128	30	)	)	PUNCT
iajs-3765	128	31	29	29	NUM
iajs-3765	128	32	)	)	PUNCT
iajs-3765	128	33	.	.	PUNCT
iajs-3765	129	1	moreover	moreover	ADV
iajs-3765	129	2	,	,	PUNCT
iajs-3765	129	3	ra	ra	PROPN
iajs-3765	129	4	patients	patient	NOUN
iajs-3765	129	5	have	have	VERB
iajs-3765	129	6	a	a	DET
iajs-3765	129	7	continuous	continuous	ADJ
iajs-3765	129	8	trend	trend	NOUN
iajs-3765	129	9	of	of	ADP
iajs-3765	129	10	reduced	reduce	VERB
iajs-3765	129	11	levels	level	NOUN
iajs-3765	129	12	of	of	ADP
iajs-3765	129	13	hdl	hdl	PROPN
iajs-3765	129	14	cholesterol	cholesterol	PROPN
iajs-3765	129	15	in	in	ADP
iajs-3765	129	16	comparison	comparison	NOUN
iajs-3765	129	17	to	to	ADP
iajs-3765	129	18	controls	control	NOUN
iajs-3765	129	19	who	who	PRON
iajs-3765	129	20	are	be	AUX
iajs-3765	129	21	matched	match	VERB
iajs-3765	129	22	in	in	ADP
iajs-3765	129	23	terms	term	NOUN
iajs-3765	129	24	of	of	ADP
iajs-3765	129	25	age	age	NOUN
iajs-3765	129	26	and	and	CCONJ
iajs-3765	129	27	sex	sex	NOUN
iajs-3765	129	28	)	)	PUNCT
iajs-3765	129	29	30	30	NUM
iajs-3765	129	30	)	)	PUNCT
iajs-3765	129	31	.	.	PUNCT
iajs-3765	130	1	however	however	ADV
iajs-3765	130	2	,	,	PUNCT
iajs-3765	130	3	the	the	DET
iajs-3765	130	4	findings	finding	NOUN
iajs-3765	130	5	regarding	regard	VERB
iajs-3765	130	6	total	total	ADJ
iajs-3765	130	7	cholesterol	cholesterol	NOUN
iajs-3765	130	8	and	and	CCONJ
iajs-3765	130	9	ldl	ldl	NOUN
iajs-3765	130	10	-	-	PUNCT
iajs-3765	130	11	c	c	NOUN
iajs-3765	130	12	levels	level	NOUN
iajs-3765	130	13	are	be	AUX
iajs-3765	130	14	more	more	ADV
iajs-3765	130	15	varied	varied	ADJ
iajs-3765	130	16	.	.	PUNCT
iajs-3765	131	1	several	several	ADJ
iajs-3765	131	2	studies	study	NOUN
iajs-3765	131	3	have	have	AUX
iajs-3765	131	4	reported	report	VERB
iajs-3765	131	5	notable	notable	ADJ
iajs-3765	131	6	increases	increase	NOUN
iajs-3765	131	7	in	in	ADP
iajs-3765	131	8	these	these	DET
iajs-3765	131	9	parameters	parameter	NOUN
iajs-3765	131	10	compared	compare	VERB
iajs-3765	131	11	to	to	ADP
iajs-3765	131	12	the	the	DET
iajs-3765	131	13	control	control	NOUN
iajs-3765	131	14	group	group	NOUN
iajs-3765	131	15	,	,	PUNCT
iajs-3765	131	16	while	while	SCONJ
iajs-3765	131	17	other	other	ADJ
iajs-3765	131	18	investigations	investigation	NOUN
iajs-3765	131	19	have	have	AUX
iajs-3765	131	20	not	not	PART
iajs-3765	131	21	found	find	VERB
iajs-3765	131	22	similar	similar	ADJ
iajs-3765	131	23	results	result	NOUN
iajs-3765	131	24	)	)	PUNCT
iajs-3765	131	25	31	31	NUM
iajs-3765	131	26	)	)	PUNCT
iajs-3765	131	27	.	.	PUNCT
iajs-3765	132	1	the	the	DET
iajs-3765	132	2	different	different	ADJ
iajs-3765	132	3	lipid	lipid	NOUN
iajs-3765	132	4	factors	factor	NOUN
iajs-3765	132	5	that	that	PRON
iajs-3765	132	6	increase	increase	VERB
iajs-3765	132	7	the	the	DET
iajs-3765	132	8	risk	risk	NOUN
iajs-3765	132	9	in	in	ADP
iajs-3765	132	10	people	people	NOUN
iajs-3765	132	11	with	with	ADP
iajs-3765	132	12	ra	ra	PROPN
iajs-3765	132	13	have	have	VERB
iajs-3765	132	14	significantly	significantly	ADV
iajs-3765	132	15	higher	high	ADJ
iajs-3765	132	16	ratios	ratio	NOUN
iajs-3765	132	17	of	of	ADP
iajs-3765	132	18	apolipoprotein	apolipoprotein	ADJ
iajs-3765	132	19	b	b	PROPN
iajs-3765	132	20	to	to	PART
iajs-3765	132	21	a1	a1	VERB
iajs-3765	132	22	,	,	PUNCT
iajs-3765	132	23	total	total	ADJ
iajs-3765	132	24	cholesterol	cholesterol	NOUN
iajs-3765	132	25	to	to	ADP
iajs-3765	132	26	hdl	hdl	PROPN
iajs-3765	132	27	cholesterol	cholesterol	PROPN
iajs-3765	132	28	,	,	PUNCT
iajs-3765	132	29	and	and	CCONJ
iajs-3765	132	30	ldl	ldl	VERB
iajs-3765	132	31	to	to	ADP
iajs-3765	132	32	hdl	hdl	PROPN
iajs-3765	132	33	cholesterol	cholesterol	PROPN
iajs-3765	132	34	)	)	PUNCT
iajs-3765	132	35	32	32	NUM
iajs-3765	132	36	)	)	PUNCT
iajs-3765	132	37	.	.	PUNCT
iajs-3765	133	1	the	the	DET
iajs-3765	133	2	mean	mean	NOUN
iajs-3765	133	3	±	±	PROPN
iajs-3765	133	4	se	se	X
iajs-3765	133	5	of	of	ADP
iajs-3765	133	6	crp	crp	PROPN
iajs-3765	133	7	levels	level	NOUN
iajs-3765	133	8	in	in	ADP
iajs-3765	133	9	patients	patient	NOUN
iajs-3765	133	10	and	and	CCONJ
iajs-3765	133	11	controls	control	NOUN
iajs-3765	133	12	was	be	AUX
iajs-3765	133	13	2443.09	2443.09	NUM
iajs-3765	133	14	±	±	NUM
iajs-3765	133	15	17.33	17.33	NUM
iajs-3765	133	16	)	)	PUNCT
iajs-3765	133	17	1272.41	1272.41	NUM
iajs-3765	133	18	±	±	NUM
iajs-3765	133	19	35.24	35.24	NUM
iajs-3765	133	20	pg	pg	NOUN
iajs-3765	133	21	/	/	SYM
iajs-3765	133	22	ml	ml	VERB
iajs-3765	133	23	)	)	PUNCT
iajs-3765	133	24	,	,	PUNCT
iajs-3765	133	25	respectively	respectively	ADV
iajs-3765	133	26	.	.	PUNCT
iajs-3765	134	1	the	the	DET
iajs-3765	134	2	findings	finding	NOUN
iajs-3765	134	3	revealed	reveal	VERB
iajs-3765	134	4	a	a	DET
iajs-3765	134	5	significantly	significantly	ADV
iajs-3765	134	6	higher	high	ADJ
iajs-3765	134	7	crp	crp	NOUN
iajs-3765	134	8	level	level	NOUN
iajs-3765	134	9	in	in	ADP
iajs-3765	134	10	patients	patient	NOUN
iajs-3765	134	11	with	with	ADP
iajs-3765	134	12	ra	ra	PROPN
iajs-3765	134	13	compared	compare	VERB
iajs-3765	134	14	to	to	ADP
iajs-3765	134	15	the	the	DET
iajs-3765	134	16	control	control	NOUN
iajs-3765	134	17	group	group	NOUN
iajs-3765	134	18	(	(	PUNCT
iajs-3765	134	19	p	p	X
iajs-3765	134	20	<	<	X
iajs-3765	134	21	0.01	0.01	NUM
iajs-3765	134	22	)	)	PUNCT
iajs-3765	134	23	,	,	PUNCT
iajs-3765	134	24	as	as	SCONJ
iajs-3765	134	25	presented	present	VERB
iajs-3765	134	26	in	in	ADP
iajs-3765	134	27	table	table	NOUN
iajs-3765	134	28	(	(	PUNCT
iajs-3765	134	29	2	2	NUM
iajs-3765	134	30	)	)	PUNCT
iajs-3765	134	31	.	.	PUNCT
iajs-3765	135	1	this	this	PRON
iajs-3765	135	2	suggests	suggest	VERB
iajs-3765	135	3	that	that	SCONJ
iajs-3765	135	4	crp	crp	PROPN
iajs-3765	135	5	can	can	AUX
iajs-3765	135	6	be	be	AUX
iajs-3765	135	7	used	use	VERB
iajs-3765	135	8	as	as	ADP
iajs-3765	135	9	a	a	DET
iajs-3765	135	10	potential	potential	ADJ
iajs-3765	135	11	biomarker	biomarker	NOUN
iajs-3765	135	12	for	for	ADP
iajs-3765	135	13	ra	ra	PROPN
iajs-3765	135	14	and	and	CCONJ
iajs-3765	135	15	may	may	AUX
iajs-3765	135	16	indicate	indicate	VERB
iajs-3765	135	17	the	the	DET
iajs-3765	135	18	presence	presence	NOUN
iajs-3765	135	19	and	and	CCONJ
iajs-3765	135	20	severity	severity	NOUN
iajs-3765	135	21	of	of	ADP
iajs-3765	135	22	the	the	DET
iajs-3765	135	23	disease	disease	NOUN
iajs-3765	135	24	)	)	PUNCT
iajs-3765	135	25	33).the	33).the	PRON
iajs-3765	135	26	mean	mean	VERB
iajs-3765	135	27	±	±	NUM
iajs-3765	135	28	se	se	X
iajs-3765	135	29	of	of	ADP
iajs-3765	135	30	esr	esr	PROPN
iajs-3765	135	31	in	in	ADP
iajs-3765	135	32	patients	patient	NOUN
iajs-3765	135	33	and	and	CCONJ
iajs-3765	135	34	controls	control	NOUN
iajs-3765	135	35	was	be	AUX
iajs-3765	135	36	33.82	33.82	NUM
iajs-3765	135	37	±	±	NUM
iajs-3765	135	38	2.53	2.53	NUM
iajs-3765	135	39	and	and	CCONJ
iajs-3765	135	40	15.54	15.54	NUM
iajs-3765	135	41	±	±	NUM
iajs-3765	135	42	1.14	1.14	NUM
iajs-3765	135	43	mm	mm	NOUN
iajs-3765	135	44	/	/	SYM
iajs-3765	135	45	h	h	PROPN
iajs-3765	135	46	,	,	PUNCT
iajs-3765	135	47	respectively	respectively	ADV
iajs-3765	135	48	.	.	PUNCT
iajs-3765	136	1	the	the	DET
iajs-3765	136	2	findings	finding	NOUN
iajs-3765	136	3	revealed	reveal	VERB
iajs-3765	136	4	a	a	DET
iajs-3765	136	5	significant	significant	ADJ
iajs-3765	136	6	increase	increase	NOUN
iajs-3765	136	7	in	in	ADP
iajs-3765	136	8	esr	esr	PROPN
iajs-3765	136	9	among	among	ADP
iajs-3765	136	10	ra	ra	PROPN
iajs-3765	136	11	patients	patient	NOUN
iajs-3765	136	12	compared	compare	VERB
iajs-3765	136	13	to	to	ADP
iajs-3765	136	14	the	the	DET
iajs-3765	136	15	control	control	NOUN
iajs-3765	136	16	group	group	NOUN
iajs-3765	136	17	,	,	PUNCT
iajs-3765	136	18	with	with	ADP
iajs-3765	136	19	a	a	DET
iajs-3765	136	20	p	p	NOUN
iajs-3765	136	21	-	-	PUNCT
iajs-3765	136	22	value	value	NOUN
iajs-3765	136	23	of	of	ADP
iajs-3765	136	24	less	less	ADJ
iajs-3765	136	25	than	than	ADP
iajs-3765	136	26	0.01	0.01	NUM
iajs-3765	136	27	(	(	PUNCT
iajs-3765	136	28	p	p	X
iajs-3765	136	29	<	<	X
iajs-3765	136	30	0.01	0.01	NUM
iajs-3765	136	31	)	)	PUNCT
iajs-3765	136	32	,	,	PUNCT
iajs-3765	136	33	as	as	SCONJ
iajs-3765	136	34	presented	present	VERB
iajs-3765	136	35	in	in	ADP
iajs-3765	136	36	table	table	NOUN
iajs-3765	136	37	(	(	PUNCT
iajs-3765	136	38	2	2	NUM
iajs-3765	136	39	)	)	PUNCT
iajs-3765	136	40	.	.	PUNCT
iajs-3765	137	1	this	this	PRON
iajs-3765	137	2	suggests	suggest	VERB
iajs-3765	137	3	that	that	SCONJ
iajs-3765	137	4	esr	esr	PROPN
iajs-3765	137	5	can	can	AUX
iajs-3765	137	6	be	be	AUX
iajs-3765	137	7	used	use	VERB
iajs-3765	137	8	as	as	ADP
iajs-3765	137	9	a	a	DET
iajs-3765	137	10	potential	potential	ADJ
iajs-3765	137	11	biomarker	biomarker	NOUN
iajs-3765	137	12	for	for	ADP
iajs-3765	137	13	ra	ra	PROPN
iajs-3765	137	14	and	and	CCONJ
iajs-3765	137	15	may	may	AUX
iajs-3765	137	16	indicate	indicate	VERB
iajs-3765	137	17	the	the	DET
iajs-3765	137	18	presence	presence	NOUN
iajs-3765	137	19	and	and	CCONJ
iajs-3765	137	20	severity	severity	NOUN
iajs-3765	137	21	of	of	ADP
iajs-3765	137	22	the	the	DET
iajs-3765	137	23	disease	disease	NOUN
iajs-3765	137	24	.	.	PUNCT
iajs-3765	138	1	monitoring	monitor	VERB
iajs-3765	138	2	esr	esr	PROPN
iajs-3765	138	3	levels	level	NOUN
iajs-3765	138	4	in	in	ADP
iajs-3765	138	5	ra	ra	PROPN
iajs-3765	138	6	patients	patient	NOUN
iajs-3765	138	7	can	can	AUX
iajs-3765	138	8	help	help	VERB
iajs-3765	138	9	assess	assess	VERB
iajs-3765	138	10	disease	disease	NOUN
iajs-3765	138	11	progression	progression	NOUN
iajs-3765	138	12	and	and	CCONJ
iajs-3765	138	13	guide	guide	VERB
iajs-3765	138	14	treatment	treatment	NOUN
iajs-3765	138	15	decisions	decision	NOUN
iajs-3765	138	16	)	)	PUNCT
iajs-3765	138	17	34	34	NUM
iajs-3765	138	18	)	)	PUNCT
iajs-3765	138	19	.	.	PUNCT
iajs-3765	139	1	the	the	DET
iajs-3765	139	2	mean	mean	NOUN
iajs-3765	139	3	±	±	NUM
iajs-3765	139	4	se	se	X
iajs-3765	139	5	of	of	ADP
iajs-3765	139	6	rf	rf	NOUN
iajs-3765	139	7	levels	level	NOUN
iajs-3765	139	8	in	in	ADP
iajs-3765	139	9	patients	patient	NOUN
iajs-3765	139	10	and	and	CCONJ
iajs-3765	139	11	controls	control	NOUN
iajs-3765	139	12	were	be	AUX
iajs-3765	139	13	0.93	0.93	NUM
iajs-3765	139	14	±	±	NUM
iajs-3765	139	15	0.13	0.13	NUM
iajs-3765	139	16	ng	ng	PROPN
iajs-3765	139	17	/	/	SYM
iajs-3765	139	18	ml	ml	NOUN
iajs-3765	139	19	and	and	CCONJ
iajs-3765	139	20	0.35	0.35	NUM
iajs-3765	139	21	±	±	NUM
iajs-3765	139	22	0.34	0.34	NUM
iajs-3765	139	23	ng	ng	PROPN
iajs-3765	139	24	/	/	SYM
iajs-3765	139	25	ml	ml	PROPN
iajs-3765	139	26	,	,	PUNCT
iajs-3765	139	27	respectively	respectively	ADV
iajs-3765	139	28	.	.	PUNCT
iajs-3765	140	1	the	the	DET
iajs-3765	140	2	results	result	NOUN
iajs-3765	140	3	demonstrate	demonstrate	VERB
iajs-3765	140	4	a	a	DET
iajs-3765	140	5	significant	significant	ADJ
iajs-3765	140	6	rise	rise	NOUN
iajs-3765	140	7	in	in	ADP
iajs-3765	140	8	rf	rf	ADJ
iajs-3765	140	9	levels	level	NOUN
iajs-3765	140	10	in	in	ADP
iajs-3765	140	11	patients	patient	NOUN
iajs-3765	140	12	with	with	ADP
iajs-3765	140	13	ra	ra	PROPN
iajs-3765	140	14	compared	compare	VERB
iajs-3765	140	15	to	to	ADP
iajs-3765	140	16	the	the	DET
iajs-3765	140	17	control	control	NOUN
iajs-3765	140	18	group	group	NOUN
iajs-3765	140	19	,	,	PUNCT
iajs-3765	140	20	with	with	ADP
iajs-3765	140	21	a	a	DET
iajs-3765	140	22	p	p	NOUN
iajs-3765	140	23	-	-	PUNCT
iajs-3765	140	24	value	value	NOUN
iajs-3765	140	25	of	of	ADP
iajs-3765	140	26	less	less	ADJ
iajs-3765	140	27	than	than	ADP
iajs-3765	140	28	0.01	0.01	NUM
iajs-3765	140	29	,	,	PUNCT
iajs-3765	140	30	as	as	SCONJ
iajs-3765	140	31	shown	show	VERB
iajs-3765	140	32	in	in	ADP
iajs-3765	140	33	table	table	NOUN
iajs-3765	140	34	(	(	PUNCT
iajs-3765	140	35	2	2	NUM
iajs-3765	140	36	)	)	PUNCT
iajs-3765	140	37	.	.	PUNCT
iajs-3765	141	1	rf	rf	NOUN
iajs-3765	141	2	levels	level	NOUN
iajs-3765	141	3	can	can	AUX
iajs-3765	141	4	serve	serve	VERB
iajs-3765	141	5	as	as	ADP
iajs-3765	141	6	a	a	DET
iajs-3765	141	7	potential	potential	ADJ
iajs-3765	141	8	biomarker	biomarker	NOUN
iajs-3765	141	9	for	for	ADP
iajs-3765	141	10	ra	ra	PROPN
iajs-3765	141	11	and	and	CCONJ
iajs-3765	141	12	may	may	AUX
iajs-3765	141	13	indicate	indicate	VERB
iajs-3765	141	14	the	the	DET
iajs-3765	141	15	disease	disease	NOUN
iajs-3765	141	16	's	's	PART
iajs-3765	141	17	presence	presence	NOUN
iajs-3765	141	18	and	and	CCONJ
iajs-3765	141	19	severity	severity	NOUN
iajs-3765	141	20	.	.	PUNCT
iajs-3765	142	1	monitoring	monitor	VERB
iajs-3765	142	2	rf	rf	NOUN
iajs-3765	142	3	levels	level	NOUN
iajs-3765	142	4	can	can	AUX
iajs-3765	142	5	help	help	VERB
iajs-3765	142	6	assess	assess	VERB
iajs-3765	142	7	disease	disease	NOUN
iajs-3765	142	8	progression	progression	NOUN
iajs-3765	142	9	and	and	CCONJ
iajs-3765	142	10	guide	guide	VERB
iajs-3765	142	11	treatment	treatment	NOUN
iajs-3765	142	12	decisions	decision	NOUN
iajs-3765	142	13	in	in	ADP
iajs-3765	142	14	ra	ra	PROPN
iajs-3765	142	15	patients	patient	NOUN
iajs-3765	142	16	.	.	PUNCT
iajs-3765	143	1	elevated	elevated	ADJ
iajs-3765	143	2	rf	rf	NOUN
iajs-3765	143	3	levels	level	NOUN
iajs-3765	143	4	in	in	ADP
iajs-3765	143	5	ra	ra	PROPN
iajs-3765	143	6	patients	patient	NOUN
iajs-3765	143	7	may	may	AUX
iajs-3765	143	8	be	be	AUX
iajs-3765	143	9	associated	associate	VERB
iajs-3765	143	10	with	with	ADP
iajs-3765	143	11	the	the	DET
iajs-3765	143	12	inflammatory	inflammatory	ADJ
iajs-3765	143	13	process	process	NOUN
iajs-3765	143	14	and	and	CCONJ
iajs-3765	143	15	disease	disease	NOUN
iajs-3765	143	16	activity	activity	NOUN
iajs-3765	143	17	in	in	ADP
iajs-3765	143	18	these	these	DET
iajs-3765	143	19	patients	patient	NOUN
iajs-3765	143	20	)	)	PUNCT
iajs-3765	143	21	33	33	NUM
iajs-3765	143	22	,	,	PUNCT
iajs-3765	143	23	34	34	NUM
iajs-3765	143	24	)	)	PUNCT
iajs-3765	143	25	.	.	PUNCT
iajs-3765	144	1	ihjpas	ihjpas	PROPN
iajs-3765	144	2	.	.	PUNCT
iajs-3765	145	1	2025	2025	NUM
iajs-3765	145	2	,	,	PUNCT
iajs-3765	145	3	38(3	38(3	NUM
iajs-3765	145	4	)	)	PUNCT
iajs-3765	145	5	271	271	NUM
iajs-3765	145	6	5	5	NUM
iajs-3765	145	7	.	.	PUNCT
iajs-3765	145	8	conclusion	conclusion	NOUN
iajs-3765	145	9	serum	serum	NOUN
iajs-3765	145	10	mmp-1	mmp-1	SCONJ
iajs-3765	145	11	levels	level	NOUN
iajs-3765	145	12	were	be	AUX
iajs-3765	145	13	considerably	considerably	ADV
iajs-3765	145	14	related	relate	VERB
iajs-3765	145	15	to	to	ADP
iajs-3765	145	16	ra	ra	PROPN
iajs-3765	145	17	.	.	PUNCT
iajs-3765	146	1	this	this	PRON
iajs-3765	146	2	might	might	AUX
iajs-3765	146	3	indicate	indicate	VERB
iajs-3765	146	4	its	its	PRON
iajs-3765	146	5	role	role	NOUN
iajs-3765	146	6	in	in	ADP
iajs-3765	146	7	the	the	DET
iajs-3765	146	8	pathophysiology	pathophysiology	NOUN
iajs-3765	146	9	of	of	ADP
iajs-3765	146	10	ra	ra	PROPN
iajs-3765	146	11	.	.	PUNCT
iajs-3765	147	1	as	as	ADP
iajs-3765	147	2	a	a	DET
iajs-3765	147	3	result	result	NOUN
iajs-3765	147	4	,	,	PUNCT
iajs-3765	147	5	it	it	PRON
iajs-3765	147	6	may	may	AUX
iajs-3765	147	7	be	be	AUX
iajs-3765	147	8	helpful	helpful	ADJ
iajs-3765	147	9	in	in	ADP
iajs-3765	147	10	treating	treat	VERB
iajs-3765	147	11	ra	ra	PROPN
iajs-3765	147	12	.	.	PUNCT
iajs-3765	148	1	furthermore	furthermore	ADV
iajs-3765	148	2	,	,	PUNCT
iajs-3765	148	3	mmp-1	mmp-1	PUNCT
iajs-3765	148	4	has	have	VERB
iajs-3765	148	5	excellent	excellent	ADJ
iajs-3765	148	6	diagnostic	diagnostic	ADJ
iajs-3765	148	7	performance	performance	NOUN
iajs-3765	148	8	with	with	ADP
iajs-3765	148	9	high	high	ADJ
iajs-3765	148	10	accuracy	accuracy	NOUN
iajs-3765	148	11	in	in	ADP
iajs-3765	148	12	distinguishing	distinguish	VERB
iajs-3765	148	13	between	between	ADP
iajs-3765	148	14	individuals	individual	NOUN
iajs-3765	148	15	with	with	ADP
iajs-3765	148	16	ra	ra	PROPN
iajs-3765	148	17	and	and	CCONJ
iajs-3765	148	18	healthy	healthy	ADJ
iajs-3765	148	19	controls	control	NOUN
iajs-3765	148	20	.	.	PUNCT
iajs-3765	149	1	acknowledgment	acknowledgment	NOUN
iajs-3765	149	2	the	the	DET
iajs-3765	149	3	authors	author	NOUN
iajs-3765	149	4	thank	thank	VERB
iajs-3765	149	5	the	the	DET
iajs-3765	149	6	medical	medical	ADJ
iajs-3765	149	7	staff	staff	NOUN
iajs-3765	149	8	at	at	ADP
iajs-3765	149	9	baghdad	baghdad	PROPN
iajs-3765	149	10	teaching	teach	VERB
iajs-3765	149	11	hospital	hospital	NOUN
iajs-3765	149	12	for	for	ADP
iajs-3765	149	13	their	their	PRON
iajs-3765	149	14	assistance	assistance	NOUN
iajs-3765	149	15	in	in	ADP
iajs-3765	149	16	completing	complete	VERB
iajs-3765	149	17	this	this	DET
iajs-3765	149	18	work	work	NOUN
iajs-3765	149	19	.	.	PUNCT
iajs-3765	150	1	conflict	conflict	NOUN
iajs-3765	150	2	of	of	ADP
iajs-3765	150	3	interest	interest	NOUN
iajs-3765	150	4	there	there	PRON
iajs-3765	150	5	are	be	VERB
iajs-3765	150	6	no	no	DET
iajs-3765	150	7	conflicts	conflict	NOUN
iajs-3765	150	8	of	of	ADP
iajs-3765	150	9	interest	interest	NOUN
iajs-3765	150	10	.	.	PUNCT
iajs-3765	151	1	funding	fund	VERB
iajs-3765	151	2	none	none	NOUN
iajs-3765	151	3	.	.	PUNCT
iajs-3765	152	1	ethical	ethical	ADJ
iajs-3765	152	2	clearance	clearance	NOUN
iajs-3765	152	3	the	the	DET
iajs-3765	152	4	scientific	scientific	ADJ
iajs-3765	152	5	committee	committee	NOUN
iajs-3765	152	6	in	in	ADP
iajs-3765	152	7	the	the	DET
iajs-3765	152	8	college	college	NOUN
iajs-3765	152	9	of	of	ADP
iajs-3765	152	10	sciences	science	NOUN
iajs-3765	152	11	for	for	ADP
iajs-3765	152	12	women	woman	NOUN
iajs-3765	152	13	at	at	ADP
iajs-3765	152	14	the	the	DET
iajs-3765	152	15	university	university	NOUN
iajs-3765	152	16	of	of	ADP
iajs-3765	152	17	baghdad	baghdad	PROPN
iajs-3765	152	18	and	and	CCONJ
iajs-3765	152	19	the	the	DET
iajs-3765	152	20	medical	medical	ADJ
iajs-3765	152	21	city	city	PROPN
iajs-3765	152	22	hospital	hospital	NOUN
iajs-3765	152	23	approved	approve	VERB
iajs-3765	152	24	this	this	DET
iajs-3765	152	25	study	study	NOUN
iajs-3765	152	26	.	.	PUNCT
iajs-3765	153	1	a	a	DET
iajs-3765	153	2	verbal	verbal	ADJ
iajs-3765	153	3	agreement	agreement	NOUN
iajs-3765	153	4	was	be	AUX
iajs-3765	153	5	obtained	obtain	VERB
iajs-3765	153	6	from	from	ADP
iajs-3765	153	7	each	each	DET
iajs-3765	153	8	person	person	NOUN
iajs-3765	153	9	included	include	VERB
iajs-3765	153	10	in	in	ADP
iajs-3765	153	11	the	the	DET
iajs-3765	153	12	survey	survey	NOUN
iajs-3765	153	13	on	on	ADP
iajs-3765	153	14	march	march	PROPN
iajs-3765	153	15	29	29	NUM
iajs-3765	153	16	,	,	PUNCT
iajs-3765	153	17	2023	2023	NUM
iajs-3765	153	18	.	.	PUNCT
iajs-3765	154	1	references	reference	NOUN
iajs-3765	154	2	1	1	NUM
iajs-3765	154	3	.	.	PUNCT
iajs-3765	154	4	murakami	murakami	PROPN
iajs-3765	154	5	k	k	PROPN
iajs-3765	154	6	,	,	PUNCT
iajs-3765	154	7	mimori	mimori	PROPN
iajs-3765	154	8	t.	t.	NOUN
iajs-3765	154	9	diagnosis	diagnosis	NOUN
iajs-3765	154	10	and	and	CCONJ
iajs-3765	154	11	treatment	treatment	NOUN
iajs-3765	154	12	of	of	ADP
iajs-3765	154	13	rheumatoid	rheumatoid	NOUN
iajs-3765	154	14	arthritis	arthritis	NOUN
iajs-3765	154	15	:	:	PUNCT
iajs-3765	154	16	toward	toward	ADP
iajs-3765	154	17	the	the	DET
iajs-3765	154	18	best	good	ADJ
iajs-3765	154	19	practice	practice	NOUN
iajs-3765	154	20	.	.	PUNCT
iajs-3765	155	1	the	the	DET
iajs-3765	155	2	pathophysiology	pathophysiology	NOUN
iajs-3765	155	3	in	in	ADP
iajs-3765	155	4	rheumatoid	rheumatoid	NOUN
iajs-3765	155	5	arthritis	arthritis	NOUN
iajs-3765	155	6	.	.	PUNCT
iajs-3765	156	1	clin	clin	PROPN
iajs-3765	156	2	calcium	calcium	NOUN
iajs-3765	156	3	.	.	PUNCT
iajs-3765	156	4	2018	2018	NUM
iajs-3765	156	5	;	;	PUNCT
iajs-3765	156	6	28(5):595–600	28(5):595–600	NUM
iajs-3765	156	7	.	.	PUNCT
iajs-3765	157	1	pmid	pmid	NOUN
iajs-3765	157	2	:	:	PUNCT
iajs-3765	157	3	29731451	29731451	NUM
iajs-3765	157	4	.	.	PUNCT
iajs-3765	158	1	2	2	X
iajs-3765	158	2	.	.	X
iajs-3765	158	3	shareef	shareef	PROPN
iajs-3765	158	4	bh	bh	PROPN
iajs-3765	158	5	,	,	PUNCT
iajs-3765	158	6	hasan	hasan	PROPN
iajs-3765	158	7	bf	bf	PROPN
iajs-3765	158	8	.	.	PROPN
iajs-3765	158	9	status	status	NOUN
iajs-3765	158	10	of	of	ADP
iajs-3765	158	11	zinc	zinc	NOUN
iajs-3765	158	12	and	and	CCONJ
iajs-3765	158	13	selenium	selenium	NOUN
iajs-3765	158	14	in	in	ADP
iajs-3765	158	15	iraqi	iraqi	ADJ
iajs-3765	158	16	women	woman	NOUN
iajs-3765	158	17	with	with	ADP
iajs-3765	158	18	rheumatoid	rheumatoid	NOUN
iajs-3765	158	19	arthritis	arthritis	NOUN
iajs-3765	158	20	and	and	CCONJ
iajs-3765	158	21	secondary	secondary	ADJ
iajs-3765	158	22	osteoporosis	osteoporosis	NOUN
iajs-3765	158	23	.	.	PUNCT
iajs-3765	159	1	biochem	biochem	PROPN
iajs-3765	159	2	cell	cell	PROPN
iajs-3765	159	3	arch	arch	NOUN
iajs-3765	159	4	.	.	PUNCT
iajs-3765	160	1	2021	2021	NUM
iajs-3765	160	2	;	;	PUNCT
iajs-3765	160	3	21(1):1185–1194	21(1):1185–1194	NUM
iajs-3765	160	4	.	.	PUNCT
iajs-3765	160	5	kaeley	kaeley	PROPN
iajs-3765	160	6	gs	gs	PROPN
iajs-3765	160	7	,	,	PUNCT
iajs-3765	160	8	bakewell	bakewell	PROPN
iajs-3765	160	9	c	c	PROPN
iajs-3765	160	10	,	,	PUNCT
iajs-3765	160	11	deodhar	deodhar	ADJ
iajs-3765	160	12	a.	a.	NOUN
iajs-3765	160	13	the	the	DET
iajs-3765	160	14	importance	importance	NOUN
iajs-3765	160	15	of	of	ADP
iajs-3765	160	16	ultrasound	ultrasound	NOUN
iajs-3765	160	17	in	in	ADP
iajs-3765	160	18	identifying	identifying	NOUN
iajs-3765	160	19	and	and	CCONJ
iajs-3765	160	20	3	3	X
iajs-3765	160	21	.	.	X
iajs-3765	160	22	differentiating	differentiate	VERB
iajs-3765	160	23	patients	patient	NOUN
iajs-3765	160	24	with	with	ADP
iajs-3765	160	25	early	early	ADJ
iajs-3765	160	26	inflammatory	inflammatory	ADJ
iajs-3765	160	27	arthritis	arthritis	NOUN
iajs-3765	160	28	:	:	PUNCT
iajs-3765	160	29	a	a	DET
iajs-3765	160	30	narrative	narrative	NOUN
iajs-3765	160	31	review	review	NOUN
iajs-3765	160	32	.	.	PUNCT
iajs-3765	161	1	arthritis	arthritis	NOUN
iajs-3765	161	2	res	re	NOUN
iajs-3765	161	3	ther	ther	ADV
iajs-3765	161	4	.	.	PUNCT
iajs-3765	162	1	2020	2020	NUM
iajs-3765	162	2	;	;	PUNCT
iajs-3765	162	3	22(1):1	22(1):1	PROPN
iajs-3765	162	4	.	.	PUNCT
iajs-3765	163	1	https://doi.org/10.1186/s13075-019-2050-4	https://doi.org/10.1186/s13075-019-2050-4	NUM
iajs-3765	163	2	.	.	PROPN
iajs-3765	164	1	4	4	NUM
iajs-3765	164	2	.	.	X
iajs-3765	164	3	johnson	johnson	PROPN
iajs-3765	164	4	kj	kj	PROPN
iajs-3765	164	5	,	,	PUNCT
iajs-3765	164	6	sanchez	sanchez	PROPN
iajs-3765	164	7	hn	hn	PROPN
iajs-3765	164	8	,	,	PUNCT
iajs-3765	164	9	schoenbrunner	schoenbrunner	NOUN
iajs-3765	164	10	n.	n.	NOUN
iajs-3765	164	11	defining	define	VERB
iajs-3765	164	12	response	response	NOUN
iajs-3765	164	13	to	to	ADP
iajs-3765	164	14	tnf	tnf	PROPN
iajs-3765	164	15	-	-	PUNCT
iajs-3765	164	16	inhibitors	inhibitor	NOUN
iajs-3765	164	17	in	in	ADP
iajs-3765	164	18	rheumatoid	rheumatoid	NOUN
iajs-3765	164	19	arthritis	arthritis	NOUN
iajs-3765	164	20	:	:	PUNCT
iajs-3765	164	21	the	the	DET
iajs-3765	164	22	negative	negative	ADJ
iajs-3765	164	23	impact	impact	NOUN
iajs-3765	164	24	of	of	ADP
iajs-3765	164	25	anti	anti	ADJ
iajs-3765	164	26	-	-	ADJ
iajs-3765	164	27	tnf	tnf	ADJ
iajs-3765	164	28	cycling	cycling	NOUN
iajs-3765	164	29	and	and	CCONJ
iajs-3765	164	30	the	the	DET
iajs-3765	164	31	need	need	NOUN
iajs-3765	164	32	for	for	ADP
iajs-3765	164	33	a	a	DET
iajs-3765	164	34	personalized	personalized	ADJ
iajs-3765	164	35	medicine	medicine	NOUN
iajs-3765	164	36	approach	approach	NOUN
iajs-3765	164	37	to	to	PART
iajs-3765	164	38	identify	identify	VERB
iajs-3765	164	39	primary	primary	ADJ
iajs-3765	164	40	non	non	NOUN
iajs-3765	164	41	-	-	NOUN
iajs-3765	164	42	responders	responder	NOUN
iajs-3765	164	43	.	.	PUNCT
iajs-3765	165	1	clin	clin	PROPN
iajs-3765	165	2	rheumatol	rheumatol	NOUN
iajs-3765	165	3	.	.	PUNCT
iajs-3765	166	1	2019	2019	NUM
iajs-3765	166	2	;	;	PUNCT
iajs-3765	167	1	38(11):2967–2976	38(11):2967–2976	NUM
iajs-3765	167	2	.	.	NOUN
iajs-3765	167	3	https://doi.org/10.1007/s10067-019-04684-1	https://doi.org/10.1007/s10067-019-04684-1	X
iajs-3765	167	4	.	.	PUNCT
iajs-3765	168	1	5	5	X
iajs-3765	168	2	.	.	X
iajs-3765	168	3	radu	radu	PROPN
iajs-3765	168	4	af	af	PROPN
iajs-3765	168	5	,	,	PUNCT
iajs-3765	168	6	bungau	bungau	VERB
iajs-3765	168	7	sg	sg	PROPN
iajs-3765	168	8	.	.	PUNCT
iajs-3765	168	9	management	management	NOUN
iajs-3765	168	10	of	of	ADP
iajs-3765	168	11	rheumatoid	rheumatoid	NOUN
iajs-3765	168	12	arthritis	arthritis	NOUN
iajs-3765	168	13	:	:	PUNCT
iajs-3765	168	14	an	an	DET
iajs-3765	168	15	overview	overview	NOUN
iajs-3765	168	16	.	.	PUNCT
iajs-3765	169	1	cells	cell	NOUN
iajs-3765	169	2	.	.	PUNCT
iajs-3765	170	1	2021	2021	NUM
iajs-3765	170	2	;	;	PUNCT
iajs-3765	170	3	10(11	10(11	NUM
iajs-3765	170	4	):	):	PUNCT
iajs-3765	170	5	2857	2857	NUM
iajs-3765	170	6	.	.	PUNCT
iajs-3765	171	1	https://doi.org/10.3390/cells10112857	https://doi.org/10.3390/cells10112857	PROPN
iajs-3765	171	2	.	.	PUNCT
iajs-3765	172	1	hamid	hamid	PROPN
iajs-3765	172	2	mm	mm	PROPN
iajs-3765	172	3	,	,	PUNCT
iajs-3765	172	4	hassan	hassan	PROPN
iajs-3765	172	5	bf	bf	PROPN
iajs-3765	172	6	,	,	PUNCT
iajs-3765	172	7	al	al	PROPN
iajs-3765	172	8	-	-	PUNCT
iajs-3765	172	9	hafidh	hafidh	PROPN
iajs-3765	172	10	ah	ah	INTJ
iajs-3765	172	11	,	,	PUNCT
iajs-3765	172	12	muhi	muhi	PROPN
iajs-3765	172	13	sa	sa	PROPN
iajs-3765	172	14	,	,	PUNCT
iajs-3765	172	15	al	al	PROPN
iajs-3765	172	16	-	-	PUNCT
iajs-3765	172	17	hashemi	hashemi	PROPN
iajs-3765	172	18	ma	ma	PROPN
iajs-3765	172	19	.	.	PROPN
iajs-3765	172	20	study	study	PROPN
iajs-3765	172	21	of	of	ADP
iajs-3765	172	22	nephroblastoma	nephroblastoma	ADJ
iajs-3765	172	23	6	6	NUM
iajs-3765	172	24	.	.	PUNCT
iajs-3765	172	25	overexpressed	overexpresse	VERB
iajs-3765	172	26	protein	protein	NOUN
iajs-3765	172	27	(	(	PUNCT
iajs-3765	172	28	nov	nov	PROPN
iajs-3765	172	29	/	/	SYM
iajs-3765	172	30	ccn3	ccn3	PROPN
iajs-3765	172	31	)	)	PUNCT
iajs-3765	172	32	as	as	ADP
iajs-3765	172	33	a	a	DET
iajs-3765	172	34	biomarker	biomarker	NOUN
iajs-3765	172	35	in	in	ADP
iajs-3765	172	36	serum	serum	NOUN
iajs-3765	172	37	of	of	ADP
iajs-3765	172	38	iraqi	iraqi	ADJ
iajs-3765	172	39	patients	patient	NOUN
iajs-3765	172	40	with	with	ADP
iajs-3765	172	41	rheumatoid	rheumatoid	NOUN
iajs-3765	172	42	arthritis	arthritis	NOUN
iajs-3765	172	43	.	.	PUNCT
iajs-3765	173	1	pak	pak	PROPN
iajs-3765	173	2	j	j	PROPN
iajs-3765	173	3	med	med	PROPN
iajs-3765	173	4	health	health	PROPN
iajs-3765	173	5	sci	sci	PROPN
iajs-3765	173	6	.	.	PROPN
iajs-3765	173	7	2022	2022	NUM
iajs-3765	173	8	;	;	PUNCT
iajs-3765	173	9	16(6):460	16(6):460	NUM
iajs-3765	173	10	.	.	PUNCT
iajs-3765	173	11	https://doi.org/10.53350/pjmhs22166460	https://doi.org/10.53350/pjmhs22166460	PROPN
iajs-3765	173	12	.	.	PUNCT
iajs-3765	174	1	al	al	PROPN
iajs-3765	174	2	-	-	PUNCT
iajs-3765	174	3	atabi	atabi	PROPN
iajs-3765	174	4	da	da	PROPN
iajs-3765	174	5	,	,	PUNCT
iajs-3765	174	6	hasan	hasan	PROPN
iajs-3765	174	7	bf	bf	PROPN
iajs-3765	174	8	,	,	PUNCT
iajs-3765	174	9	al	al	PROPN
iajs-3765	174	10	-	-	PUNCT
iajs-3765	174	11	hafidh	hafidh	PROPN
iajs-3765	174	12	ah	ah	INTJ
iajs-3765	174	13	.	.	PUNCT
iajs-3765	175	1	estimation	estimation	NOUN
iajs-3765	175	2	of	of	ADP
iajs-3765	175	3	some	some	PRON
iajs-3765	175	4	immunological	immunological	ADJ
iajs-3765	175	5	and	and	CCONJ
iajs-3765	175	6	biochemical	biochemical	ADJ
iajs-3765	175	7	in	in	ADP
iajs-3765	175	8	7	7	NUM
iajs-3765	175	9	.	.	PUNCT
iajs-3765	176	1	the	the	DET
iajs-3765	176	2	patients	patient	NOUN
iajs-3765	176	3	with	with	ADP
iajs-3765	176	4	systemic	systemic	ADJ
iajs-3765	176	5	lupus	lupus	NOUN
iajs-3765	176	6	erythematosus	erythematosus	NOUN
iajs-3765	176	7	in	in	ADP
iajs-3765	176	8	males	male	NOUN
iajs-3765	176	9	and	and	CCONJ
iajs-3765	176	10	females	female	NOUN
iajs-3765	176	11	in	in	ADP
iajs-3765	176	12	baghdad	baghdad	PROPN
iajs-3765	176	13	.	.	PUNCT
iajs-3765	177	1	med	med	PROPN
iajs-3765	177	2	leg	leg	PROPN
iajs-3765	177	3	updat	updat	PROPN
iajs-3765	177	4	.	.	PUNCT
iajs-3765	178	1	2020	2020	NUM
iajs-3765	178	2	;	;	PUNCT
iajs-3765	178	3	20(3):972–978	20(3):972–978	NOUN
iajs-3765	178	4	.	.	PUNCT
iajs-3765	179	1	https://doi.org/10.37506/mlu.v20i3.1529	https://doi.org/10.37506/mlu.v20i3.1529	NOUN
iajs-3765	179	2	.	.	PUNCT
iajs-3765	180	1	emery	emery	PROPN
iajs-3765	180	2	p	p	PROPN
iajs-3765	180	3	,	,	PUNCT
iajs-3765	180	4	salmon	salmon	NOUN
iajs-3765	180	5	m.	m.	NOUN
iajs-3765	180	6	early	early	ADV
iajs-3765	180	7	rheumatoid	rheumatoid	VERB
iajs-3765	180	8	arthritis	arthritis	NOUN
iajs-3765	180	9	:	:	PUNCT
iajs-3765	180	10	time	time	NOUN
iajs-3765	180	11	to	to	PART
iajs-3765	180	12	aim	aim	VERB
iajs-3765	180	13	for	for	ADP
iajs-3765	180	14	remission	remission	NOUN
iajs-3765	180	15	?	?	PUNCT
iajs-3765	181	1	ann	ann	PROPN
iajs-3765	181	2	rheum	rheum	PROPN
iajs-3765	181	3	dis	dis	PROPN
iajs-3765	181	4	.	.	PUNCT
iajs-3765	182	1	8	8	NUM
iajs-3765	182	2	.	.	NOUN
iajs-3765	182	3	1995	1995	NUM
iajs-3765	182	4	;	;	PUNCT
iajs-3765	183	1	54(12):944–947	54(12):944–947	NUM
iajs-3765	183	2	.	.	PUNCT
iajs-3765	184	1	https://doi.org/10.1136/ard.54.12.944	https://doi.org/10.1136/ard.54.12.944	PROPN
iajs-3765	184	2	.	.	PUNCT
iajs-3765	185	1	finckh	finckh	PROPN
iajs-3765	185	2	a.	a.	PROPN
iajs-3765	185	3	early	early	ADV
iajs-3765	185	4	inflammatory	inflammatory	ADJ
iajs-3765	185	5	arthritis	arthritis	NOUN
iajs-3765	185	6	versus	versus	ADP
iajs-3765	185	7	rheumatoid	rheumatoid	VERB
iajs-3765	185	8	arthritis	arthritis	NOUN
iajs-3765	185	9	.	.	PUNCT
iajs-3765	186	1	curr	curr	PROPN
iajs-3765	186	2	opin	opin	PROPN
iajs-3765	186	3	rheumatol	rheumatol	NOUN
iajs-3765	186	4	.	.	PUNCT
iajs-3765	187	1	2009	2009	NUM
iajs-3765	187	2	;	;	PUNCT
iajs-3765	187	3	9	9	NUM
iajs-3765	187	4	.	.	X
iajs-3765	188	1	21(2):118–123	21(2):118–123	X
iajs-3765	188	2	.	.	PUNCT
iajs-3765	189	1	https://doi.org/10.1097/bor.0b013e3283235ac4	https://doi.org/10.1097/bor.0b013e3283235ac4	NOUN
iajs-3765	189	2	.	.	PUNCT
iajs-3765	190	1	ma	ma	PROPN
iajs-3765	190	2	jd	jd	PROPN
iajs-3765	190	3	,	,	PUNCT
iajs-3765	190	4	zhou	zhou	PROPN
iajs-3765	190	5	jj	jj	PROPN
iajs-3765	190	6	,	,	PUNCT
iajs-3765	190	7	zheng	zheng	PROPN
iajs-3765	190	8	dh	dh	PROPN
iajs-3765	190	9	,	,	PUNCT
iajs-3765	190	10	chen	chen	PROPN
iajs-3765	190	11	lf	lf	PROPN
iajs-3765	190	12	,	,	PUNCT
iajs-3765	190	13	mo	mo	PROPN
iajs-3765	190	14	yq	yq	PROPN
iajs-3765	190	15	,	,	PUNCT
iajs-3765	190	16	wei	wei	PROPN
iajs-3765	190	17	xn	xn	PROPN
iajs-3765	190	18	,	,	PUNCT
iajs-3765	190	19	yang	yang	PROPN
iajs-3765	190	20	lj	lj	PROPN
iajs-3765	190	21	,	,	PUNCT
iajs-3765	190	22	dai	dai	PROPN
iajs-3765	190	23	l.	l.	PROPN
iajs-3765	190	24	serum	serum	PROPN
iajs-3765	190	25	matrix	matrix	PROPN
iajs-3765	190	26	10	10	NUM
iajs-3765	190	27	.	.	PUNCT
iajs-3765	191	1	metalloproteinase-3	metalloproteinase-3	VERB
iajs-3765	191	2	as	as	ADP
iajs-3765	191	3	a	a	DET
iajs-3765	191	4	noninvasive	noninvasive	ADJ
iajs-3765	191	5	biomarker	biomarker	NOUN
iajs-3765	191	6	of	of	ADP
iajs-3765	191	7	histological	histological	ADJ
iajs-3765	191	8	synovitis	synovitis	NOUN
iajs-3765	191	9	for	for	ADP
iajs-3765	191	10	diagnosis	diagnosis	NOUN
iajs-3765	191	11	of	of	ADP
iajs-3765	191	12	rheumatoid	rheumatoid	NOUN
iajs-3765	191	13	arthritis	arthritis	NOUN
iajs-3765	191	14	.	.	PUNCT
iajs-3765	192	1	mediators	mediator	NOUN
iajs-3765	192	2	inflamm	inflamm	PROPN
iajs-3765	192	3	.	.	PUNCT
iajs-3765	193	1	2014	2014	NUM
iajs-3765	193	2	;	;	PUNCT
iajs-3765	193	3	2014:179284	2014:179284	NUM
iajs-3765	193	4	.	.	PUNCT
iajs-3765	194	1	https://doi.org/10.1155/2014/179284	https://doi.org/10.1155/2014/179284	PROPN
iajs-3765	194	2	https://doi.org/10.1186/s13075-019-2050-4	https://doi.org/10.1186/s13075-019-2050-4	NUM
iajs-3765	194	3	https://doi.org/10.1007/s10067-019-04684-1	https://doi.org/10.1007/s10067-019-04684-1	NUM
iajs-3765	194	4	https://doi.org/10.3390/cells10112857	https://doi.org/10.3390/cells10112857	NOUN
iajs-3765	194	5	https://doi.org/10.53350/pjmhs22166460	https://doi.org/10.53350/pjmhs22166460	VERB
iajs-3765	194	6	https://doi.org/10.37506/mlu.v20i3.1529	https://doi.org/10.37506/mlu.v20i3.1529	ADP
iajs-3765	194	7	https://doi.org/10.1136/ard.54.12.944	https://doi.org/10.1136/ard.54.12.944	PROPN
iajs-3765	194	8	https://doi.org/10.1097/bor.0b013e3283235ac4	https://doi.org/10.1097/bor.0b013e3283235ac4	PROPN
iajs-3765	194	9	https://doi.org/10.1155/2014/179284	https://doi.org/10.1155/2014/179284	PROPN
iajs-3765	194	10	ihjpas	ihjpa	VERB
iajs-3765	194	11	.	.	PUNCT
iajs-3765	195	1	2025	2025	NUM
iajs-3765	195	2	,	,	PUNCT
iajs-3765	195	3	38(3	38(3	NUM
iajs-3765	195	4	)	)	PUNCT
iajs-3765	195	5	272	272	NUM
iajs-3765	195	6	11	11	NUM
iajs-3765	195	7	.	.	PUNCT
iajs-3765	196	1	mulherin	mulherin	PROPN
iajs-3765	196	2	d	d	PROPN
iajs-3765	196	3	,	,	PUNCT
iajs-3765	196	4	fitzgerald	fitzgerald	PROPN
iajs-3765	196	5	o	o	PROPN
iajs-3765	196	6	,	,	PUNCT
iajs-3765	196	7	bresnihan	bresnihan	PROPN
iajs-3765	196	8	b.	b.	PROPN
iajs-3765	196	9	clinical	clinical	ADJ
iajs-3765	196	10	improvement	improvement	NOUN
iajs-3765	196	11	and	and	CCONJ
iajs-3765	196	12	radiological	radiological	ADJ
iajs-3765	196	13	deterioration	deterioration	NOUN
iajs-3765	196	14	in	in	ADP
iajs-3765	196	15	rheumatoid	rheumatoid	NOUN
iajs-3765	196	16	arthritis	arthritis	NOUN
iajs-3765	196	17	:	:	PUNCT
iajs-3765	196	18	evidence	evidence	NOUN
iajs-3765	196	19	that	that	SCONJ
iajs-3765	196	20	the	the	DET
iajs-3765	196	21	pathogenesis	pathogenesis	NOUN
iajs-3765	196	22	of	of	ADP
iajs-3765	196	23	synovial	synovial	ADJ
iajs-3765	196	24	inflammation	inflammation	NOUN
iajs-3765	196	25	and	and	CCONJ
iajs-3765	196	26	articular	articular	ADJ
iajs-3765	196	27	erosion	erosion	NOUN
iajs-3765	196	28	may	may	AUX
iajs-3765	196	29	differ	differ	VERB
iajs-3765	196	30	.	.	PUNCT
iajs-3765	197	1	rheumatology	rheumatology	NOUN
iajs-3765	197	2	.	.	PUNCT
iajs-3765	198	1	1996	1996	NUM
iajs-3765	198	2	;	;	PUNCT
iajs-3765	199	1	35(12):1263–1268	35(12):1263–1268	NUM
iajs-3765	199	2	.	.	PUNCT
iajs-3765	200	1	https://doi.org/10.1093/rheumatology/35.12.1263	https://doi.org/10.1093/rheumatology/35.12.1263	PROPN
iajs-3765	200	2	.	.	PUNCT
iajs-3765	201	1	12	12	NUM
iajs-3765	201	2	.	.	PUNCT
iajs-3765	202	1	tchetverikov	tchetverikov	PROPN
iajs-3765	202	2	i	i	PRON
iajs-3765	202	3	,	,	PUNCT
iajs-3765	202	4	lohmander	lohmander	PROPN
iajs-3765	202	5	ls	ls	PROPN
iajs-3765	202	6	,	,	PUNCT
iajs-3765	202	7	verzijl	verzijl	PROPN
iajs-3765	202	8	n	n	CCONJ
iajs-3765	202	9	,	,	PUNCT
iajs-3765	202	10	huizinga	huizinga	PROPN
iajs-3765	202	11	tw	tw	NOUN
iajs-3765	202	12	,	,	PUNCT
iajs-3765	202	13	tekoppele	tekoppele	PROPN
iajs-3765	202	14	jm	jm	PROPN
iajs-3765	202	15	,	,	PUNCT
iajs-3765	202	16	hanemaaijer	hanemaaijer	NOUN
iajs-3765	202	17	r	r	NOUN
iajs-3765	202	18	,	,	PUNCT
iajs-3765	202	19	degroot	degroot	PROPN
iajs-3765	202	20	j.	j.	PROPN
iajs-3765	202	21	mmp	mmp	PROPN
iajs-3765	202	22	protein	protein	NOUN
iajs-3765	202	23	and	and	CCONJ
iajs-3765	202	24	activity	activity	NOUN
iajs-3765	202	25	levels	level	NOUN
iajs-3765	202	26	in	in	ADP
iajs-3765	202	27	synovial	synovial	ADJ
iajs-3765	202	28	fluid	fluid	NOUN
iajs-3765	202	29	from	from	ADP
iajs-3765	202	30	patients	patient	NOUN
iajs-3765	202	31	with	with	ADP
iajs-3765	202	32	joint	joint	ADJ
iajs-3765	202	33	injury	injury	NOUN
iajs-3765	202	34	,	,	PUNCT
iajs-3765	202	35	inflammatory	inflammatory	ADJ
iajs-3765	202	36	arthritis	arthritis	NOUN
iajs-3765	202	37	,	,	PUNCT
iajs-3765	202	38	and	and	CCONJ
iajs-3765	202	39	osteoarthritis	osteoarthritis	NOUN
iajs-3765	202	40	.	.	PUNCT
iajs-3765	203	1	ann	ann	PROPN
iajs-3765	203	2	rheum	rheum	PROPN
iajs-3765	203	3	dis	dis	PROPN
iajs-3765	203	4	.	.	PUNCT
iajs-3765	204	1	2005	2005	NUM
iajs-3765	204	2	;	;	PUNCT
iajs-3765	205	1	64(5):694–698	64(5):694–698	NUM
iajs-3765	205	2	.	.	PUNCT
iajs-3765	206	1	https://doi.org/10.1136/ard.2004.022434	https://doi.org/10.1136/ard.2004.022434	ADJ
iajs-3765	206	2	.	.	PUNCT
iajs-3765	207	1	13	13	NUM
iajs-3765	207	2	.	.	PUNCT
iajs-3765	207	3	burrage	burrage	PROPN
iajs-3765	207	4	ps	ps	PROPN
iajs-3765	207	5	,	,	PUNCT
iajs-3765	207	6	mix	mix	VERB
iajs-3765	207	7	ks	ks	NOUN
iajs-3765	207	8	,	,	PUNCT
iajs-3765	207	9	brinckerhoff	brinckerhoff	PROPN
iajs-3765	207	10	ce	ce	PROPN
iajs-3765	207	11	.	.	PROPN
iajs-3765	207	12	matrix	matrix	NOUN
iajs-3765	207	13	metalloproteinases	metalloproteinase	NOUN
iajs-3765	207	14	:	:	PUNCT
iajs-3765	207	15	role	role	NOUN
iajs-3765	207	16	in	in	ADP
iajs-3765	207	17	arthritis	arthritis	NOUN
iajs-3765	207	18	.	.	PUNCT
iajs-3765	208	1	front	front	PROPN
iajs-3765	208	2	biosci	biosci	PROPN
iajs-3765	208	3	.	.	PUNCT
iajs-3765	209	1	2006	2006	NUM
iajs-3765	209	2	;	;	PUNCT
iajs-3765	210	1	11:529–543	11:529–543	NUM
iajs-3765	210	2	.	.	PUNCT
iajs-3765	210	3	https://doi.org/10.2741/1817	https://doi.org/10.2741/1817	PROPN
iajs-3765	210	4	.	.	PUNCT
iajs-3765	211	1	14	14	NUM
iajs-3765	211	2	.	.	PUNCT
iajs-3765	212	1	sultan	sultan	PROPN
iajs-3765	212	2	ns	ns	PROPN
iajs-3765	212	3	,	,	PUNCT
iajs-3765	212	4	al	al	PROPN
iajs-3765	212	5	-	-	PUNCT
iajs-3765	212	6	tai	tai	PROPN
iajs-3765	212	7	af	af	PROPN
iajs-3765	212	8	.	.	PUNCT
iajs-3765	213	1	estimation	estimation	NOUN
iajs-3765	213	2	of	of	ADP
iajs-3765	213	3	pentraxin-3	pentraxin-3	PROPN
iajs-3765	213	4	(	(	PUNCT
iajs-3765	213	5	ptx3	ptx3	PROPN
iajs-3765	213	6	)	)	PUNCT
iajs-3765	213	7	in	in	ADP
iajs-3765	213	8	rheumatoid	rheumatoid	NOUN
iajs-3765	213	9	arthritis	arthritis	NOUN
iajs-3765	213	10	male	male	ADJ
iajs-3765	213	11	patients	patient	NOUN
iajs-3765	213	12	with	with	ADP
iajs-3765	213	13	(	(	PUNCT
iajs-3765	213	14	with	with	ADP
iajs-3765	213	15	and	and	CCONJ
iajs-3765	213	16	without	without	ADP
iajs-3765	213	17	)	)	PUNCT
iajs-3765	213	18	type	type	NOUN
iajs-3765	213	19	ii	ii	NOUN
iajs-3765	213	20	diabetes	diabetes	NOUN
iajs-3765	213	21	mellitus	mellitus	NOUN
iajs-3765	213	22	in	in	ADP
iajs-3765	213	23	iraq	iraq	PROPN
iajs-3765	213	24	.	.	PUNCT
iajs-3765	214	1	ibn	ibn	PROPN
iajs-3765	214	2	al	al	PROPN
iajs-3765	214	3	-	-	PUNCT
iajs-3765	214	4	haitham	haitham	PROPN
iajs-3765	214	5	j	j	PROPN
iajs-3765	214	6	pure	pure	PROPN
iajs-3765	214	7	appl	appl	PROPN
iajs-3765	214	8	sci	sci	PROPN
iajs-3765	214	9	.	.	PROPN
iajs-3765	214	10	2018	2018	NUM
iajs-3765	214	11	;	;	PUNCT
iajs-3765	214	12	31(3):55–62	31(3):55–62	NUM
iajs-3765	214	13	.	.	PUNCT
iajs-3765	215	1	https://doi.org/10.30526/31.3.2010	https://doi.org/10.30526/31.3.2010	X
iajs-3765	215	2	.	.	NOUN
iajs-3765	215	3	15	15	NUM
iajs-3765	215	4	.	.	PUNCT
iajs-3765	216	1	beckers	beckers	PROPN
iajs-3765	216	2	c	c	PROPN
iajs-3765	216	3	,	,	PUNCT
iajs-3765	216	4	jeukens	jeuken	VERB
iajs-3765	216	5	x	x	PRON
iajs-3765	216	6	,	,	PUNCT
iajs-3765	216	7	ribbens	ribben	VERB
iajs-3765	216	8	c	c	PROPN
iajs-3765	216	9	,	,	PUNCT
iajs-3765	216	10	andré	andré	VERB
iajs-3765	216	11	b	b	PROPN
iajs-3765	216	12	,	,	PUNCT
iajs-3765	216	13	marcelis	marcelis	PROPN
iajs-3765	216	14	s	s	NOUN
iajs-3765	216	15	,	,	PUNCT
iajs-3765	216	16	leclercq	leclercq	VERB
iajs-3765	216	17	p	p	NOUN
iajs-3765	216	18	,	,	PUNCT
iajs-3765	216	19	kaiser	kaiser	PROPN
iajs-3765	216	20	mj	mj	PROPN
iajs-3765	216	21	,	,	PUNCT
iajs-3765	216	22	foidart	foidart	PROPN
iajs-3765	216	23	j	j	PROPN
iajs-3765	216	24	,	,	PUNCT
iajs-3765	216	25	hustinx	hustinx	PROPN
iajs-3765	216	26	r	r	NOUN
iajs-3765	216	27	,	,	PUNCT
iajs-3765	216	28	malaise	malaise	NOUN
iajs-3765	216	29	mg	mg	PROPN
iajs-3765	216	30	.	.	PUNCT
iajs-3765	217	1	18f	18f	PROPN
iajs-3765	217	2	-	-	PUNCT
iajs-3765	217	3	fdg	fdg	PROPN
iajs-3765	217	4	pet	pet	PROPN
iajs-3765	217	5	imaging	imaging	NOUN
iajs-3765	217	6	of	of	ADP
iajs-3765	217	7	rheumatoid	rheumatoid	NOUN
iajs-3765	217	8	knee	knee	NOUN
iajs-3765	217	9	synovitis	synovitis	PROPN
iajs-3765	217	10	correlates	correlate	VERB
iajs-3765	217	11	with	with	ADP
iajs-3765	217	12	dynamic	dynamic	ADJ
iajs-3765	217	13	magnetic	magnetic	ADJ
iajs-3765	217	14	resonance	resonance	NOUN
iajs-3765	217	15	and	and	CCONJ
iajs-3765	217	16	sonographic	sonographic	ADJ
iajs-3765	217	17	assessments	assessment	NOUN
iajs-3765	217	18	as	as	ADV
iajs-3765	217	19	well	well	ADV
iajs-3765	217	20	as	as	ADP
iajs-3765	217	21	with	with	ADP
iajs-3765	217	22	the	the	DET
iajs-3765	217	23	serum	serum	NOUN
iajs-3765	217	24	level	level	NOUN
iajs-3765	217	25	of	of	ADP
iajs-3765	217	26	metalloproteinase	metalloproteinase	NOUN
iajs-3765	217	27	3	3	X
iajs-3765	217	28	.	.	PUNCT
iajs-3765	217	29	eur	eur	PROPN
iajs-3765	217	30	j	j	PROPN
iajs-3765	217	31	nucl	nucl	PROPN
iajs-3765	217	32	med	me	VERB
iajs-3765	217	33	mol	mol	ADP
iajs-3765	217	34	imaging	imaging	NOUN
iajs-3765	217	35	.	.	PUNCT
iajs-3765	218	1	2006	2006	NUM
iajs-3765	218	2	;	;	PUNCT
iajs-3765	219	1	33(3):275–280	33(3):275–280	PROPN
iajs-3765	219	2	.	.	PUNCT
iajs-3765	219	3	https://doi.org/10.1007/s00259-005-1952-3	https://doi.org/10.1007/s00259-005-1952-3	NUM
iajs-3765	219	4	.	.	PUNCT
iajs-3765	220	1	16	16	NUM
iajs-3765	220	2	.	.	PUNCT
iajs-3765	221	1	scherer	scherer	PROPN
iajs-3765	221	2	s	s	PROPN
iajs-3765	221	3	,	,	PUNCT
iajs-3765	221	4	de	de	PROPN
iajs-3765	221	5	souza	souza	PROPN
iajs-3765	221	6	tb	tb	PROPN
iajs-3765	221	7	,	,	PUNCT
iajs-3765	221	8	de	de	PROPN
iajs-3765	221	9	paoli	paoli	PROPN
iajs-3765	221	10	j	j	PROPN
iajs-3765	221	11	,	,	PUNCT
iajs-3765	221	12	brenol	brenol	PROPN
iajs-3765	221	13	cv	cv	PROPN
iajs-3765	221	14	,	,	PUNCT
iajs-3765	221	15	xavier	xavier	PROPN
iajs-3765	221	16	rm	rm	PROPN
iajs-3765	221	17	,	,	PUNCT
iajs-3765	221	18	brenol	brenol	PROPN
iajs-3765	221	19	jc	jc	PROPN
iajs-3765	221	20	,	,	PUNCT
iajs-3765	221	21	chies	chies	PROPN
iajs-3765	221	22	ja	ja	PROPN
iajs-3765	221	23	,	,	PUNCT
iajs-3765	221	24	simon	simon	PROPN
iajs-3765	221	25	d.	d.	PROPN
iajs-3765	221	26	matrix	matrix	PROPN
iajs-3765	221	27	metalloproteinase	metalloproteinase	NOUN
iajs-3765	221	28	gene	gene	NOUN
iajs-3765	221	29	polymorphisms	polymorphism	NOUN
iajs-3765	221	30	in	in	ADP
iajs-3765	221	31	patients	patient	NOUN
iajs-3765	221	32	with	with	ADP
iajs-3765	221	33	rheumatoid	rheumatoid	NOUN
iajs-3765	221	34	arthritis	arthritis	NOUN
iajs-3765	221	35	.	.	PUNCT
iajs-3765	222	1	rheumatol	rheumatol	PROPN
iajs-3765	222	2	int	int	PROPN
iajs-3765	222	3	.	.	PUNCT
iajs-3765	223	1	2010	2010	NUM
iajs-3765	223	2	;	;	PUNCT
iajs-3765	224	1	30(3):369–373	30(3):369–373	PROPN
iajs-3765	224	2	.	.	PUNCT
iajs-3765	225	1	https://doi.org/10.1007/s00296-009-0974-8	https://doi.org/10.1007/s00296-009-0974-8	NUM
iajs-3765	225	2	.	.	PUNCT
iajs-3765	226	1	17	17	NUM
iajs-3765	226	2	.	.	PUNCT
iajs-3765	227	1	sundaramurthy	sundaramurthy	PROPN
iajs-3765	227	2	s	s	PART
iajs-3765	227	3	,	,	PUNCT
iajs-3765	227	4	saravanabhavan	saravanabhavan	NOUN
iajs-3765	227	5	c	c	NOUN
iajs-3765	227	6	,	,	PUNCT
iajs-3765	227	7	kshirsagar	kshirsagar	NOUN
iajs-3765	227	8	p.	p.	NOUN
iajs-3765	227	9	prediction	prediction	NOUN
iajs-3765	227	10	and	and	CCONJ
iajs-3765	227	11	classification	classification	NOUN
iajs-3765	227	12	of	of	ADP
iajs-3765	227	13	rheumatoid	rheumatoid	NOUN
iajs-3765	227	14	arthritis	arthritis	NOUN
iajs-3765	227	15	using	use	VERB
iajs-3765	227	16	ensemble	ensemble	ADJ
iajs-3765	227	17	machine	machine	NOUN
iajs-3765	227	18	learning	learning	NOUN
iajs-3765	227	19	approaches	approach	NOUN
iajs-3765	227	20	.	.	PUNCT
iajs-3765	228	1	in	in	ADP
iajs-3765	228	2	:	:	PUNCT
iajs-3765	228	3	proc	proc	NOUN
iajs-3765	228	4	int	int	NOUN
iajs-3765	228	5	conf	conf	NOUN
iajs-3765	228	6	decision	decision	NOUN
iajs-3765	228	7	aid	aid	NOUN
iajs-3765	228	8	sci	sci	PROPN
iajs-3765	228	9	appl	appl	PROPN
iajs-3765	228	10	(	(	PUNCT
iajs-3765	228	11	dasa	dasa	PROPN
iajs-3765	228	12	)	)	PUNCT
iajs-3765	228	13	.	.	PUNCT
iajs-3765	229	1	ieee	ieee	PROPN
iajs-3765	229	2	;	;	PUNCT
iajs-3765	229	3	2020	2020	NUM
iajs-3765	229	4	;	;	PUNCT
iajs-3765	229	5	p.	p.	NOUN
iajs-3765	229	6	17–21	17–21	NUM
iajs-3765	229	7	.	.	PUNCT
iajs-3765	230	1	https://doi.org/10.1109/dasa51403.2020.9317253	https://doi.org/10.1109/dasa51403.2020.9317253	PROPN
iajs-3765	230	2	.	.	PUNCT
iajs-3765	231	1	18	18	NUM
iajs-3765	231	2	.	.	PUNCT
iajs-3765	231	3	almutairi	almutairi	PROPN
iajs-3765	231	4	k	k	PROPN
iajs-3765	231	5	,	,	PUNCT
iajs-3765	231	6	nossent	nossent	PROPN
iajs-3765	231	7	j	j	NOUN
iajs-3765	231	8	,	,	PUNCT
iajs-3765	231	9	preen	preen	VERB
iajs-3765	231	10	d	d	NOUN
iajs-3765	231	11	,	,	PUNCT
iajs-3765	231	12	keen	keen	ADJ
iajs-3765	231	13	h	h	NOUN
iajs-3765	231	14	,	,	PUNCT
iajs-3765	231	15	inderjeeth	inderjeeth	PROPN
iajs-3765	231	16	c.	c.	PROPN
iajs-3765	231	17	the	the	DET
iajs-3765	231	18	global	global	ADJ
iajs-3765	231	19	prevalence	prevalence	NOUN
iajs-3765	231	20	of	of	ADP
iajs-3765	231	21	rheumatoid	rheumatoid	NOUN
iajs-3765	231	22	arthritis	arthritis	NOUN
iajs-3765	231	23	:	:	PUNCT
iajs-3765	231	24	a	a	DET
iajs-3765	231	25	meta	meta	ADJ
iajs-3765	231	26	-	-	PUNCT
iajs-3765	231	27	analysis	analysis	NOUN
iajs-3765	231	28	based	base	VERB
iajs-3765	231	29	on	on	ADP
iajs-3765	231	30	a	a	DET
iajs-3765	231	31	systematic	systematic	ADJ
iajs-3765	231	32	review	review	NOUN
iajs-3765	231	33	.	.	PUNCT
iajs-3765	232	1	rheumatol	rheumatol	PROPN
iajs-3765	232	2	int	int	PROPN
iajs-3765	232	3	.	.	PUNCT
iajs-3765	233	1	2021	2021	NUM
iajs-3765	233	2	;	;	PUNCT
iajs-3765	234	1	41(5):863–877	41(5):863–877	PROPN
iajs-3765	234	2	.	.	PUNCT
iajs-3765	235	1	https://doi.org/10.1007/s00296-020-04731-0	https://doi.org/10.1007/s00296-020-04731-0	PROPN
iajs-3765	235	2	.	.	PUNCT
iajs-3765	236	1	19	19	NUM
iajs-3765	236	2	.	.	PUNCT
iajs-3765	236	3	hamid	hamid	PROPN
iajs-3765	236	4	mm	mm	PROPN
iajs-3765	236	5	,	,	PUNCT
iajs-3765	236	6	hassan	hassan	PROPN
iajs-3765	236	7	bf	bf	PROPN
iajs-3765	236	8	,	,	PUNCT
iajs-3765	236	9	al	al	PROPN
iajs-3765	236	10	-	-	PUNCT
iajs-3765	236	11	hafidh	hafidh	PROPN
iajs-3765	236	12	ah	ah	INTJ
iajs-3765	236	13	,	,	PUNCT
iajs-3765	236	14	muhi	muhi	PROPN
iajs-3765	236	15	sa	sa	PROPN
iajs-3765	236	16	.	.	PUNCT
iajs-3765	237	1	study	study	PROPN
iajs-3765	237	2	of	of	ADP
iajs-3765	237	3	pentraxin	pentraxin	NOUN
iajs-3765	237	4	3	3	NUM
iajs-3765	237	5	protein	protein	NOUN
iajs-3765	237	6	(	(	PUNCT
iajs-3765	237	7	ptx3	ptx3	PROPN
iajs-3765	237	8	)	)	PUNCT
iajs-3765	237	9	as	as	ADP
iajs-3765	237	10	a	a	DET
iajs-3765	237	11	biomarker	biomarker	NOUN
iajs-3765	237	12	in	in	ADP
iajs-3765	237	13	the	the	DET
iajs-3765	237	14	serum	serum	NOUN
iajs-3765	237	15	of	of	ADP
iajs-3765	237	16	iraqi	iraqi	ADJ
iajs-3765	237	17	patients	patient	NOUN
iajs-3765	237	18	with	with	ADP
iajs-3765	237	19	rheumatoid	rheumatoid	NOUN
iajs-3765	237	20	arthritis	arthritis	NOUN
iajs-3765	237	21	.	.	PUNCT
iajs-3765	238	1	neuroquantology	neuroquantology	NOUN
iajs-3765	238	2	.	.	PUNCT
iajs-3765	239	1	2022	2022	NUM
iajs-3765	239	2	;	;	PUNCT
iajs-3765	239	3	20	20	NUM
iajs-3765	239	4	:	:	PUNCT
iajs-3765	240	1	145–152	145–152	NUM
iajs-3765	240	2	.	.	NOUN
iajs-3765	240	3	20	20	NUM
iajs-3765	240	4	.	.	PUNCT
iajs-3765	241	1	itoh	itoh	PROPN
iajs-3765	241	2	y.	y.	PROPN
iajs-3765	241	3	metalloproteinases	metalloproteinase	NOUN
iajs-3765	241	4	:	:	PUNCT
iajs-3765	241	5	potential	potential	ADJ
iajs-3765	241	6	therapeutic	therapeutic	ADJ
iajs-3765	241	7	targets	target	NOUN
iajs-3765	241	8	for	for	ADP
iajs-3765	241	9	rheumatoid	rheumatoid	NOUN
iajs-3765	241	10	arthritis	arthritis	NOUN
iajs-3765	241	11	.	.	PUNCT
iajs-3765	242	1	endocr	endocr	PROPN
iajs-3765	242	2	metab	metab	PROPN
iajs-3765	242	3	immune	immune	ADJ
iajs-3765	242	4	disord	disord	NOUN
iajs-3765	242	5	drug	drug	NOUN
iajs-3765	242	6	targets	target	NOUN
iajs-3765	242	7	.	.	PUNCT
iajs-3765	243	1	2015	2015	NUM
iajs-3765	243	2	;	;	PUNCT
iajs-3765	244	1	15(3):216–222	15(3):216–222	NUM
iajs-3765	244	2	.	.	PUNCT
iajs-3765	245	1	https://doi.org/10.2174/1871530315666150316122335	https://doi.org/10.2174/1871530315666150316122335	NUM
iajs-3765	245	2	.	.	PUNCT
iajs-3765	246	1	21	21	NUM
iajs-3765	246	2	.	.	PUNCT
iajs-3765	246	3	araki	araki	PROPN
iajs-3765	246	4	y	y	PROPN
iajs-3765	246	5	,	,	PUNCT
iajs-3765	246	6	mimura	mimura	ADJ
iajs-3765	246	7	t.	t.	NOUN
iajs-3765	246	8	matrix	matrix	NOUN
iajs-3765	246	9	metalloproteinase	metalloproteinase	NOUN
iajs-3765	246	10	gene	gene	NOUN
iajs-3765	246	11	activation	activation	NOUN
iajs-3765	246	12	resulting	result	VERB
iajs-3765	246	13	from	from	ADP
iajs-3765	246	14	disordered	disordered	ADJ
iajs-3765	246	15	epigenetic	epigenetic	ADJ
iajs-3765	246	16	mechanisms	mechanism	NOUN
iajs-3765	246	17	in	in	ADP
iajs-3765	246	18	rheumatoid	rheumatoid	NOUN
iajs-3765	246	19	arthritis	arthritis	NOUN
iajs-3765	246	20	.	.	PUNCT
iajs-3765	247	1	int	int	PROPN
iajs-3765	247	2	j	j	PROPN
iajs-3765	247	3	mol	mol	ADP
iajs-3765	247	4	sci	sci	PROPN
iajs-3765	247	5	.	.	PROPN
iajs-3765	247	6	2017	2017	NUM
iajs-3765	247	7	;	;	PUNCT
iajs-3765	247	8	18(5):905	18(5):905	NUM
iajs-3765	247	9	.	.	PUNCT
iajs-3765	248	1	https://doi.org/10.3390/ijms18050905	https://doi.org/10.3390/ijms18050905	PROPN
iajs-3765	248	2	.	.	PUNCT
iajs-3765	249	1	22	22	NUM
iajs-3765	249	2	.	.	PUNCT
iajs-3765	250	1	huang	huang	PROPN
iajs-3765	250	2	tl	tl	PROPN
iajs-3765	250	3	,	,	PUNCT
iajs-3765	250	4	mu	mu	PROPN
iajs-3765	250	5	n	n	CCONJ
iajs-3765	250	6	,	,	PUNCT
iajs-3765	250	7	gu	gu	PROPN
iajs-3765	250	8	jt	jt	PROPN
iajs-3765	250	9	,	,	PUNCT
iajs-3765	250	10	shu	shu	PROPN
iajs-3765	250	11	z	z	PROPN
iajs-3765	250	12	,	,	PUNCT
iajs-3765	250	13	zhang	zhang	PROPN
iajs-3765	250	14	k	k	PROPN
iajs-3765	250	15	,	,	PUNCT
iajs-3765	250	16	zhao	zhao	PROPN
iajs-3765	250	17	jk	jk	PROPN
iajs-3765	250	18	,	,	PUNCT
iajs-3765	250	19	zhang	zhang	PROPN
iajs-3765	250	20	c	c	PROPN
iajs-3765	250	21	,	,	PUNCT
iajs-3765	250	22	hao	hao	PROPN
iajs-3765	250	23	q	q	PROPN
iajs-3765	250	24	,	,	PUNCT
iajs-3765	250	25	li	li	PROPN
iajs-3765	250	26	wn	wn	PROPN
iajs-3765	250	27	,	,	PUNCT
iajs-3765	250	28	zhang	zhang	PROPN
iajs-3765	250	29	wq	wq	PROPN
iajs-3765	250	30	,	,	PUNCT
iajs-3765	250	31	liu	liu	PROPN
iajs-3765	250	32	nn	nn	PROPN
iajs-3765	250	33	,	,	PUNCT
iajs-3765	250	34	zhang	zhang	PROPN
iajs-3765	250	35	y	y	PROPN
iajs-3765	250	36	,	,	PUNCT
iajs-3765	250	37	zhang	zhang	PROPN
iajs-3765	250	38	w	w	PROPN
iajs-3765	250	39	,	,	PUNCT
iajs-3765	250	40	xue	xue	PROPN
iajs-3765	250	41	xc	xc	PROPN
iajs-3765	250	42	,	,	PUNCT
iajs-3765	250	43	zhang	zhang	PROPN
iajs-3765	250	44	yq	yq	PROPN
iajs-3765	250	45	.	.	PUNCT
iajs-3765	250	46	ddr2	ddr2	PROPN
iajs-3765	250	47	-	-	PUNCT
iajs-3765	250	48	cyr61	cyr61	PROPN
iajs-3765	250	49	-	-	PUNCT
iajs-3765	250	50	mmp1	mmp1	NOUN
iajs-3765	250	51	signaling	signal	VERB
iajs-3765	250	52	pathway	pathway	NOUN
iajs-3765	250	53	promotes	promote	VERB
iajs-3765	250	54	bone	bone	NOUN
iajs-3765	250	55	erosion	erosion	NOUN
iajs-3765	250	56	in	in	ADP
iajs-3765	250	57	rheumatoid	rheumatoid	NOUN
iajs-3765	250	58	arthritis	arthritis	NOUN
iajs-3765	250	59	through	through	ADP
iajs-3765	250	60	regulating	regulate	VERB
iajs-3765	250	61	migration	migration	NOUN
iajs-3765	250	62	and	and	CCONJ
iajs-3765	250	63	invasion	invasion	NOUN
iajs-3765	250	64	of	of	ADP
iajs-3765	250	65	fibroblast	fibroblast	ADJ
iajs-3765	250	66	-	-	PUNCT
iajs-3765	250	67	like	like	ADJ
iajs-3765	250	68	synoviocytes	synoviocyte	NOUN
iajs-3765	250	69	.	.	PUNCT
iajs-3765	251	1	j	j	PROPN
iajs-3765	251	2	bone	bone	NOUN
iajs-3765	251	3	miner	miner	NOUN
iajs-3765	251	4	res	re	NOUN
iajs-3765	251	5	.	.	PROPN
iajs-3765	251	6	2019	2019	NUM
iajs-3765	251	7	;	;	PUNCT
iajs-3765	251	8	34(4):779–780	34(4):779–780	NUM
iajs-3765	251	9	.	.	PUNCT
iajs-3765	251	10	https://doi.org/10.1002/jbmr.3688	https://doi.org/10.1002/jbmr.3688	NOUN
iajs-3765	251	11	.	.	PUNCT
iajs-3765	252	1	23	23	NUM
iajs-3765	252	2	.	.	PUNCT
iajs-3765	253	1	chen	chen	PROPN
iajs-3765	253	2	z	z	PROPN
iajs-3765	253	3	,	,	PUNCT
iajs-3765	253	4	wang	wang	PROPN
iajs-3765	253	5	h	h	PROPN
iajs-3765	253	6	,	,	PUNCT
iajs-3765	253	7	xia	xia	PROPN
iajs-3765	253	8	y	y	PROPN
iajs-3765	253	9	,	,	PUNCT
iajs-3765	253	10	yan	yan	PROPN
iajs-3765	254	1	f	f	AUX
iajs-3765	254	2	,	,	PUNCT
iajs-3765	254	3	lu	lu	PROPN
iajs-3765	254	4	y.	y.	NOUN
iajs-3765	254	5	therapeutic	therapeutic	ADJ
iajs-3765	254	6	potential	potential	NOUN
iajs-3765	254	7	of	of	ADP
iajs-3765	254	8	mesenchymal	mesenchymal	ADJ
iajs-3765	254	9	cell	cell	NOUN
iajs-3765	254	10	–	–	PUNCT
iajs-3765	254	11	derived	derive	VERB
iajs-3765	254	12	mirna-150	mirna-150	ADJ
iajs-3765	254	13	-	-	PUNCT
iajs-3765	254	14	5p	5p	NUM
iajs-3765	254	15	–	–	PUNCT
iajs-3765	254	16	expressing	express	VERB
iajs-3765	254	17	exosomes	exosome	NOUN
iajs-3765	254	18	in	in	ADP
iajs-3765	254	19	rheumatoid	rheumatoid	NOUN
iajs-3765	254	20	arthritis	arthritis	NOUN
iajs-3765	254	21	mediated	mediate	VERB
iajs-3765	254	22	by	by	ADP
iajs-3765	254	23	the	the	DET
iajs-3765	254	24	modulation	modulation	NOUN
iajs-3765	254	25	of	of	ADP
iajs-3765	254	26	mmp14	mmp14	PROPN
iajs-3765	254	27	and	and	CCONJ
iajs-3765	254	28	vegf	vegf	PROPN
iajs-3765	254	29	.	.	PUNCT
iajs-3765	255	1	j	j	PROPN
iajs-3765	255	2	immunol	immunol	NOUN
iajs-3765	255	3	.	.	PUNCT
iajs-3765	255	4	2018	2018	NUM
iajs-3765	255	5	;	;	PUNCT
iajs-3765	256	1	201(8):2472–2482	201(8):2472–2482	NUM
iajs-3765	256	2	.	.	PUNCT
iajs-3765	256	3	https://doi.org/10.4049/jimmunol.1800304	https://doi.org/10.4049/jimmunol.1800304	NOUN
iajs-3765	256	4	.	.	PUNCT
iajs-3765	257	1	24	24	NUM
iajs-3765	257	2	.	.	PUNCT
iajs-3765	258	1	zhang	zhang	PROPN
iajs-3765	258	2	b	b	PROPN
iajs-3765	258	3	,	,	PUNCT
iajs-3765	258	4	jiang	jiang	PROPN
iajs-3765	258	5	w.	w.	PROPN
iajs-3765	258	6	il-1β	il-1β	PROPN
iajs-3765	258	7	,	,	PUNCT
iajs-3765	258	8	il-17a	il-17a	PROPN
iajs-3765	258	9	,	,	PUNCT
iajs-3765	258	10	crp	crp	PROPN
iajs-3765	258	11	and	and	CCONJ
iajs-3765	258	12	biologics	biologic	NOUN
iajs-3765	258	13	history	history	NOUN
iajs-3765	258	14	might	might	AUX
iajs-3765	258	15	serve	serve	VERB
iajs-3765	258	16	as	as	ADP
iajs-3765	258	17	potential	potential	ADJ
iajs-3765	258	18	markers	marker	NOUN
iajs-3765	258	19	for	for	ADP
iajs-3765	258	20	clinical	clinical	ADJ
iajs-3765	258	21	response	response	NOUN
iajs-3765	258	22	to	to	PART
iajs-3765	258	23	etanercept	etanercept	VERB
iajs-3765	258	24	in	in	ADP
iajs-3765	258	25	rheumatoid	rheumatoid	NOUN
iajs-3765	258	26	arthritis	arthritis	NOUN
iajs-3765	258	27	patients	patient	NOUN
iajs-3765	258	28	.	.	PUNCT
iajs-3765	259	1	inflammopharmacology	inflammopharmacology	NOUN
iajs-3765	259	2	.	.	PUNCT
iajs-3765	260	1	2019	2019	NUM
iajs-3765	260	2	;	;	PUNCT
iajs-3765	261	1	27(6):1123–1130	27(6):1123–1130	NUM
iajs-3765	261	2	.	.	PUNCT
iajs-3765	262	1	https://doi.org/10.1007/s10787-019-00624-2	https://doi.org/10.1007/s10787-019-00624-2	NOUN
iajs-3765	262	2	.	.	PUNCT
iajs-3765	263	1	25	25	NUM
iajs-3765	263	2	.	.	X
iajs-3765	264	1	alwan	alwan	PROPN
iajs-3765	264	2	it	it	PRON
iajs-3765	264	3	,	,	PUNCT
iajs-3765	264	4	ghali	ghali	PROPN
iajs-3765	264	5	kh	kh	PROPN
iajs-3765	264	6	.	.	PROPN
iajs-3765	264	7	association	association	PROPN
iajs-3765	264	8	risk	risk	NOUN
iajs-3765	264	9	of	of	ADP
iajs-3765	264	10	matrix	matrix	NOUN
iajs-3765	264	11	metalloproteinase	metalloproteinase	NOUN
iajs-3765	264	12	enzymes	enzyme	NOUN
iajs-3765	264	13	levels	level	NOUN
iajs-3765	264	14	(	(	PUNCT
iajs-3765	264	15	mmp-1	mmp-1	NOUN
iajs-3765	264	16	,	,	PUNCT
iajs-3765	264	17	mmp-9	mmp-9	NOUN
iajs-3765	264	18	and	and	CCONJ
iajs-3765	264	19	mmp-13	mmp-13	NOUN
iajs-3765	264	20	)	)	PUNCT
iajs-3765	264	21	with	with	ADP
iajs-3765	264	22	development	development	NOUN
iajs-3765	264	23	of	of	ADP
iajs-3765	264	24	rheumatoid	rheumatoid	NOUN
iajs-3765	264	25	arthritis	arthritis	NOUN
iajs-3765	264	26	.	.	PUNCT
iajs-3765	265	1	ann	ann	PROPN
iajs-3765	265	2	rom	rom	PROPN
iajs-3765	265	3	soc	soc	NOUN
iajs-3765	265	4	cell	cell	NOUN
iajs-3765	265	5	biol	biol	PROPN
iajs-3765	265	6	.	.	PUNCT
iajs-3765	266	1	2021	2021	NUM
iajs-3765	266	2	;	;	PUNCT
iajs-3765	267	1	25(4	25(4	NOUN
iajs-3765	267	2	):	):	PUNCT
iajs-3765	267	3	11369–11378	11369–11378	NUM
iajs-3765	267	4	.	.	PUNCT
iajs-3765	268	1	http://www.annalsofrscb.ro/index.php/journal/article/view/3915	http://www.annalsofrscb.ro/index.php/journal/article/view/3915	NOUN
iajs-3765	268	2	.	.	NOUN
iajs-3765	268	3	26	26	NUM
iajs-3765	268	4	.	.	PUNCT
iajs-3765	268	5	yu	yu	PROPN
iajs-3765	269	1	z	z	PROPN
iajs-3765	269	2	,	,	PUNCT
iajs-3765	269	3	wang	wang	PROPN
iajs-3765	269	4	y	y	PROPN
iajs-3765	269	5	,	,	PUNCT
iajs-3765	269	6	li	li	PROPN
iajs-3765	269	7	y	y	PROPN
iajs-3765	269	8	,	,	PUNCT
iajs-3765	269	9	liao	liao	PROPN
iajs-3765	269	10	c	c	PROPN
iajs-3765	269	11	,	,	PUNCT
iajs-3765	269	12	dai	dai	PROPN
iajs-3765	269	13	j	j	PROPN
iajs-3765	269	14	,	,	PUNCT
iajs-3765	269	15	luo	luo	PROPN
iajs-3765	269	16	y	y	PROPN
iajs-3765	269	17	,	,	PUNCT
iajs-3765	269	18	hu	hu	PROPN
iajs-3765	269	19	y	y	PROPN
iajs-3765	269	20	,	,	PUNCT
iajs-3765	269	21	tao	tao	PROPN
iajs-3765	269	22	s	s	PROPN
iajs-3765	269	23	,	,	PUNCT
iajs-3765	269	24	tang	tang	PROPN
iajs-3765	269	25	j	j	PROPN
iajs-3765	269	26	,	,	PUNCT
iajs-3765	269	27	chen	chen	PROPN
iajs-3765	269	28	g	g	PROPN
iajs-3765	269	29	,	,	PUNCT
iajs-3765	269	30	wu	wu	PROPN
iajs-3765	269	31	p.	p.	PROPN
iajs-3765	269	32	effect	effect	NOUN
iajs-3765	269	33	of	of	ADP
iajs-3765	269	34	https://doi.org/10.1093/rheumatology/35.12.1263	https://doi.org/10.1093/rheumatology/35.12.1263	PRON
iajs-3765	269	35	https://doi.org/10.1136/ard.2004.022434	https://doi.org/10.1136/ard.2004.022434	PROPN
iajs-3765	269	36	https://doi.org/10.2741/1817	https://doi.org/10.2741/1817	NOUN
iajs-3765	269	37	https://doi.org/10.30526/31.3.2010	https://doi.org/10.30526/31.3.2010	PROPN
iajs-3765	269	38	https://doi.org/10.1007/s00259-005-1952-3	https://doi.org/10.1007/s00259-005-1952-3	NUM
iajs-3765	269	39	https://doi.org/10.1007/s00296-009-0974-8	https://doi.org/10.1007/s00296-009-0974-8	NUM
iajs-3765	269	40	https://doi.org/10.1109/dasa51403.2020.9317253	https://doi.org/10.1109/dasa51403.2020.9317253	PROPN
iajs-3765	269	41	https://doi.org/10.1007/s00296-020-04731-0	https://doi.org/10.1007/s00296-020-04731-0	VERB
iajs-3765	269	42	https://doi.org/10.2174/1871530315666150316122335	https://doi.org/10.2174/1871530315666150316122335	NUM
iajs-3765	269	43	https://doi.org/10.3390/ijms18050905	https://doi.org/10.3390/ijms18050905	NOUN
iajs-3765	269	44	https://doi.org/10.1002/jbmr.3688	https://doi.org/10.1002/jbmr.3688	NOUN
iajs-3765	269	45	https://doi.org/10.4049/jimmunol.1800304	https://doi.org/10.4049/jimmunol.1800304	NOUN
iajs-3765	270	1	https://doi.org/10.1007/s10787-019-00624-2	https://doi.org/10.1007/s10787-019-00624-2	NUM
iajs-3765	271	1	http://www.annalsofrscb.ro/index.php/journal/article/view/3915	http://www.annalsofrscb.ro/index.php/journal/article/view/3915	PRON
iajs-3765	271	2	ihjpas	ihjpas	PROPN
iajs-3765	271	3	.	.	PUNCT
iajs-3765	272	1	2025	2025	NUM
iajs-3765	272	2	,	,	PUNCT
iajs-3765	272	3	38(3	38(3	NUM
iajs-3765	272	4	)	)	PUNCT
iajs-3765	272	5	273	273	NUM
iajs-3765	272	6	moxibustion	moxibustion	NOUN
iajs-3765	272	7	on	on	ADP
iajs-3765	272	8	the	the	DET
iajs-3765	272	9	serum	serum	NOUN
iajs-3765	272	10	levels	level	NOUN
iajs-3765	272	11	of	of	ADP
iajs-3765	272	12	mmp-1	mmp-1	NOUN
iajs-3765	272	13	,	,	PUNCT
iajs-3765	272	14	mmp-3	mmp-3	NOUN
iajs-3765	272	15	,	,	PUNCT
iajs-3765	272	16	and	and	CCONJ
iajs-3765	272	17	vegf	vegf	NOUN
iajs-3765	272	18	in	in	ADP
iajs-3765	272	19	patients	patient	NOUN
iajs-3765	272	20	with	with	ADP
iajs-3765	272	21	rheumatoid	rheumatoid	NOUN
iajs-3765	272	22	arthritis	arthritis	NOUN
iajs-3765	272	23	.	.	PUNCT
iajs-3765	273	1	evid	evid	PROPN
iajs-3765	273	2	based	base	VERB
iajs-3765	273	3	complement	complement	PROPN
iajs-3765	273	4	alternat	alternat	NOUN
iajs-3765	273	5	med	me	VERB
iajs-3765	273	6	.	.	PUNCT
iajs-3765	273	7	2020	2020	NUM
iajs-3765	273	8	;	;	PUNCT
iajs-3765	273	9	2020:7150605	2020:7150605	X
iajs-3765	273	10	.	.	PUNCT
iajs-3765	274	1	https://doi.org/10.1155/2020/7150605	https://doi.org/10.1155/2020/7150605	PROPN
iajs-3765	274	2	.	.	PUNCT
iajs-3765	275	1	27	27	NUM
iajs-3765	275	2	.	.	PUNCT
iajs-3765	275	3	taha	taha	PROPN
iajs-3765	275	4	aaa	aaa	PROPN
iajs-3765	275	5	,	,	PUNCT
iajs-3765	275	6	khadr	khadr	NOUN
iajs-3765	275	7	na	na	NOUN
iajs-3765	275	8	,	,	PUNCT
iajs-3765	275	9	elneily	elneily	ADV
iajs-3765	275	10	dae	dae	VERB
iajs-3765	275	11	,	,	PUNCT
iajs-3765	275	12	elkhalifa	elkhalifa	PROPN
iajs-3765	275	13	msa	msa	PROPN
iajs-3765	275	14	,	,	PUNCT
iajs-3765	275	15	mohamad	mohamad	PROPN
iajs-3765	275	16	ssm	ssm	PROPN
iajs-3765	275	17	.	.	PROPN
iajs-3765	275	18	serum	serum	NOUN
iajs-3765	275	19	matrix	matrix	NOUN
iajs-3765	275	20	metalloproteinase-3	metalloproteinase-3	VERB
iajs-3765	275	21	in	in	ADP
iajs-3765	275	22	patients	patient	NOUN
iajs-3765	275	23	with	with	ADP
iajs-3765	275	24	psoriasis	psoriasis	NOUN
iajs-3765	275	25	with	with	ADP
iajs-3765	275	26	and	and	CCONJ
iajs-3765	275	27	without	without	ADP
iajs-3765	275	28	arthritis	arthritis	NOUN
iajs-3765	275	29	.	.	PUNCT
iajs-3765	276	1	j	j	PROPN
iajs-3765	276	2	egypt	egypt	PROPN
iajs-3765	276	3	women	women	PROPN
iajs-3765	276	4	dermatol	dermatol	NOUN
iajs-3765	276	5	soc	soc	NOUN
iajs-3765	276	6	.	.	PUNCT
iajs-3765	277	1	2023	2023	NUM
iajs-3765	277	2	;	;	PUNCT
iajs-3765	277	3	20(2):125–130	20(2):125–130	NUM
iajs-3765	277	4	.	.	PUNCT
iajs-3765	277	5	https://doi.org/10.4103/jewd.jewd_5_23	https://doi.org/10.4103/jewd.jewd_5_23	PROPN
iajs-3765	277	6	.	.	PUNCT
iajs-3765	278	1	28	28	NUM
iajs-3765	278	2	.	.	PUNCT
iajs-3765	279	1	abd	abd	PROPN
iajs-3765	279	2	-	-	PUNCT
iajs-3765	279	3	allah	allah	PROPN
iajs-3765	279	4	sh	sh	PROPN
iajs-3765	279	5	,	,	PUNCT
iajs-3765	279	6	shalaby	shalaby	X
iajs-3765	279	7	sm	sm	PROPN
iajs-3765	279	8	,	,	PUNCT
iajs-3765	279	9	pasha	pasha	PROPN
iajs-3765	279	10	hf	hf	PROPN
iajs-3765	279	11	,	,	PUNCT
iajs-3765	279	12	el	el	PROPN
iajs-3765	279	13	-	-	NOUN
iajs-3765	279	14	shal	shal	PROPN
iajs-3765	279	15	as	as	ADP
iajs-3765	279	16	,	,	PUNCT
iajs-3765	279	17	abou	abou	PROPN
iajs-3765	279	18	el	el	PROPN
iajs-3765	279	19	-	-	PUNCT
iajs-3765	279	20	saoud	saoud	ADJ
iajs-3765	279	21	am	am	NOUN
iajs-3765	279	22	.	.	PUNCT
iajs-3765	280	1	variation	variation	NOUN
iajs-3765	280	2	of	of	ADP
iajs-3765	280	3	matrix	matrix	NOUN
iajs-3765	280	4	metalloproteinase	metalloproteinase	NOUN
iajs-3765	280	5	1	1	NUM
iajs-3765	280	6	and	and	CCONJ
iajs-3765	280	7	3	3	NUM
iajs-3765	280	8	haplotypes	haplotype	NOUN
iajs-3765	280	9	and	and	CCONJ
iajs-3765	280	10	their	their	PRON
iajs-3765	280	11	serum	serum	NOUN
iajs-3765	280	12	levels	level	NOUN
iajs-3765	280	13	in	in	ADP
iajs-3765	280	14	patients	patient	NOUN
iajs-3765	280	15	with	with	ADP
iajs-3765	280	16	rheumatoid	rheumatoid	NOUN
iajs-3765	280	17	arthritis	arthritis	NOUN
iajs-3765	280	18	and	and	CCONJ
iajs-3765	280	19	osteoarthritis	osteoarthritis	NOUN
iajs-3765	280	20	.	.	PUNCT
iajs-3765	281	1	genet	genet	PROPN
iajs-3765	281	2	test	test	NOUN
iajs-3765	281	3	mol	mol	ADP
iajs-3765	281	4	biomarkers	biomarker	NOUN
iajs-3765	281	5	.	.	PUNCT
iajs-3765	282	1	2012	2012	NUM
iajs-3765	282	2	;	;	PUNCT
iajs-3765	282	3	16(1):15–20	16(1):15–20	NUM
iajs-3765	282	4	.	.	PUNCT
iajs-3765	283	1	https://doi.org/10.1089/gtmb.2011.0003	https://doi.org/10.1089/gtmb.2011.0003	NOUN
iajs-3765	283	2	.	.	PROPN
iajs-3765	283	3	29	29	NUM
iajs-3765	283	4	.	.	PUNCT
iajs-3765	284	1	kasher	kasher	PROPN
iajs-3765	284	2	m	m	PROPN
iajs-3765	284	3	,	,	PUNCT
iajs-3765	284	4	cherny	cherny	PROPN
iajs-3765	284	5	ss	ss	PROPN
iajs-3765	284	6	,	,	PUNCT
iajs-3765	284	7	livshits	livshit	VERB
iajs-3765	284	8	g	g	NOUN
iajs-3765	284	9	,	,	PUNCT
iajs-3765	284	10	group	group	NOUN
iajs-3765	284	11	ciw	ciw	PROPN
iajs-3765	284	12	.	.	PUNCT
iajs-3765	284	13	exploring	explore	VERB
iajs-3765	284	14	potential	potential	ADJ
iajs-3765	284	15	shared	share	VERB
iajs-3765	284	16	genetic	genetic	ADJ
iajs-3765	284	17	influences	influence	NOUN
iajs-3765	284	18	between	between	ADP
iajs-3765	284	19	rheumatoid	rheumatoid	NOUN
iajs-3765	284	20	arthritis	arthritis	NOUN
iajs-3765	284	21	and	and	CCONJ
iajs-3765	284	22	blood	blood	NOUN
iajs-3765	284	23	lipid	lipid	NOUN
iajs-3765	284	24	levels	level	NOUN
iajs-3765	284	25	.	.	PUNCT
iajs-3765	285	1	atherosclerosis	atherosclerosis	NOUN
iajs-3765	285	2	.	.	PUNCT
iajs-3765	286	1	2022	2022	NUM
iajs-3765	286	2	;	;	PUNCT
iajs-3765	286	3	363:48–56	363:48–56	X
iajs-3765	286	4	.	.	PUNCT
iajs-3765	286	5	https://doi.org/10.1016/j.atherosclerosis.2022.11.006	https://doi.org/10.1016/j.atherosclerosis.2022.11.006	PROPN
iajs-3765	286	6	.	.	PUNCT
iajs-3765	287	1	30	30	NUM
iajs-3765	287	2	.	.	PUNCT
iajs-3765	288	1	alghamdi	alghamdi	PROPN
iajs-3765	288	2	m	m	PROPN
iajs-3765	288	3	,	,	PUNCT
iajs-3765	288	4	alamry	alamry	PROPN
iajs-3765	288	5	sa	sa	PROPN
iajs-3765	288	6	,	,	PUNCT
iajs-3765	288	7	bahlas	bahlas	PROPN
iajs-3765	288	8	sm	sm	PROPN
iajs-3765	288	9	,	,	PUNCT
iajs-3765	288	10	uversky	uversky	PROPN
iajs-3765	288	11	vn	vn	NOUN
iajs-3765	288	12	,	,	PUNCT
iajs-3765	288	13	redwan	redwan	VERB
iajs-3765	288	14	em	em	PRON
iajs-3765	288	15	.	.	PUNCT
iajs-3765	289	1	circulating	circulate	VERB
iajs-3765	289	2	extracellular	extracellular	ADJ
iajs-3765	289	3	vesicles	vesicle	NOUN
iajs-3765	289	4	and	and	CCONJ
iajs-3765	289	5	rheumatoid	rheumatoid	VERB
iajs-3765	289	6	arthritis	arthritis	NOUN
iajs-3765	289	7	:	:	PUNCT
iajs-3765	289	8	a	a	DET
iajs-3765	289	9	proteomic	proteomic	ADJ
iajs-3765	289	10	analysis	analysis	NOUN
iajs-3765	289	11	.	.	PUNCT
iajs-3765	290	1	cell	cell	NOUN
iajs-3765	290	2	mol	mol	ADP
iajs-3765	290	3	life	life	PROPN
iajs-3765	290	4	sci	sci	PROPN
iajs-3765	290	5	.	.	PROPN
iajs-3765	290	6	2022	2022	NUM
iajs-3765	290	7	;	;	PUNCT
iajs-3765	290	8	79(1):25	79(1):25	NUM
iajs-3765	290	9	.	.	PUNCT
iajs-3765	290	10	https://doi.org/10.1007/s00018-021-04020-4	https://doi.org/10.1007/s00018-021-04020-4	NUM
iajs-3765	290	11	.	.	PROPN
iajs-3765	290	12	31	31	NUM
iajs-3765	290	13	.	.	PUNCT
iajs-3765	291	1	jabbar	jabbar	PROPN
iajs-3765	291	2	eak	eak	PROPN
iajs-3765	291	3	,	,	PUNCT
iajs-3765	291	4	al	al	PROPN
iajs-3765	291	5	-	-	PUNCT
iajs-3765	291	6	rumaidh	rumaidh	PROPN
iajs-3765	291	7	sz	sz	NOUN
iajs-3765	291	8	,	,	PUNCT
iajs-3765	291	9	jouda	jouda	PROPN
iajs-3765	291	10	j.	j.	PROPN
iajs-3765	291	11	estimation	estimation	NOUN
iajs-3765	291	12	of	of	ADP
iajs-3765	291	13	some	some	DET
iajs-3765	291	14	biomarkers	biomarker	NOUN
iajs-3765	291	15	and	and	CCONJ
iajs-3765	291	16	cholesterol	cholesterol	NOUN
iajs-3765	291	17	/	/	SYM
iajs-3765	291	18	hdl	hdl	PROPN
iajs-3765	291	19	ratio	ratio	NOUN
iajs-3765	291	20	to	to	PART
iajs-3765	291	21	predict	predict	VERB
iajs-3765	291	22	the	the	DET
iajs-3765	291	23	risk	risk	NOUN
iajs-3765	291	24	of	of	ADP
iajs-3765	291	25	cardiovascular	cardiovascular	ADJ
iajs-3765	291	26	disease	disease	NOUN
iajs-3765	291	27	in	in	ADP
iajs-3765	291	28	rheumatoid	rheumatoid	NOUN
iajs-3765	291	29	arthritis	arthritis	NOUN
iajs-3765	291	30	.	.	PUNCT
iajs-3765	292	1	ibn	ibn	PROPN
iajs-3765	292	2	al	al	PROPN
iajs-3765	292	3	-	-	PUNCT
iajs-3765	292	4	haitham	haitham	PROPN
iajs-3765	292	5	j	j	PROPN
iajs-3765	292	6	pure	pure	PROPN
iajs-3765	292	7	appl	appl	PROPN
iajs-3765	292	8	sci	sci	PROPN
iajs-3765	292	9	.	.	PROPN
iajs-3765	292	10	2021	2021	NUM
iajs-3765	292	11	;	;	PUNCT
iajs-3765	292	12	2021:23–28	2021:23–28	NUM
iajs-3765	292	13	.	.	PUNCT
iajs-3765	293	1	https://doi.org/10.30526/2021.ihicpas.2646	https://doi.org/10.30526/2021.ihicpas.2646	PROPN
iajs-3765	293	2	.	.	PROPN
iajs-3765	294	1	32	32	NUM
iajs-3765	294	2	.	.	PUNCT
iajs-3765	295	1	dursunoğlu	dursunoğlu	PROPN
iajs-3765	295	2	d	d	PROPN
iajs-3765	295	3	,	,	PUNCT
iajs-3765	295	4	evrengül	evrengül	NOUN
iajs-3765	295	5	h	h	PROPN
iajs-3765	295	6	,	,	PUNCT
iajs-3765	295	7	polat	polat	PROPN
iajs-3765	295	8	b	b	PROPN
iajs-3765	295	9	,	,	PUNCT
iajs-3765	295	10	tanriverdi	tanriverdi	PROPN
iajs-3765	295	11	h	h	NOUN
iajs-3765	295	12	,	,	PUNCT
iajs-3765	295	13	cobankara	cobankara	ADJ
iajs-3765	295	14	v	v	NOUN
iajs-3765	295	15	,	,	PUNCT
iajs-3765	295	16	kaftan	kaftan	PROPN
iajs-3765	295	17	a	a	PROPN
iajs-3765	295	18	,	,	PUNCT
iajs-3765	295	19	kiliç	kiliç	PROPN
iajs-3765	295	20	m.	m.	NOUN
iajs-3765	295	21	lp(a	lp(a	NOUN
iajs-3765	295	22	)	)	PUNCT
iajs-3765	295	23	lipoprotein	lipoprotein	NOUN
iajs-3765	295	24	and	and	CCONJ
iajs-3765	295	25	lipids	lipid	NOUN
iajs-3765	295	26	in	in	ADP
iajs-3765	295	27	patients	patient	NOUN
iajs-3765	295	28	with	with	ADP
iajs-3765	295	29	rheumatoid	rheumatoid	NOUN
iajs-3765	295	30	arthritis	arthritis	NOUN
iajs-3765	295	31	:	:	PUNCT
iajs-3765	295	32	serum	serum	NOUN
iajs-3765	295	33	levels	level	NOUN
iajs-3765	295	34	and	and	CCONJ
iajs-3765	295	35	relationship	relationship	NOUN
iajs-3765	295	36	to	to	ADP
iajs-3765	295	37	inflammation	inflammation	NOUN
iajs-3765	295	38	.	.	PUNCT
iajs-3765	296	1	rheumatol	rheumatol	PROPN
iajs-3765	296	2	int	int	PROPN
iajs-3765	296	3	.	.	PUNCT
iajs-3765	297	1	2005	2005	NUM
iajs-3765	297	2	;	;	PUNCT
iajs-3765	297	3	25(4):241–245	25(4):241–245	NUM
iajs-3765	297	4	.	.	PUNCT
iajs-3765	298	1	https://doi.org/10.1007/s00296-004-0438-0	https://doi.org/10.1007/s00296-004-0438-0	NUM
iajs-3765	298	2	.	.	PUNCT
iajs-3765	299	1	33	33	NUM
iajs-3765	299	2	.	.	PUNCT
iajs-3765	299	3	oleiwi	oleiwi	PROPN
iajs-3765	299	4	ar	ar	PROPN
iajs-3765	299	5	,	,	PUNCT
iajs-3765	299	6	zgair	zgair	PROPN
iajs-3765	299	7	ak	ak	PROPN
iajs-3765	299	8	.	.	PROPN
iajs-3765	299	9	estimation	estimation	NOUN
iajs-3765	299	10	levels	level	NOUN
iajs-3765	299	11	of	of	ADP
iajs-3765	299	12	cthrc1	cthrc1	PROPN
iajs-3765	299	13	and	and	CCONJ
iajs-3765	299	14	some	some	DET
iajs-3765	299	15	cytokines	cytokine	NOUN
iajs-3765	299	16	in	in	ADP
iajs-3765	299	17	iraqi	iraqi	ADJ
iajs-3765	299	18	patients	patient	NOUN
iajs-3765	299	19	with	with	ADP
iajs-3765	299	20	rheumatoid	rheumatoid	NOUN
iajs-3765	299	21	arthritis	arthritis	NOUN
iajs-3765	299	22	.	.	PUNCT
iajs-3765	300	1	baghdad	baghdad	PROPN
iajs-3765	300	2	sci	sci	PROPN
iajs-3765	300	3	j.	j.	PROPN
iajs-3765	300	4	2023	2023	NUM
iajs-3765	300	5	;	;	PUNCT
iajs-3765	300	6	20(3):928–936	20(3):928–936	X
iajs-3765	300	7	.	.	PUNCT
iajs-3765	300	8	https://doi.org/10.21123/bsj.2023.8036	https://doi.org/10.21123/bsj.2023.8036	PROPN
iajs-3765	300	9	.	.	PUNCT
iajs-3765	301	1	34	34	NUM
iajs-3765	301	2	.	.	PUNCT
iajs-3765	302	1	khadim	khadim	PROPN
iajs-3765	302	2	rm	rm	PROPN
iajs-3765	302	3	,	,	PUNCT
iajs-3765	302	4	al	al	PROPN
iajs-3765	302	5	-	-	PUNCT
iajs-3765	302	6	fartusie	fartusie	ADJ
iajs-3765	302	7	fs	fs	PROPN
iajs-3765	302	8	.	.	PROPN
iajs-3765	302	9	evaluation	evaluation	NOUN
iajs-3765	302	10	of	of	ADP
iajs-3765	302	11	liver	liver	NOUN
iajs-3765	302	12	function	function	NOUN
iajs-3765	302	13	and	and	CCONJ
iajs-3765	302	14	lipid	lipid	NOUN
iajs-3765	302	15	profiles	profile	NOUN
iajs-3765	302	16	in	in	ADP
iajs-3765	302	17	iraqi	iraqi	ADJ
iajs-3765	302	18	patients	patient	NOUN
iajs-3765	302	19	with	with	ADP
iajs-3765	302	20	rheumatoid	rheumatoid	NOUN
iajs-3765	302	21	arthritis	arthritis	NOUN
iajs-3765	302	22	.	.	PUNCT
iajs-3765	303	1	j	j	PROPN
iajs-3765	303	2	phys	phys	PROPN
iajs-3765	303	3	conf	conf	NOUN
iajs-3765	303	4	ser	ser	NOUN
iajs-3765	303	5	.	.	PROPN
iajs-3765	303	6	2021	2021	NUM
iajs-3765	303	7	;	;	PUNCT
iajs-3765	303	8	1853:1	1853:1	NUM
iajs-3765	303	9	-	-	SYM
iajs-3765	303	10	11	11	NUM
iajs-3765	303	11	.	.	PUNCT
iajs-3765	304	1	https://doi.org/10.1088/17426596/1853/1/012040	https://doi.org/10.1088/17426596/1853/1/012040	NOUN
iajs-3765	304	2	.	.	PUNCT
iajs-3765	305	1	https://doi.org/10.1155/2020/7150605	https://doi.org/10.1155/2020/7150605	PROPN
iajs-3765	305	2	https://doi.org/10.4103/jewd.jewd_5_23	https://doi.org/10.4103/jewd.jewd_5_23	PROPN
iajs-3765	305	3	https://doi.org/10.1089/gtmb.2011.0003	https://doi.org/10.1089/gtmb.2011.0003	PROPN
iajs-3765	305	4	https://doi.org/10.1016/j.atherosclerosis.2022.11.006	https://doi.org/10.1016/j.atherosclerosis.2022.11.006	X
iajs-3765	305	5	https://doi.org/10.1007/s00018-021-04020-4	https://doi.org/10.1007/s00018-021-04020-4	NUM
iajs-3765	305	6	https://doi.org/10.30526/2021.ihicpas.2646	https://doi.org/10.30526/2021.ihicpas.2646	NOUN
iajs-3765	305	7	https://doi.org/10.1007/s00296-004-0438-0	https://doi.org/10.1007/s00296-004-0438-0	NUM
iajs-3765	305	8	https://doi.org/10.21123/bsj.2023.8036	https://doi.org/10.21123/bsj.2023.8036	NOUN
iajs-3765	305	9	https://doi.org/10.1088/1742-6596/1853/1/012040	https://doi.org/10.1088/1742-6596/1853/1/012040	PUNCT
iajs-3765	306	1	https://doi.org/10.1088/1742-6596/1853/1/012040	https://doi.org/10.1088/1742-6596/1853/1/012040	NOUN